id	sid	tid	token	lemma	pos
dpc-3653	1	1	dermatology	dermatology	NOUN
dpc-3653	1	2	:	:	PUNCT
dpc-3653	1	3	practical	practical	ADJ
dpc-3653	1	4	and	and	CCONJ
dpc-3653	1	5	conceptual	conceptual	ADJ
dpc-3653	1	6	original	original	ADJ
dpc-3653	1	7	article	article	NOUN
dpc-3653	1	8	|	|	ADV
dpc-3653	1	9	dermatol	dermatol	ADJ
dpc-3653	1	10	pract	pract	NOUN
dpc-3653	1	11	concept	concept	NOUN
dpc-3653	1	12	.	.	PUNCT
dpc-3653	2	1	2024;14(2):e2024066	2024;14(2):e2024066	NUM
dpc-3653	2	2	1	1	NUM
dpc-3653	2	3	intralesional	intralesional	ADJ
dpc-3653	2	4	quadrivalent	quadrivalent	NOUN
dpc-3653	2	5	human	human	ADJ
dpc-3653	2	6	papilloma	papilloma	NOUN
dpc-3653	2	7	virus	virus	NOUN
dpc-3653	2	8	vaccine	vaccine	NOUN
dpc-3653	2	9	versus	versus	ADP
dpc-3653	2	10	candida	candida	PROPN
dpc-3653	2	11	antigen	antigen	ADV
dpc-3653	2	12	in	in	ADP
dpc-3653	2	13	the	the	DET
dpc-3653	2	14	treatment	treatment	NOUN
dpc-3653	2	15	of	of	ADP
dpc-3653	2	16	 	 	SPACE
dpc-3653	2	17	multiple	multiple	ADJ
dpc-3653	2	18	recalcitrant	recalcitrant	ADJ
dpc-3653	2	19	non	non	ADJ
dpc-3653	2	20	-	-	ADJ
dpc-3653	2	21	genital	genital	ADJ
dpc-3653	2	22	warts	wart	NOUN
dpc-3653	2	23	ibrahim	ibrahim	PROPN
dpc-3653	2	24	fouda1	fouda1	PROPN
dpc-3653	2	25	,	,	PUNCT
dpc-3653	2	26	hassan	hassan	PROPN
dpc-3653	2	27	abou	abou	PROPN
dpc-3653	2	28	khodair	khodair	PROPN
dpc-3653	2	29	mohammed1	mohammed1	PROPN
dpc-3653	2	30	,	,	PUNCT
dpc-3653	2	31	ghada	ghada	PROPN
dpc-3653	2	32	mohammed	mohammed	PROPN
dpc-3653	2	33	yousef	yousef	PROPN
dpc-3653	2	34	mohammed2	mohammed2	NOUN
dpc-3653	2	35	1	1	NUM
dpc-3653	2	36	dermatology	dermatology	NOUN
dpc-3653	2	37	,	,	PUNCT
dpc-3653	2	38	venereology	venereology	NOUN
dpc-3653	2	39	and	and	CCONJ
dpc-3653	2	40	andrology	andrology	PROPN
dpc-3653	2	41	department	department	PROPN
dpc-3653	2	42	,	,	PUNCT
dpc-3653	2	43	damietta	damietta	PROPN
dpc-3653	2	44	faculty	faculty	NOUN
dpc-3653	2	45	of	of	ADP
dpc-3653	2	46	medicine	medicine	NOUN
dpc-3653	2	47	,	,	PUNCT
dpc-3653	2	48	al	al	PROPN
dpc-3653	2	49	-	-	PUNCT
dpc-3653	2	50	azhar	azhar	PROPN
dpc-3653	2	51	university	university	PROPN
dpc-3653	2	52	,	,	PUNCT
dpc-3653	2	53	egypt	egypt	PROPN
dpc-3653	2	54	2	2	NUM
dpc-3653	2	55	dermatology	dermatology	NOUN
dpc-3653	2	56	and	and	CCONJ
dpc-3653	2	57	venereology	venereology	NOUN
dpc-3653	2	58	department	department	NOUN
dpc-3653	2	59	,	,	PUNCT
dpc-3653	2	60	talkha	talkha	ADJ
dpc-3653	2	61	central	central	ADJ
dpc-3653	2	62	hospital	hospital	NOUN
dpc-3653	2	63	,	,	PUNCT
dpc-3653	2	64	dakahlia	dakahlia	PROPN
dpc-3653	2	65	,	,	PUNCT
dpc-3653	2	66	egypt	egypt	PROPN
dpc-3653	2	67	key	key	ADJ
dpc-3653	2	68	words	word	NOUN
dpc-3653	2	69	:	:	PUNCT
dpc-3653	2	70	warts	wart	NOUN
dpc-3653	2	71	,	,	PUNCT
dpc-3653	2	72	non	non	ADJ
dpc-3653	2	73	-	-	ADJ
dpc-3653	2	74	genital	genital	ADJ
dpc-3653	2	75	,	,	PUNCT
dpc-3653	2	76	recalcitrant	recalcitrant	ADJ
dpc-3653	2	77	,	,	PUNCT
dpc-3653	2	78	human	human	ADJ
dpc-3653	2	79	papillomavirus	papillomavirus	NOUN
dpc-3653	2	80	vaccine	vaccine	NOUN
dpc-3653	2	81	,	,	PUNCT
dpc-3653	2	82	candida	candida	PROPN
dpc-3653	2	83	antigen	antigen	NOUN
dpc-3653	2	84	citation	citation	NOUN
dpc-3653	2	85	:	:	PUNCT
dpc-3653	2	86	fouda	fouda	PROPN
dpc-3653	2	87	i	i	PROPN
dpc-3653	2	88	,	,	PUNCT
dpc-3653	2	89	mohammed	mohammed	PROPN
dpc-3653	2	90	hak	hak	PROPN
dpc-3653	2	91	,	,	PUNCT
dpc-3653	3	1	mohammed	mohammed	PROPN
dpc-3653	3	2	gmy	gmy	PROPN
dpc-3653	3	3	.	.	PUNCT
dpc-3653	3	4	intralesional	intralesional	ADJ
dpc-3653	3	5	quadrivalent	quadrivalent	NOUN
dpc-3653	3	6	human	human	ADJ
dpc-3653	3	7	papillomavirus	papillomavirus	NOUN
dpc-3653	3	8	(	(	PUNCT
dpc-3653	3	9	hpv	hpv	NOUN
dpc-3653	3	10	)	)	PUNCT
dpc-3653	3	11	vaccine	vaccine	NOUN
dpc-3653	3	12	versus	versus	ADP
dpc-3653	3	13	candida	candida	PROPN
dpc-3653	3	14	antigen	antigen	ADV
dpc-3653	3	15	in	in	ADP
dpc-3653	3	16	the	the	DET
dpc-3653	3	17	treatment	treatment	NOUN
dpc-3653	3	18	of	of	ADP
dpc-3653	3	19	multiple	multiple	ADJ
dpc-3653	3	20	recalcitrant	recalcitrant	ADJ
dpc-3653	3	21	non	non	ADJ
dpc-3653	3	22	-	-	ADJ
dpc-3653	3	23	genital	genital	ADJ
dpc-3653	3	24	warts	wart	NOUN
dpc-3653	3	25	.	.	PUNCT
dpc-3653	4	1	dermatol	dermatol	NOUN
dpc-3653	4	2	pract	pract	PROPN
dpc-3653	4	3	concept	concept	NOUN
dpc-3653	4	4	.	.	PUNCT
dpc-3653	5	1	2024;14(2):e2024066	2024;14(2):e2024066	X
dpc-3653	5	2	.	.	PUNCT
dpc-3653	5	3	doi	doi	NOUN
dpc-3653	5	4	:	:	PUNCT
dpc-3653	5	5	https://doi.org/10.5826/dpc.1402a66	https://doi.org/10.5826/dpc.1402a66	PROPN
dpc-3653	5	6	accepted	accept	VERB
dpc-3653	5	7	:	:	PUNCT
dpc-3653	5	8	october	october	PROPN
dpc-3653	5	9	2	2	NUM
dpc-3653	5	10	,	,	PUNCT
dpc-3653	5	11	2023	2023	NUM
dpc-3653	5	12	;	;	PUNCT
dpc-3653	5	13	published	publish	VERB
dpc-3653	5	14	:	:	PUNCT
dpc-3653	6	1	april	april	PROPN
dpc-3653	6	2	2024	2024	NUM
dpc-3653	6	3	copyright	copyright	NOUN
dpc-3653	6	4	:	:	PUNCT
dpc-3653	6	5	©	©	PROPN
dpc-3653	6	6	2024	2024	NUM
dpc-3653	6	7	fouda	fouda	NOUN
dpc-3653	6	8	et	et	PROPN
dpc-3653	6	9	al	al	PROPN
dpc-3653	6	10	.	.	PUNCT
dpc-3653	7	1	this	this	PRON
dpc-3653	7	2	is	be	AUX
dpc-3653	7	3	an	an	DET
dpc-3653	7	4	open	open	ADJ
dpc-3653	7	5	-	-	PUNCT
dpc-3653	7	6	access	access	NOUN
dpc-3653	7	7	article	article	NOUN
dpc-3653	7	8	distributed	distribute	VERB
dpc-3653	7	9	under	under	ADP
dpc-3653	7	10	the	the	DET
dpc-3653	7	11	terms	term	NOUN
dpc-3653	7	12	of	of	ADP
dpc-3653	7	13	the	the	DET
dpc-3653	7	14	creative	creative	ADJ
dpc-3653	7	15	commons	common	NOUN
dpc-3653	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-3653	7	17	license	license	NOUN
dpc-3653	7	18	(	(	PUNCT
dpc-3653	7	19	by	by	ADP
dpc-3653	7	20	-	-	PUNCT
dpc-3653	7	21	nc-4.0	nc-4.0	NOUN
dpc-3653	7	22	)	)	PUNCT
dpc-3653	7	23	,	,	PUNCT
dpc-3653	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3653	7	25	,	,	PUNCT
dpc-3653	7	26	which	which	PRON
dpc-3653	7	27	permits	permit	VERB
dpc-3653	7	28	unrestricted	unrestricted	ADJ
dpc-3653	7	29	noncommercial	noncommercial	ADJ
dpc-3653	7	30	use	use	NOUN
dpc-3653	7	31	,	,	PUNCT
dpc-3653	7	32	distribution	distribution	NOUN
dpc-3653	7	33	,	,	PUNCT
dpc-3653	7	34	and	and	CCONJ
dpc-3653	7	35	reproduction	reproduction	NOUN
dpc-3653	7	36	in	in	ADP
dpc-3653	7	37	any	any	DET
dpc-3653	7	38	medium	medium	NOUN
dpc-3653	7	39	,	,	PUNCT
dpc-3653	7	40	provided	provide	VERB
dpc-3653	7	41	the	the	DET
dpc-3653	7	42	original	original	ADJ
dpc-3653	7	43	authors	author	NOUN
dpc-3653	7	44	and	and	CCONJ
dpc-3653	7	45	source	source	NOUN
dpc-3653	7	46	are	be	AUX
dpc-3653	7	47	credited	credit	VERB
dpc-3653	7	48	.	.	PUNCT
dpc-3653	8	1	funding	funding	NOUN
dpc-3653	8	2	:	:	PUNCT
dpc-3653	8	3	none	none	NOUN
dpc-3653	8	4	.	.	PUNCT
dpc-3653	9	1	competing	compete	VERB
dpc-3653	9	2	interests	interest	NOUN
dpc-3653	9	3	:	:	PUNCT
dpc-3653	9	4	none	none	NOUN
dpc-3653	9	5	.	.	PUNCT
dpc-3653	10	1	authorship	authorship	NOUN
dpc-3653	10	2	:	:	PUNCT
dpc-3653	10	3	all	all	DET
dpc-3653	10	4	authors	author	NOUN
dpc-3653	10	5	have	have	AUX
dpc-3653	10	6	contributed	contribute	VERB
dpc-3653	10	7	significantly	significantly	ADV
dpc-3653	10	8	to	to	ADP
dpc-3653	10	9	this	this	DET
dpc-3653	10	10	publication	publication	NOUN
dpc-3653	10	11	.	.	PUNCT
dpc-3653	11	1	corresponding	correspond	VERB
dpc-3653	11	2	author	author	NOUN
dpc-3653	11	3	:	:	PUNCT
dpc-3653	11	4	ibrahim	ibrahim	PROPN
dpc-3653	11	5	fouda	fouda	PROPN
dpc-3653	11	6	,	,	PUNCT
dpc-3653	11	7	dermatology	dermatology	NOUN
dpc-3653	11	8	,	,	PUNCT
dpc-3653	11	9	venereology	venereology	NOUN
dpc-3653	11	10	and	and	CCONJ
dpc-3653	11	11	andrology	andrology	PROPN
dpc-3653	11	12	department	department	PROPN
dpc-3653	11	13	,	,	PUNCT
dpc-3653	11	14	damietta	damietta	PROPN
dpc-3653	11	15	faculty	faculty	NOUN
dpc-3653	11	16	of	of	ADP
dpc-3653	11	17	medicine	medicine	NOUN
dpc-3653	11	18	,	,	PUNCT
dpc-3653	11	19	al	al	PROPN
dpc-3653	11	20	-	-	PUNCT
dpc-3653	11	21	azhar	azhar	PROPN
dpc-3653	11	22	university	university	PROPN
dpc-3653	11	23	,	,	PUNCT
dpc-3653	11	24	egypt	egypt	PROPN
dpc-3653	11	25	.	.	PUNCT
dpc-3653	12	1	email	email	NOUN
dpc-3653	12	2	:	:	PUNCT
dpc-3653	12	3	ifouda77@gmail.com	ifouda77@gmail.com	X
dpc-3653	12	4	introduction	introduction	NOUN
dpc-3653	12	5	:	:	PUNCT
dpc-3653	12	6	warts	wart	NOUN
dpc-3653	12	7	are	be	AUX
dpc-3653	12	8	the	the	DET
dpc-3653	12	9	most	most	ADV
dpc-3653	12	10	prevalent	prevalent	ADJ
dpc-3653	12	11	clinical	clinical	ADJ
dpc-3653	12	12	manifestation	manifestation	NOUN
dpc-3653	12	13	of	of	ADP
dpc-3653	12	14	human	human	ADJ
dpc-3653	12	15	papilloma	papilloma	PROPN
dpc-3653	12	16	virus	virus	NOUN
dpc-3653	12	17	(	(	PUNCT
dpc-3653	12	18	hpv	hpv	NOUN
dpc-3653	12	19	)	)	PUNCT
dpc-3653	12	20	infections	infection	NOUN
dpc-3653	12	21	,	,	PUNCT
dpc-3653	12	22	which	which	PRON
dpc-3653	12	23	vary	vary	VERB
dpc-3653	12	24	in	in	ADP
dpc-3653	12	25	morphological	morphological	ADJ
dpc-3653	12	26	pattern	pattern	NOUN
dpc-3653	12	27	depending	depend	VERB
dpc-3653	12	28	on	on	ADP
dpc-3653	12	29	the	the	DET
dpc-3653	12	30	site	site	NOUN
dpc-3653	12	31	of	of	ADP
dpc-3653	12	32	the	the	DET
dpc-3653	12	33	body	body	NOUN
dpc-3653	12	34	affected	affect	VERB
dpc-3653	12	35	.	.	PUNCT
dpc-3653	13	1	objectives	objective	NOUN
dpc-3653	13	2	:	:	PUNCT
dpc-3653	13	3	to	to	PART
dpc-3653	13	4	evaluate	evaluate	VERB
dpc-3653	13	5	the	the	DET
dpc-3653	13	6	safety	safety	NOUN
dpc-3653	13	7	and	and	CCONJ
dpc-3653	13	8	efficacy	efficacy	NOUN
dpc-3653	13	9	of	of	ADP
dpc-3653	13	10	intralesional	intralesional	ADJ
dpc-3653	13	11	quadrivalent	quadrivalent	NOUN
dpc-3653	13	12	hpv	hpv	NOUN
dpc-3653	13	13	vaccine	vaccine	NOUN
dpc-3653	13	14	versus	versus	ADP
dpc-3653	13	15	candida	candida	PROPN
dpc-3653	13	16	antigen	antigen	ADV
dpc-3653	13	17	in	in	ADP
dpc-3653	13	18	treatment	treatment	NOUN
dpc-3653	13	19	of	of	ADP
dpc-3653	13	20	multiple	multiple	ADJ
dpc-3653	13	21	recalcitrant	recalcitrant	ADJ
dpc-3653	13	22	non	non	ADJ
dpc-3653	13	23	-	-	ADJ
dpc-3653	13	24	genital	genital	ADJ
dpc-3653	13	25	warts	wart	NOUN
dpc-3653	13	26	.	.	PUNCT
dpc-3653	14	1	methods	method	NOUN
dpc-3653	14	2	:	:	PUNCT
dpc-3653	14	3	a	a	DET
dpc-3653	14	4	randomizedcontrol	randomizedcontrol	NOUN
dpc-3653	14	5	clinical	clinical	ADJ
dpc-3653	14	6	trial	trial	NOUN
dpc-3653	14	7	included	include	VERB
dpc-3653	14	8	60	60	NUM
dpc-3653	14	9	cases	case	NOUN
dpc-3653	14	10	with	with	ADP
dpc-3653	14	11	multiple	multiple	ADJ
dpc-3653	14	12	recalcitrant	recalcitrant	ADJ
dpc-3653	14	13	warts	wart	NOUN
dpc-3653	14	14	who	who	PRON
dpc-3653	14	15	were	be	AUX
dpc-3653	14	16	randomly	randomly	ADV
dpc-3653	14	17	distributed	distribute	VERB
dpc-3653	14	18	into	into	ADP
dpc-3653	14	19	three	three	NUM
dpc-3653	14	20	groups	group	NOUN
dpc-3653	14	21	;	;	PUNCT
dpc-3653	14	22	group	group	NOUN
dpc-3653	14	23	i	i	PRON
dpc-3653	14	24	included	include	VERB
dpc-3653	14	25	20	20	NUM
dpc-3653	14	26	patients	patient	NOUN
dpc-3653	14	27	who	who	PRON
dpc-3653	14	28	received	receive	VERB
dpc-3653	14	29	intralesional	intralesional	ADJ
dpc-3653	14	30	candida	candida	NOUN
dpc-3653	14	31	antigen	antigen	NOUN
dpc-3653	14	32	at	at	ADP
dpc-3653	14	33	a	a	DET
dpc-3653	14	34	dose	dose	NOUN
dpc-3653	14	35	of	of	ADP
dpc-3653	14	36	0.3	0.3	NUM
dpc-3653	14	37	ml	ml	NOUN
dpc-3653	14	38	of	of	ADP
dpc-3653	14	39	1/1000	1/1000	NUM
dpc-3653	14	40	solution	solution	NOUN
dpc-3653	14	41	,	,	PUNCT
dpc-3653	14	42	group	group	NOUN
dpc-3653	14	43	ii	ii	PROPN
dpc-3653	14	44	included	include	VERB
dpc-3653	14	45	20	20	NUM
dpc-3653	14	46	patients	patient	NOUN
dpc-3653	14	47	who	who	PRON
dpc-3653	14	48	received	receive	VERB
dpc-3653	14	49	intralesional	intralesional	ADJ
dpc-3653	14	50	quadrivalent	quadrivalent	NOUN
dpc-3653	14	51	hpv	hpv	NOUN
dpc-3653	14	52	vaccine	vaccine	NOUN
dpc-3653	14	53	at	at	ADP
dpc-3653	14	54	a	a	DET
dpc-3653	14	55	dose	dose	NOUN
dpc-3653	14	56	of	of	ADP
dpc-3653	14	57	0.3ml	0.3ml	NUM
dpc-3653	14	58	and	and	CCONJ
dpc-3653	14	59	group	group	PROPN
dpc-3653	14	60	iii	iii	PROPN
dpc-3653	14	61	included	include	VERB
dpc-3653	14	62	20	20	NUM
dpc-3653	14	63	patients	patient	NOUN
dpc-3653	14	64	who	who	PRON
dpc-3653	14	65	received	receive	VERB
dpc-3653	14	66	intralesional	intralesional	ADJ
dpc-3653	14	67	injection	injection	NOUN
dpc-3653	14	68	0.3	0.3	NUM
dpc-3653	14	69	ml	ml	NOUN
dpc-3653	14	70	of	of	ADP
dpc-3653	14	71	normal	normal	ADJ
dpc-3653	14	72	saline	saline	NOUN
dpc-3653	14	73	0.9	0.9	NUM
dpc-3653	14	74	%	%	NOUN
dpc-3653	14	75	as	as	ADP
dpc-3653	14	76	a	a	DET
dpc-3653	14	77	control	control	NOUN
dpc-3653	14	78	group	group	NOUN
dpc-3653	14	79	)	)	PUNCT
dpc-3653	14	80	.	.	PUNCT
dpc-3653	15	1	each	each	DET
dpc-3653	15	2	agent	agent	NOUN
dpc-3653	15	3	was	be	AUX
dpc-3653	15	4	injected	inject	VERB
dpc-3653	15	5	at	at	ADP
dpc-3653	15	6	the	the	DET
dpc-3653	15	7	base	base	NOUN
dpc-3653	15	8	of	of	ADP
dpc-3653	15	9	the	the	DET
dpc-3653	15	10	largest	large	ADJ
dpc-3653	15	11	wart	wart	NOUN
dpc-3653	15	12	every	every	DET
dpc-3653	15	13	three	three	NUM
dpc-3653	15	14	weeks	week	NOUN
dpc-3653	15	15	until	until	SCONJ
dpc-3653	15	16	it	it	PRON
dpc-3653	15	17	was	be	AUX
dpc-3653	15	18	completely	completely	ADV
dpc-3653	15	19	cleared	clear	VERB
dpc-3653	15	20	,	,	PUNCT
dpc-3653	15	21	or	or	CCONJ
dpc-3653	15	22	for	for	ADP
dpc-3653	15	23	a	a	DET
dpc-3653	15	24	total	total	NOUN
dpc-3653	15	25	of	of	ADP
dpc-3653	15	26	four	four	NUM
dpc-3653	15	27	sessions	session	NOUN
dpc-3653	15	28	.	.	PUNCT
dpc-3653	16	1	results	result	NOUN
dpc-3653	16	2	:	:	PUNCT
dpc-3653	16	3	the	the	DET
dpc-3653	16	4	highest	high	ADJ
dpc-3653	16	5	response	response	NOUN
dpc-3653	16	6	rate	rate	NOUN
dpc-3653	16	7	was	be	AUX
dpc-3653	16	8	detected	detect	VERB
dpc-3653	16	9	in	in	ADP
dpc-3653	16	10	the	the	DET
dpc-3653	16	11	quadrivalent	quadrivalent	NOUN
dpc-3653	16	12	hpv	hpv	PROPN
dpc-3653	16	13	vaccine	vaccine	NOUN
dpc-3653	16	14	group	group	NOUN
dpc-3653	16	15	(	(	PUNCT
dpc-3653	16	16	75	75	NUM
dpc-3653	16	17	%	%	NOUN
dpc-3653	16	18	complete	complete	ADJ
dpc-3653	16	19	response	response	NOUN
dpc-3653	16	20	)	)	PUNCT
dpc-3653	16	21	followed	follow	VERB
dpc-3653	16	22	by	by	ADP
dpc-3653	16	23	the	the	DET
dpc-3653	16	24	candida	candida	PROPN
dpc-3653	16	25	vaccine	vaccine	NOUN
dpc-3653	16	26	group	group	NOUN
dpc-3653	16	27	(	(	PUNCT
dpc-3653	16	28	40	40	NUM
dpc-3653	16	29	%	%	NOUN
dpc-3653	16	30	complete	complete	ADJ
dpc-3653	16	31	response	response	NOUN
dpc-3653	16	32	and	and	CCONJ
dpc-3653	16	33	15	15	NUM
dpc-3653	16	34	%	%	NOUN
dpc-3653	16	35	partial	partial	ADJ
dpc-3653	16	36	response	response	NOUN
dpc-3653	16	37	)	)	PUNCT
dpc-3653	16	38	.	.	PUNCT
dpc-3653	17	1	also	also	ADV
dpc-3653	17	2	,	,	PUNCT
dpc-3653	17	3	regarding	regard	VERB
dpc-3653	17	4	the	the	DET
dpc-3653	17	5	distant	distant	ADJ
dpc-3653	17	6	response	response	NOUN
dpc-3653	17	7	rate	rate	NOUN
dpc-3653	17	8	,	,	PUNCT
dpc-3653	17	9	the	the	DET
dpc-3653	17	10	highest	high	ADJ
dpc-3653	17	11	response	response	NOUN
dpc-3653	17	12	rate	rate	NOUN
dpc-3653	17	13	was	be	AUX
dpc-3653	17	14	detected	detect	VERB
dpc-3653	17	15	in	in	ADP
dpc-3653	17	16	the	the	DET
dpc-3653	17	17	quadrivalent	quadrivalent	NOUN
dpc-3653	17	18	hpv	hpv	PROPN
dpc-3653	17	19	vaccine	vaccine	NOUN
dpc-3653	17	20	group	group	NOUN
dpc-3653	17	21	(	(	PUNCT
dpc-3653	17	22	72.7	72.7	NUM
dpc-3653	17	23	%	%	NOUN
dpc-3653	17	24	complete	complete	ADJ
dpc-3653	17	25	response	response	NOUN
dpc-3653	17	26	and	and	CCONJ
dpc-3653	17	27	27.3	27.3	NUM
dpc-3653	17	28	%	%	NOUN
dpc-3653	17	29	partial	partial	ADJ
dpc-3653	17	30	response	response	NOUN
dpc-3653	17	31	)	)	PUNCT
dpc-3653	17	32	followed	follow	VERB
dpc-3653	17	33	by	by	ADP
dpc-3653	17	34	the	the	DET
dpc-3653	17	35	candida	candida	PROPN
dpc-3653	17	36	vaccine	vaccine	NOUN
dpc-3653	17	37	group	group	NOUN
dpc-3653	17	38	(	(	PUNCT
dpc-3653	17	39	33.3	33.3	NUM
dpc-3653	17	40	%	%	NOUN
dpc-3653	17	41	complete	complete	ADJ
dpc-3653	17	42	response	response	NOUN
dpc-3653	17	43	and	and	CCONJ
dpc-3653	17	44	50	50	NUM
dpc-3653	17	45	%	%	NOUN
dpc-3653	17	46	partial	partial	ADJ
dpc-3653	17	47	response	response	NOUN
dpc-3653	17	48	)	)	PUNCT
dpc-3653	17	49	.	.	PUNCT
dpc-3653	18	1	conclusions	conclusion	NOUN
dpc-3653	18	2	:	:	PUNCT
dpc-3653	18	3	intralesional	intralesional	ADJ
dpc-3653	18	4	immunotherapy	immunotherapy	NOUN
dpc-3653	18	5	appears	appear	VERB
dpc-3653	18	6	to	to	PART
dpc-3653	18	7	be	be	AUX
dpc-3653	18	8	effective	effective	ADJ
dpc-3653	18	9	and	and	CCONJ
dpc-3653	18	10	safe	safe	ADJ
dpc-3653	18	11	in	in	ADP
dpc-3653	18	12	treating	treat	VERB
dpc-3653	18	13	multiple	multiple	ADJ
dpc-3653	18	14	recalcitrant	recalcitrant	ADJ
dpc-3653	18	15	non	non	ADJ
dpc-3653	18	16	-	-	ADJ
dpc-3653	18	17	genital	genital	ADJ
dpc-3653	18	18	warts	wart	NOUN
dpc-3653	18	19	,	,	PUNCT
dpc-3653	18	20	with	with	ADP
dpc-3653	18	21	intralesional	intralesional	ADJ
dpc-3653	18	22	quadrivalent	quadrivalent	ADJ
dpc-3653	18	23	hpv	hpv	NOUN
dpc-3653	18	24	vaccine	vaccine	NOUN
dpc-3653	18	25	outperforming	outperform	VERB
dpc-3653	18	26	intralesional	intralesional	ADJ
dpc-3653	18	27	candida	candida	PROPN
dpc-3653	18	28	antigen	antigen	PROPN
dpc-3653	18	29	.	.	PUNCT
dpc-3653	19	1	abstract	abstract	ADJ
dpc-3653	19	2	2	2	NUM
dpc-3653	19	3	original	original	ADJ
dpc-3653	19	4	article	article	NOUN
dpc-3653	19	5	|	|	ADV
dpc-3653	19	6	dermatol	dermatol	ADJ
dpc-3653	19	7	pract	pract	NOUN
dpc-3653	19	8	concept	concept	NOUN
dpc-3653	19	9	.	.	PUNCT
dpc-3653	20	1	2024;14(2):e2024066	2024;14(2):e2024066	NUM
dpc-3653	20	2	introduction	introduction	NOUN
dpc-3653	20	3	warts	wart	NOUN
dpc-3653	20	4	are	be	AUX
dpc-3653	20	5	benign	benign	ADJ
dpc-3653	20	6	epithelial	epithelial	ADJ
dpc-3653	20	7	proliferations	proliferation	NOUN
dpc-3653	20	8	resulting	result	VERB
dpc-3653	20	9	from	from	ADP
dpc-3653	20	10	more	more	ADJ
dpc-3653	20	11	than	than	ADP
dpc-3653	20	12	200	200	NUM
dpc-3653	20	13	serotypes	serotype	NOUN
dpc-3653	20	14	of	of	ADP
dpc-3653	20	15	human	human	ADJ
dpc-3653	20	16	papilloma	papilloma	NOUN
dpc-3653	20	17	virus	virus	NOUN
dpc-3653	20	18	(	(	PUNCT
dpc-3653	20	19	hpv	hpv	NOUN
dpc-3653	20	20	)	)	PUNCT
dpc-3653	20	21	infection	infection	NOUN
dpc-3653	20	22	occurring	occur	VERB
dpc-3653	20	23	on	on	ADP
dpc-3653	20	24	the	the	DET
dpc-3653	20	25	skin	skin	NOUN
dpc-3653	20	26	and	and	CCONJ
dpc-3653	20	27	mucosa	mucosa	NOUN
dpc-3653	20	28	[	[	X
dpc-3653	20	29	1	1	NUM
dpc-3653	20	30	]	]	PUNCT
dpc-3653	20	31	.	.	PUNCT
dpc-3653	21	1	warts	wart	NOUN
dpc-3653	21	2	are	be	AUX
dpc-3653	21	3	not	not	PART
dpc-3653	21	4	lifethreatening	lifethreatene	VERB
dpc-3653	21	5	or	or	CCONJ
dpc-3653	21	6	harmful	harmful	ADJ
dpc-3653	21	7	,	,	PUNCT
dpc-3653	21	8	but	but	CCONJ
dpc-3653	21	9	they	they	PRON
dpc-3653	21	10	can	can	AUX
dpc-3653	21	11	be	be	AUX
dpc-3653	21	12	embarrassing	embarrassing	ADJ
dpc-3653	21	13	to	to	ADP
dpc-3653	21	14	the	the	DET
dpc-3653	21	15	patient	patient	NOUN
dpc-3653	21	16	when	when	SCONJ
dpc-3653	21	17	present	present	ADJ
dpc-3653	21	18	in	in	ADP
dpc-3653	21	19	the	the	DET
dpc-3653	21	20	exposed	expose	VERB
dpc-3653	21	21	areas	area	NOUN
dpc-3653	21	22	of	of	ADP
dpc-3653	21	23	the	the	DET
dpc-3653	21	24	body	body	NOUN
dpc-3653	21	25	.	.	PUNCT
dpc-3653	22	1	warts	wart	NOUN
dpc-3653	22	2	are	be	AUX
dpc-3653	22	3	infectious	infectious	ADJ
dpc-3653	22	4	and	and	CCONJ
dpc-3653	22	5	can	can	AUX
dpc-3653	22	6	spread	spread	VERB
dpc-3653	22	7	by	by	ADP
dpc-3653	22	8	skin	skin	NOUN
dpc-3653	22	9	-	-	PUNCT
dpc-3653	22	10	to	to	ADP
dpc-3653	22	11	-	-	PUNCT
dpc-3653	22	12	skin	skin	NOUN
dpc-3653	22	13	contact	contact	NOUN
dpc-3653	22	14	.	.	PUNCT
dpc-3653	23	1	however	however	ADV
dpc-3653	23	2	,	,	PUNCT
dpc-3653	23	3	the	the	DET
dpc-3653	23	4	strains	strain	NOUN
dpc-3653	23	5	vary	vary	VERB
dpc-3653	23	6	in	in	ADP
dpc-3653	23	7	their	their	PRON
dpc-3653	23	8	intensity	intensity	NOUN
dpc-3653	23	9	of	of	ADP
dpc-3653	23	10	contagiousness	contagiousness	NOUN
dpc-3653	23	11	[	[	X
dpc-3653	23	12	2	2	NUM
dpc-3653	23	13	]	]	PUNCT
dpc-3653	23	14	.	.	PUNCT
dpc-3653	24	1	warts	wart	NOUN
dpc-3653	24	2	are	be	AUX
dpc-3653	24	3	categorized	categorize	VERB
dpc-3653	24	4	into	into	ADP
dpc-3653	24	5	two	two	NUM
dpc-3653	24	6	types	type	NOUN
dpc-3653	24	7	:	:	PUNCT
dpc-3653	24	8	cutaneous	cutaneous	ADJ
dpc-3653	24	9	and	and	CCONJ
dpc-3653	24	10	extracutaneous	extracutaneous	ADJ
dpc-3653	24	11	.	.	PUNCT
dpc-3653	25	1	common	common	ADJ
dpc-3653	25	2	warts	wart	NOUN
dpc-3653	25	3	,	,	PUNCT
dpc-3653	25	4	filiform	filiform	NOUN
dpc-3653	25	5	warts	wart	NOUN
dpc-3653	25	6	,	,	PUNCT
dpc-3653	25	7	planter	planter	NOUN
dpc-3653	25	8	warts	wart	NOUN
dpc-3653	25	9	,	,	PUNCT
dpc-3653	25	10	plane	plane	NOUN
dpc-3653	25	11	warts	wart	NOUN
dpc-3653	25	12	,	,	PUNCT
dpc-3653	25	13	anogenital	anogenital	ADJ
dpc-3653	25	14	warts	wart	NOUN
dpc-3653	25	15	are	be	AUX
dpc-3653	25	16	among	among	ADP
dpc-3653	25	17	the	the	DET
dpc-3653	25	18	cutaneous	cutaneous	ADJ
dpc-3653	25	19	lesions	lesion	NOUN
dpc-3653	25	20	.	.	PUNCT
dpc-3653	26	1	oral	oral	ADJ
dpc-3653	26	2	common	common	ADJ
dpc-3653	26	3	warts	wart	NOUN
dpc-3653	26	4	,	,	PUNCT
dpc-3653	26	5	oral	oral	ADJ
dpc-3653	26	6	condylomata	condylomata	ADJ
dpc-3653	26	7	acuminata	acuminata	NOUN
dpc-3653	26	8	,	,	PUNCT
dpc-3653	26	9	focal	focal	ADJ
dpc-3653	26	10	epithelial	epithelial	ADJ
dpc-3653	26	11	hyperplasia	hyperplasia	NOUN
dpc-3653	26	12	,	,	PUNCT
dpc-3653	26	13	oral	oral	ADJ
dpc-3653	26	14	florid	florid	ADJ
dpc-3653	26	15	papillomatosis	papillomatosis	NOUN
dpc-3653	26	16	,	,	PUNCT
dpc-3653	26	17	nasal	nasal	PROPN
dpc-3653	26	18	papillomas	papilloma	NOUN
dpc-3653	26	19	,	,	PUNCT
dpc-3653	26	20	conjunctival	conjunctival	NOUN
dpc-3653	26	21	papillomas	papilloma	NOUN
dpc-3653	26	22	,	,	PUNCT
dpc-3653	26	23	laryngeal	laryngeal	ADJ
dpc-3653	26	24	papillomatosis	papillomatosis	NOUN
dpc-3653	26	25	,	,	PUNCT
dpc-3653	26	26	and	and	CCONJ
dpc-3653	26	27	cervical	cervical	ADJ
dpc-3653	26	28	warts	wart	NOUN
dpc-3653	26	29	are	be	AUX
dpc-3653	26	30	extracutaneous	extracutaneous	ADJ
dpc-3653	26	31	lesions	lesion	NOUN
dpc-3653	26	32	that	that	PRON
dpc-3653	26	33	affect	affect	VERB
dpc-3653	26	34	the	the	DET
dpc-3653	26	35	mucous	mucous	ADJ
dpc-3653	26	36	membranes	membrane	NOUN
dpc-3653	26	37	[	[	X
dpc-3653	26	38	3	3	NUM
dpc-3653	26	39	]	]	PUNCT
dpc-3653	26	40	.	.	PUNCT
dpc-3653	27	1	unfortunately	unfortunately	ADV
dpc-3653	27	2	,	,	PUNCT
dpc-3653	27	3	a	a	DET
dpc-3653	27	4	specific	specific	ADJ
dpc-3653	27	5	antiviral	antiviral	ADJ
dpc-3653	27	6	agent	agent	NOUN
dpc-3653	27	7	against	against	ADP
dpc-3653	27	8	hpv	hpv	PROPN
dpc-3653	27	9	is	be	AUX
dpc-3653	27	10	lacking	lack	VERB
dpc-3653	27	11	and	and	CCONJ
dpc-3653	27	12	while	while	SCONJ
dpc-3653	27	13	most	most	ADJ
dpc-3653	27	14	warts	wart	NOUN
dpc-3653	27	15	spontaneously	spontaneously	ADV
dpc-3653	27	16	disappear	disappear	VERB
dpc-3653	27	17	,	,	PUNCT
dpc-3653	27	18	some	some	PRON
dpc-3653	27	19	persist	persist	NOUN
dpc-3653	27	20	and	and	CCONJ
dpc-3653	27	21	are	be	AUX
dpc-3653	27	22	resistant	resistant	ADJ
dpc-3653	27	23	to	to	ADP
dpc-3653	27	24	treatment	treatment	NOUN
dpc-3653	27	25	.	.	PUNCT
dpc-3653	28	1	all	all	DET
dpc-3653	28	2	available	available	ADJ
dpc-3653	28	3	treatment	treatment	NOUN
dpc-3653	28	4	modalities	modality	NOUN
dpc-3653	28	5	intend	intend	VERB
dpc-3653	28	6	to	to	PART
dpc-3653	28	7	destroy	destroy	VERB
dpc-3653	28	8	lesions	lesion	NOUN
dpc-3653	28	9	by	by	ADP
dpc-3653	28	10	chemical	chemical	ADJ
dpc-3653	28	11	agents	agent	NOUN
dpc-3653	28	12	such	such	ADJ
dpc-3653	28	13	as	as	ADP
dpc-3653	28	14	salicylic	salicylic	ADJ
dpc-3653	28	15	acid	acid	NOUN
dpc-3653	28	16	,	,	PUNCT
dpc-3653	28	17	5fluorouracil	5fluorouracil	NUM
dpc-3653	28	18	,	,	PUNCT
dpc-3653	28	19	and/or	and/or	CCONJ
dpc-3653	28	20	by	by	ADP
dpc-3653	28	21	physical	physical	ADJ
dpc-3653	28	22	destructive	destructive	ADJ
dpc-3653	28	23	methods	method	NOUN
dpc-3653	28	24	;	;	PUNCT
dpc-3653	28	25	eg	eg	NOUN
dpc-3653	28	26	(	(	PUNCT
dpc-3653	28	27	electrocautery	electrocautery	NOUN
dpc-3653	28	28	,	,	PUNCT
dpc-3653	28	29	cryotherapy	cryotherapy	NOUN
dpc-3653	28	30	,	,	PUNCT
dpc-3653	28	31	photodynamic	photodynamic	ADJ
dpc-3653	28	32	therapy	therapy	NOUN
dpc-3653	28	33	and	and	CCONJ
dpc-3653	28	34	surgical	surgical	ADJ
dpc-3653	28	35	excision	excision	NOUN
dpc-3653	28	36	)	)	PUNCT
dpc-3653	28	37	.	.	PUNCT
dpc-3653	29	1	these	these	DET
dpc-3653	29	2	methods	method	NOUN
dpc-3653	29	3	,	,	PUNCT
dpc-3653	29	4	however	however	ADV
dpc-3653	29	5	might	might	AUX
dpc-3653	29	6	be	be	AUX
dpc-3653	29	7	associated	associate	VERB
dpc-3653	29	8	with	with	ADP
dpc-3653	29	9	scarring	scarring	NOUN
dpc-3653	29	10	,	,	PUNCT
dpc-3653	29	11	pain	pain	NOUN
dpc-3653	29	12	and	and	CCONJ
dpc-3653	29	13	high	high	ADJ
dpc-3653	29	14	rates	rate	NOUN
dpc-3653	29	15	recurrence	recurrence	NOUN
dpc-3653	29	16	[	[	X
dpc-3653	29	17	4	4	NUM
dpc-3653	29	18	-	-	SYM
dpc-3653	29	19	6	6	NUM
dpc-3653	29	20	]	]	PUNCT
dpc-3653	29	21	.	.	PUNCT
dpc-3653	30	1	intralesional	intralesional	ADJ
dpc-3653	30	2	antigen	antigen	ADJ
dpc-3653	30	3	immunotherapy	immunotherapy	NOUN
dpc-3653	30	4	represents	represent	VERB
dpc-3653	30	5	a	a	DET
dpc-3653	30	6	promising	promising	ADJ
dpc-3653	30	7	therapeutic	therapeutic	ADJ
dpc-3653	30	8	approach	approach	NOUN
dpc-3653	30	9	for	for	ADP
dpc-3653	30	10	the	the	DET
dpc-3653	30	11	treatment	treatment	NOUN
dpc-3653	30	12	of	of	ADP
dpc-3653	30	13	different	different	ADJ
dpc-3653	30	14	types	type	NOUN
dpc-3653	30	15	of	of	ADP
dpc-3653	30	16	warts	wart	NOUN
dpc-3653	30	17	,	,	PUNCT
dpc-3653	30	18	particularly	particularly	ADV
dpc-3653	30	19	if	if	SCONJ
dpc-3653	30	20	multiple	multiple	ADJ
dpc-3653	30	21	and/or	and/or	CCONJ
dpc-3653	30	22	recalcitrant	recalcitrant	ADJ
dpc-3653	30	23	.	.	PUNCT
dpc-3653	31	1	immunotherapeutic	immunotherapeutic	ADJ
dpc-3653	31	2	approaches	approach	NOUN
dpc-3653	31	3	act	act	VERB
dpc-3653	31	4	by	by	ADP
dpc-3653	31	5	enhancing	enhance	VERB
dpc-3653	31	6	the	the	DET
dpc-3653	31	7	host	host	NOUN
dpc-3653	31	8	cell	cell	NOUN
dpc-3653	31	9	-	-	PUNCT
dpc-3653	31	10	mediated	mediate	VERB
dpc-3653	31	11	immunity	immunity	NOUN
dpc-3653	31	12	to	to	PART
dpc-3653	31	13	eliminate	eliminate	VERB
dpc-3653	31	14	the	the	DET
dpc-3653	31	15	virus	virus	NOUN
dpc-3653	31	16	rather	rather	ADV
dpc-3653	31	17	than	than	ADP
dpc-3653	31	18	just	just	ADV
dpc-3653	31	19	clearing	clear	VERB
dpc-3653	31	20	the	the	DET
dpc-3653	31	21	skin	skin	NOUN
dpc-3653	31	22	lesions	lesion	NOUN
dpc-3653	31	23	[	[	X
dpc-3653	31	24	7	7	NUM
dpc-3653	31	25	]	]	PUNCT
dpc-3653	31	26	.	.	PUNCT
dpc-3653	32	1	the	the	DET
dpc-3653	32	2	efficacy	efficacy	NOUN
dpc-3653	32	3	of	of	ADP
dpc-3653	32	4	immunotherapy	immunotherapy	NOUN
dpc-3653	32	5	using	use	VERB
dpc-3653	32	6	a	a	DET
dpc-3653	32	7	single	single	ADJ
dpc-3653	32	8	test	test	NOUN
dpc-3653	32	9	antigen	antigen	NOUN
dpc-3653	32	10	and	and	CCONJ
dpc-3653	32	11	multiple	multiple	ADJ
dpc-3653	32	12	test	test	NOUN
dpc-3653	32	13	antigens	antigen	NOUN
dpc-3653	32	14	in	in	ADP
dpc-3653	32	15	the	the	DET
dpc-3653	32	16	treatment	treatment	NOUN
dpc-3653	32	17	of	of	ADP
dpc-3653	32	18	warts	wart	NOUN
dpc-3653	32	19	has	have	AUX
dpc-3653	32	20	been	be	AUX
dpc-3653	32	21	investigated	investigate	VERB
dpc-3653	32	22	with	with	ADP
dpc-3653	32	23	various	various	ADJ
dpc-3653	32	24	degrees	degree	NOUN
dpc-3653	32	25	of	of	ADP
dpc-3653	32	26	success	success	NOUN
dpc-3653	32	27	.	.	PUNCT
dpc-3653	33	1	tuberculin	tuberculin	PROPN
dpc-3653	33	2	purified	purify	VERB
dpc-3653	33	3	protein	protein	NOUN
dpc-3653	33	4	derivative	derivative	NOUN
dpc-3653	33	5	(	(	PUNCT
dpc-3653	33	6	ppd	ppd	NOUN
dpc-3653	33	7	)	)	PUNCT
dpc-3653	33	8	,	,	PUNCT
dpc-3653	33	9	measles	measle	NOUN
dpc-3653	33	10	,	,	PUNCT
dpc-3653	33	11	mumps	mump	NOUN
dpc-3653	33	12	,	,	PUNCT
dpc-3653	33	13	and	and	CCONJ
dpc-3653	33	14	rubella	rubella	NOUN
dpc-3653	33	15	(	(	PUNCT
dpc-3653	33	16	mmr	mmr	PROPN
dpc-3653	33	17	)	)	PUNCT
dpc-3653	33	18	vaccine	vaccine	NOUN
dpc-3653	33	19	,	,	PUNCT
dpc-3653	33	20	mycobacterium	mycobacterium	NOUN
dpc-3653	33	21	w	w	PROPN
dpc-3653	33	22	vaccine	vaccine	NOUN
dpc-3653	33	23	,	,	PUNCT
dpc-3653	33	24	interferon	interferon	NOUN
dpc-3653	33	25	-	-	PUNCT
dpc-3653	33	26	α	α	NOUN
dpc-3653	33	27	or	or	CCONJ
dpc-3653	33	28	β	β	NOUN
dpc-3653	33	29	,	,	PUNCT
dpc-3653	33	30	candida	candida	PROPN
dpc-3653	33	31	antigen	antigen	NOUN
dpc-3653	33	32	,	,	PUNCT
dpc-3653	33	33	and	and	CCONJ
dpc-3653	33	34	bacillus	bacillus	NOUN
dpc-3653	33	35	calmette	calmette	PROPN
dpc-3653	33	36	-	-	PUNCT
dpc-3653	33	37	guerin	guerin	PROPN
dpc-3653	33	38	(	(	PUNCT
dpc-3653	33	39	bcg	bcg	PROPN
dpc-3653	33	40	)	)	PUNCT
dpc-3653	33	41	vaccine	vaccine	NOUN
dpc-3653	33	42	are	be	AUX
dpc-3653	33	43	a	a	DET
dpc-3653	33	44	few	few	ADJ
dpc-3653	33	45	examples	example	NOUN
dpc-3653	33	46	of	of	ADP
dpc-3653	33	47	immunotherapeutic	immunotherapeutic	ADJ
dpc-3653	33	48	drugs	drug	NOUN
dpc-3653	33	49	that	that	PRON
dpc-3653	33	50	have	have	AUX
dpc-3653	33	51	been	be	AUX
dpc-3653	33	52	researched	research	VERB
dpc-3653	33	53	[	[	PUNCT
dpc-3653	33	54	8	8	NUM
dpc-3653	33	55	-	-	SYM
dpc-3653	33	56	10	10	NUM
dpc-3653	33	57	]	]	PUNCT
dpc-3653	33	58	the	the	DET
dpc-3653	33	59	efficacy	efficacy	NOUN
dpc-3653	33	60	of	of	ADP
dpc-3653	33	61	candida	candida	PROPN
dpc-3653	33	62	skin	skin	NOUN
dpc-3653	33	63	-	-	PUNCT
dpc-3653	33	64	test	test	NOUN
dpc-3653	33	65	antigen	antigen	NOUN
dpc-3653	33	66	in	in	ADP
dpc-3653	33	67	wart	wart	NOUN
dpc-3653	33	68	resolution	resolution	NOUN
dpc-3653	33	69	was	be	AUX
dpc-3653	33	70	demonstrated	demonstrate	VERB
dpc-3653	33	71	in	in	ADP
dpc-3653	33	72	the	the	DET
dpc-3653	33	73	first	first	ADJ
dpc-3653	33	74	such	such	ADJ
dpc-3653	33	75	trial	trial	NOUN
dpc-3653	33	76	[	[	X
dpc-3653	33	77	11	11	NUM
dpc-3653	33	78	]	]	PUNCT
dpc-3653	33	79	.	.	PUNCT
dpc-3653	34	1	several	several	ADJ
dpc-3653	34	2	studies	study	NOUN
dpc-3653	34	3	have	have	AUX
dpc-3653	34	4	confirmed	confirm	VERB
dpc-3653	34	5	the	the	DET
dpc-3653	34	6	role	role	NOUN
dpc-3653	34	7	of	of	ADP
dpc-3653	34	8	a	a	DET
dpc-3653	34	9	prophylactic	prophylactic	ADJ
dpc-3653	34	10	quadrivalent	quadrivalent	NOUN
dpc-3653	34	11	hpv	hpv	NOUN
dpc-3653	34	12	vaccine	vaccine	NOUN
dpc-3653	34	13	(	(	PUNCT
dpc-3653	34	14	hpv	hpv	ADJ
dpc-3653	34	15	types	type	NOUN
dpc-3653	34	16	6	6	NUM
dpc-3653	34	17	,	,	PUNCT
dpc-3653	34	18	11	11	NUM
dpc-3653	34	19	,	,	PUNCT
dpc-3653	34	20	16	16	NUM
dpc-3653	34	21	,	,	PUNCT
dpc-3653	34	22	and	and	CCONJ
dpc-3653	34	23	18	18	NUM
dpc-3653	34	24	)	)	PUNCT
dpc-3653	34	25	in	in	ADP
dpc-3653	34	26	the	the	DET
dpc-3653	34	27	prevention	prevention	NOUN
dpc-3653	34	28	of	of	ADP
dpc-3653	34	29	hpv	hpv	PROPN
dpc-3653	34	30	-	-	PUNCT
dpc-3653	34	31	associated	associate	VERB
dpc-3653	34	32	precancerous	precancerous	ADJ
dpc-3653	34	33	and	and	CCONJ
dpc-3653	34	34	cancerous	cancerous	ADJ
dpc-3653	34	35	lesions	lesion	NOUN
dpc-3653	34	36	.	.	PUNCT
dpc-3653	35	1	there	there	PRON
dpc-3653	35	2	might	might	AUX
dpc-3653	35	3	be	be	AUX
dpc-3653	35	4	some	some	DET
dpc-3653	35	5	cross	cross	ADJ
dpc-3653	35	6	-	-	NOUN
dpc-3653	35	7	reactivity	reactivity	NOUN
dpc-3653	35	8	of	of	ADP
dpc-3653	35	9	antigenic	antigenic	ADJ
dpc-3653	35	10	epitopes	epitope	NOUN
dpc-3653	35	11	in	in	ADP
dpc-3653	35	12	the	the	DET
dpc-3653	35	13	hpv	hpv	ADJ
dpc-3653	35	14	types	type	NOUN
dpc-3653	35	15	covered	cover	VERB
dpc-3653	35	16	by	by	ADP
dpc-3653	35	17	the	the	DET
dpc-3653	35	18	vaccine	vaccine	NOUN
dpc-3653	35	19	and	and	CCONJ
dpc-3653	35	20	other	other	ADJ
dpc-3653	35	21	hpv	hpv	ADJ
dpc-3653	35	22	types	type	NOUN
dpc-3653	35	23	responsible	responsible	ADJ
dpc-3653	35	24	for	for	ADP
dpc-3653	35	25	common	common	ADJ
dpc-3653	35	26	warts	wart	NOUN
dpc-3653	35	27	[	[	X
dpc-3653	35	28	12	12	NUM
dpc-3653	35	29	-	-	SYM
dpc-3653	35	30	14	14	NUM
dpc-3653	35	31	]	]	PUNCT
dpc-3653	35	32	.	.	PUNCT
dpc-3653	36	1	objectives	objective	NOUN
dpc-3653	36	2	in	in	ADP
dpc-3653	36	3	this	this	DET
dpc-3653	36	4	study	study	NOUN
dpc-3653	36	5	we	we	PRON
dpc-3653	36	6	aimed	aim	VERB
dpc-3653	36	7	to	to	PART
dpc-3653	36	8	evaluate	evaluate	VERB
dpc-3653	36	9	and	and	CCONJ
dpc-3653	36	10	compare	compare	VERB
dpc-3653	36	11	the	the	DET
dpc-3653	36	12	safety	safety	NOUN
dpc-3653	36	13	and	and	CCONJ
dpc-3653	36	14	efficacy	efficacy	NOUN
dpc-3653	36	15	of	of	ADP
dpc-3653	36	16	intralesional	intralesional	ADJ
dpc-3653	36	17	candida	candida	NOUN
dpc-3653	36	18	antigen	antigen	NOUN
dpc-3653	36	19	versus	versus	ADP
dpc-3653	36	20	quadrivalent	quadrivalent	ADJ
dpc-3653	36	21	hpv	hpv	NOUN
dpc-3653	36	22	vaccine	vaccine	NOUN
dpc-3653	36	23	in	in	ADP
dpc-3653	36	24	treatment	treatment	NOUN
dpc-3653	36	25	of	of	ADP
dpc-3653	36	26	multiple	multiple	ADJ
dpc-3653	36	27	recalcitrant	recalcitrant	ADJ
dpc-3653	36	28	nongenital	nongenital	ADJ
dpc-3653	36	29	warts	wart	NOUN
dpc-3653	36	30	.	.	PUNCT
dpc-3653	37	1	methods	method	NOUN
dpc-3653	37	2	patients	patient	NOUN
dpc-3653	37	3	this	this	PRON
dpc-3653	37	4	is	be	AUX
dpc-3653	37	5	a	a	DET
dpc-3653	37	6	three	three	NUM
dpc-3653	37	7	arm	arm	NOUN
dpc-3653	37	8	,	,	PUNCT
dpc-3653	37	9	single	single	ADJ
dpc-3653	37	10	blinded	blind	VERB
dpc-3653	37	11	,	,	PUNCT
dpc-3653	37	12	randomized	randomize	VERB
dpc-3653	37	13	controlled	control	VERB
dpc-3653	37	14	clinical	clinical	ADJ
dpc-3653	37	15	trial	trial	NOUN
dpc-3653	37	16	included	include	VERB
dpc-3653	37	17	60	60	NUM
dpc-3653	37	18	cases	case	NOUN
dpc-3653	37	19	.	.	PUNCT
dpc-3653	38	1	inclusion	inclusion	NOUN
dpc-3653	38	2	criteria	criterion	NOUN
dpc-3653	38	3	patients	patient	NOUN
dpc-3653	38	4	who	who	PRON
dpc-3653	38	5	have	have	VERB
dpc-3653	38	6	multiple	multiple	ADJ
dpc-3653	38	7	recalcitrant	recalcitrant	ADJ
dpc-3653	38	8	non	non	ADJ
dpc-3653	38	9	-	-	ADJ
dpc-3653	38	10	genital	genital	ADJ
dpc-3653	38	11	warts	wart	NOUN
dpc-3653	38	12	.	.	PUNCT
dpc-3653	39	1	recalcitrant	recalcitrant	ADJ
dpc-3653	39	2	warts	wart	NOUN
dpc-3653	39	3	were	be	AUX
dpc-3653	39	4	defined	define	VERB
dpc-3653	39	5	as	as	ADP
dpc-3653	39	6	warts	wart	NOUN
dpc-3653	39	7	that	that	PRON
dpc-3653	39	8	persisted	persist	VERB
dpc-3653	39	9	for	for	ADP
dpc-3653	39	10	more	more	ADJ
dpc-3653	39	11	than	than	ADP
dpc-3653	39	12	one	one	NUM
dpc-3653	39	13	year	year	NOUN
dpc-3653	39	14	and	and	CCONJ
dpc-3653	39	15	were	be	AUX
dpc-3653	39	16	resistant	resistant	ADJ
dpc-3653	39	17	to	to	ADP
dpc-3653	39	18	at	at	ADV
dpc-3653	39	19	least	least	ADV
dpc-3653	39	20	two	two	NUM
dpc-3653	39	21	therapeutic	therapeutic	ADJ
dpc-3653	39	22	modalities	modality	NOUN
dpc-3653	39	23	.	.	PUNCT
dpc-3653	40	1	exclusion	exclusion	NOUN
dpc-3653	40	2	criteria	criterion	NOUN
dpc-3653	40	3	patients	patient	NOUN
dpc-3653	40	4	on	on	ADP
dpc-3653	40	5	any	any	DET
dpc-3653	40	6	treatment	treatment	NOUN
dpc-3653	40	7	modality	modality	NOUN
dpc-3653	40	8	for	for	ADP
dpc-3653	40	9	warts	wart	NOUN
dpc-3653	40	10	during	during	ADP
dpc-3653	40	11	the	the	DET
dpc-3653	40	12	last	last	ADJ
dpc-3653	40	13	month	month	NOUN
dpc-3653	40	14	prior	prior	ADV
dpc-3653	40	15	to	to	ADP
dpc-3653	40	16	enrollment	enrollment	NOUN
dpc-3653	40	17	,	,	PUNCT
dpc-3653	40	18	pregnant	pregnant	ADJ
dpc-3653	40	19	and	and	CCONJ
dpc-3653	40	20	lactating	lactate	VERB
dpc-3653	40	21	females	female	NOUN
dpc-3653	40	22	;	;	PUNCT
dpc-3653	40	23	patients	patient	NOUN
dpc-3653	40	24	with	with	ADP
dpc-3653	40	25	known	know	VERB
dpc-3653	40	26	hypersensitivity	hypersensitivity	NOUN
dpc-3653	40	27	to	to	ADP
dpc-3653	40	28	candida	candida	PROPN
dpc-3653	40	29	albicans	albican	NOUN
dpc-3653	40	30	antigen	antigen	ADV
dpc-3653	40	31	,	,	PUNCT
dpc-3653	40	32	with	with	ADP
dpc-3653	40	33	acute	acute	ADJ
dpc-3653	40	34	febrile	febrile	NOUN
dpc-3653	40	35	illness	illness	NOUN
dpc-3653	40	36	,	,	PUNCT
dpc-3653	40	37	autoimmune	autoimmune	ADJ
dpc-3653	40	38	disease	disease	NOUN
dpc-3653	40	39	or	or	CCONJ
dpc-3653	40	40	immunodeficiency	immunodeficiency	NOUN
dpc-3653	40	41	were	be	AUX
dpc-3653	40	42	excluded	exclude	VERB
dpc-3653	40	43	from	from	ADP
dpc-3653	40	44	the	the	DET
dpc-3653	40	45	study	study	NOUN
dpc-3653	40	46	.	.	PUNCT
dpc-3653	41	1	assessments	assessment	NOUN
dpc-3653	41	2	all	all	DET
dpc-3653	41	3	patients	patient	NOUN
dpc-3653	41	4	enrolled	enrol	VERB
dpc-3653	41	5	in	in	ADP
dpc-3653	41	6	the	the	DET
dpc-3653	41	7	study	study	NOUN
dpc-3653	41	8	were	be	AUX
dpc-3653	41	9	subjected	subject	VERB
dpc-3653	41	10	to	to	ADP
dpc-3653	41	11	full	full	ADJ
dpc-3653	41	12	history	history	NOUN
dpc-3653	41	13	taking	taking	NOUN
dpc-3653	41	14	,	,	PUNCT
dpc-3653	41	15	general	general	ADJ
dpc-3653	41	16	and	and	CCONJ
dpc-3653	41	17	dermatological	dermatological	ADJ
dpc-3653	41	18	examination	examination	NOUN
dpc-3653	41	19	to	to	PART
dpc-3653	41	20	determine	determine	VERB
dpc-3653	41	21	number	number	NOUN
dpc-3653	41	22	,	,	PUNCT
dpc-3653	41	23	site	site	NOUN
dpc-3653	41	24	,	,	PUNCT
dpc-3653	41	25	and	and	CCONJ
dpc-3653	41	26	size	size	NOUN
dpc-3653	41	27	of	of	ADP
dpc-3653	41	28	warts	wart	NOUN
dpc-3653	41	29	and	and	CCONJ
dpc-3653	41	30	to	to	PART
dpc-3653	41	31	detect	detect	VERB
dpc-3653	41	32	presence	presence	NOUN
dpc-3653	41	33	or	or	CCONJ
dpc-3653	41	34	absence	absence	NOUN
dpc-3653	41	35	of	of	ADP
dpc-3653	41	36	distant	distant	ADJ
dpc-3653	41	37	warts	wart	NOUN
dpc-3653	41	38	or	or	CCONJ
dpc-3653	41	39	other	other	ADJ
dpc-3653	41	40	skin	skin	NOUN
dpc-3653	41	41	diseases	disease	NOUN
dpc-3653	41	42	.	.	PUNCT
dpc-3653	42	1	digital	digital	ADJ
dpc-3653	42	2	photography	photography	NOUN
dpc-3653	42	3	was	be	AUX
dpc-3653	42	4	done	do	VERB
dpc-3653	42	5	for	for	ADP
dpc-3653	42	6	all	all	DET
dpc-3653	42	7	patients	patient	NOUN
dpc-3653	42	8	at	at	ADP
dpc-3653	42	9	baseline	baseline	NOUN
dpc-3653	42	10	,	,	PUNCT
dpc-3653	42	11	follow	follow	VERB
dpc-3653	42	12	up	up	ADP
dpc-3653	42	13	visits	visit	NOUN
dpc-3653	42	14	and	and	CCONJ
dpc-3653	42	15	after	after	ADP
dpc-3653	42	16	completion	completion	NOUN
dpc-3653	42	17	of	of	ADP
dpc-3653	42	18	treatment	treatment	NOUN
dpc-3653	42	19	sessions	session	NOUN
dpc-3653	42	20	.	.	PUNCT
dpc-3653	43	1	patients	patient	NOUN
dpc-3653	43	2	were	be	AUX
dpc-3653	43	3	randomly	randomly	ADV
dpc-3653	43	4	distributed	distribute	VERB
dpc-3653	43	5	into	into	ADP
dpc-3653	43	6	three	three	NUM
dpc-3653	43	7	equal	equal	ADJ
dpc-3653	43	8	groups	group	NOUN
dpc-3653	43	9	:	:	PUNCT
dpc-3653	43	10	group	group	NOUN
dpc-3653	43	11	i	i	PRON
dpc-3653	43	12	included	include	VERB
dpc-3653	43	13	20	20	NUM
dpc-3653	43	14	patients	patient	NOUN
dpc-3653	43	15	who	who	PRON
dpc-3653	43	16	received	receive	VERB
dpc-3653	43	17	intralesional	intralesional	ADJ
dpc-3653	43	18	candida	candida	NOUN
dpc-3653	43	19	antigen	antigen	NOUN
dpc-3653	43	20	at	at	ADP
dpc-3653	43	21	a	a	DET
dpc-3653	43	22	dose	dose	NOUN
dpc-3653	43	23	of	of	ADP
dpc-3653	43	24	0.3	0.3	NUM
dpc-3653	43	25	ml	ml	NOUN
dpc-3653	43	26	of	of	ADP
dpc-3653	43	27	1/1000	1/1000	NUM
dpc-3653	43	28	solution	solution	NOUN
dpc-3653	43	29	.	.	PUNCT
dpc-3653	44	1	group	group	PROPN
dpc-3653	44	2	ii	ii	PROPN
dpc-3653	44	3	included	include	VERB
dpc-3653	44	4	20	20	NUM
dpc-3653	44	5	patients	patient	NOUN
dpc-3653	44	6	who	who	PRON
dpc-3653	44	7	received	receive	VERB
dpc-3653	44	8	intralesional	intralesional	ADJ
dpc-3653	44	9	quadrivalent	quadrivalent	NOUN
dpc-3653	44	10	hpv	hpv	NOUN
dpc-3653	44	11	vaccine	vaccine	NOUN
dpc-3653	44	12	at	at	ADP
dpc-3653	44	13	a	a	DET
dpc-3653	44	14	dose	dose	NOUN
dpc-3653	44	15	of	of	ADP
dpc-3653	44	16	0.3ml	0.3ml	PROPN
dpc-3653	44	17	.	.	PROPN
dpc-3653	44	18	group	group	PROPN
dpc-3653	44	19	iii	iii	PROPN
dpc-3653	44	20	included	include	VERB
dpc-3653	44	21	20	20	NUM
dpc-3653	44	22	patients	patient	NOUN
dpc-3653	44	23	who	who	PRON
dpc-3653	44	24	received	receive	VERB
dpc-3653	44	25	intralesional	intralesional	ADJ
dpc-3653	44	26	injection	injection	NOUN
dpc-3653	44	27	0.3	0.3	NUM
dpc-3653	44	28	ml	ml	NOUN
dpc-3653	44	29	of	of	ADP
dpc-3653	44	30	normal	normal	ADJ
dpc-3653	44	31	saline	saline	NOUN
dpc-3653	44	32	0.9	0.9	NUM
dpc-3653	44	33	%	%	NOUN
dpc-3653	44	34	as	as	ADP
dpc-3653	44	35	a	a	DET
dpc-3653	44	36	control	control	NOUN
dpc-3653	44	37	group	group	NOUN
dpc-3653	44	38	)	)	PUNCT
dpc-3653	44	39	.	.	PUNCT
dpc-3653	45	1	following	follow	VERB
dpc-3653	45	2	the	the	DET
dpc-3653	45	3	study	study	NOUN
dpc-3653	45	4	completion	completion	NOUN
dpc-3653	45	5	,	,	PUNCT
dpc-3653	45	6	these	these	DET
dpc-3653	45	7	patients	patient	NOUN
dpc-3653	45	8	were	be	AUX
dpc-3653	45	9	treated	treat	VERB
dpc-3653	45	10	.	.	PUNCT
dpc-3653	46	1	each	each	DET
dpc-3653	46	2	agent	agent	NOUN
dpc-3653	46	3	was	be	AUX
dpc-3653	46	4	injected	inject	VERB
dpc-3653	46	5	every	every	DET
dpc-3653	46	6	three	three	NUM
dpc-3653	46	7	weeks	week	NOUN
dpc-3653	46	8	at	at	ADP
dpc-3653	46	9	the	the	DET
dpc-3653	46	10	base	base	NOUN
dpc-3653	46	11	of	of	ADP
dpc-3653	46	12	the	the	DET
dpc-3653	46	13	largest	large	ADJ
dpc-3653	46	14	wart	wart	NOUN
dpc-3653	46	15	until	until	SCONJ
dpc-3653	46	16	it	it	PRON
dpc-3653	46	17	was	be	AUX
dpc-3653	46	18	entirely	entirely	ADV
dpc-3653	46	19	removed	remove	VERB
dpc-3653	46	20	or	or	CCONJ
dpc-3653	46	21	for	for	ADP
dpc-3653	46	22	a	a	DET
dpc-3653	46	23	maximum	maximum	NOUN
dpc-3653	46	24	of	of	ADP
dpc-3653	46	25	four	four	NUM
dpc-3653	46	26	sessions	session	NOUN
dpc-3653	46	27	.	.	PUNCT
dpc-3653	47	1	the	the	DET
dpc-3653	47	2	study	study	NOUN
dpc-3653	47	3	was	be	AUX
dpc-3653	47	4	approved	approve	VERB
dpc-3653	47	5	by	by	ADP
dpc-3653	47	6	an	an	DET
dpc-3653	47	7	ethics	ethic	NOUN
dpc-3653	47	8	committee	committee	NOUN
dpc-3653	47	9	of	of	ADP
dpc-3653	47	10	damietta	damietta	PROPN
dpc-3653	47	11	faculty	faculty	NOUN
dpc-3653	47	12	of	of	ADP
dpc-3653	47	13	medicine	medicine	NOUN
dpc-3653	47	14	irb	irb	PROPN
dpc-3653	47	15	(	(	PUNCT
dpc-3653	47	16	00012367	00012367	NUM
dpc-3653	47	17	-	-	SYM
dpc-3653	47	18	20	20	NUM
dpc-3653	47	19	-	-	PUNCT
dpc-3653	47	20	12	12	NUM
dpc-3653	47	21	-	-	PUNCT
dpc-3653	47	22	004	004	NUM
dpc-3653	47	23	)	)	PUNCT
dpc-3653	47	24	,	,	PUNCT
dpc-3653	47	25	al	al	PROPN
dpc-3653	47	26	-	-	PUNCT
dpc-3653	47	27	azhar	azhar	PROPN
dpc-3653	47	28	university	university	PROPN
dpc-3653	47	29	,	,	PUNCT
dpc-3653	47	30	egypt	egypt	PROPN
dpc-3653	47	31	.	.	PUNCT
dpc-3653	48	1	written	write	VERB
dpc-3653	48	2	informed	informed	ADJ
dpc-3653	48	3	consent	consent	NOUN
dpc-3653	48	4	was	be	AUX
dpc-3653	48	5	obtained	obtain	VERB
dpc-3653	48	6	from	from	ADP
dpc-3653	48	7	adult	adult	NOUN
dpc-3653	48	8	patients	patient	NOUN
dpc-3653	48	9	and	and	CCONJ
dpc-3653	48	10	parents	parent	NOUN
dpc-3653	48	11	of	of	ADP
dpc-3653	48	12	children	child	NOUN
dpc-3653	48	13	included	include	VERB
dpc-3653	48	14	into	into	ADP
dpc-3653	48	15	the	the	DET
dpc-3653	48	16	study	study	NOUN
dpc-3653	48	17	.	.	PUNCT
dpc-3653	49	1	evaluation	evaluation	NOUN
dpc-3653	49	2	of	of	ADP
dpc-3653	49	3	the	the	DET
dpc-3653	49	4	clinical	clinical	ADJ
dpc-3653	49	5	response	response	NOUN
dpc-3653	49	6	the	the	DET
dpc-3653	49	7	evaluation	evaluation	NOUN
dpc-3653	49	8	of	of	ADP
dpc-3653	49	9	therapeutic	therapeutic	ADJ
dpc-3653	49	10	response	response	NOUN
dpc-3653	49	11	was	be	AUX
dpc-3653	49	12	carried	carry	VERB
dpc-3653	49	13	out	out	ADP
dpc-3653	49	14	by	by	ADP
dpc-3653	49	15	evaluating	evaluate	VERB
dpc-3653	49	16	the	the	DET
dpc-3653	49	17	size	size	NOUN
dpc-3653	49	18	and	and	CCONJ
dpc-3653	49	19	counting	count	VERB
dpc-3653	49	20	the	the	DET
dpc-3653	49	21	number	number	NOUN
dpc-3653	49	22	of	of	ADP
dpc-3653	49	23	injected	inject	VERB
dpc-3653	49	24	and	and	CCONJ
dpc-3653	49	25	distant	distant	ADJ
dpc-3653	49	26	warts	wart	NOUN
dpc-3653	49	27	by	by	ADP
dpc-3653	49	28	digital	digital	ADJ
dpc-3653	49	29	photographic	photographic	ADJ
dpc-3653	49	30	comparison	comparison	NOUN
dpc-3653	49	31	at	at	ADP
dpc-3653	49	32	baseline	baseline	NOUN
dpc-3653	49	33	and	and	CCONJ
dpc-3653	49	34	at	at	ADP
dpc-3653	49	35	each	each	DET
dpc-3653	49	36	visit	visit	NOUN
dpc-3653	49	37	.	.	PUNCT
dpc-3653	50	1	complete	complete	ADJ
dpc-3653	50	2	response	response	NOUN
dpc-3653	50	3	(	(	PUNCT
dpc-3653	50	4	disappearance	disappearance	NOUN
dpc-3653	50	5	of	of	ADP
dpc-3653	50	6	the	the	DET
dpc-3653	50	7	warts	wart	NOUN
dpc-3653	50	8	and	and	CCONJ
dpc-3653	50	9	appearance	appearance	NOUN
dpc-3653	50	10	of	of	ADP
dpc-3653	50	11	normal	normal	ADJ
dpc-3653	50	12	skin	skin	NOUN
dpc-3653	50	13	)	)	PUNCT
dpc-3653	50	14	,	,	PUNCT
dpc-3653	50	15	partial	partial	ADJ
dpc-3653	50	16	response	response	NOUN
dpc-3653	50	17	original	original	ADJ
dpc-3653	50	18	article	article	NOUN
dpc-3653	50	19	|	|	ADV
dpc-3653	50	20	dermatol	dermatol	ADJ
dpc-3653	50	21	pract	pract	NOUN
dpc-3653	50	22	concept	concept	NOUN
dpc-3653	50	23	.	.	PUNCT
dpc-3653	51	1	2024;14(2):e2024066	2024;14(2):e2024066	NUM
dpc-3653	51	2	3	3	NUM
dpc-3653	51	3	(	(	PUNCT
dpc-3653	51	4	50%-99	50%-99	NUM
dpc-3653	51	5	%	%	NOUN
dpc-3653	51	6	reduction	reduction	NOUN
dpc-3653	51	7	in	in	ADP
dpc-3653	51	8	size	size	NOUN
dpc-3653	51	9	)	)	PUNCT
dpc-3653	51	10	and	and	CCONJ
dpc-3653	51	11	no	no	DET
dpc-3653	51	12	response	response	NOUN
dpc-3653	51	13	(	(	PUNCT
dpc-3653	51	14	0%-49	0%-49	NUM
dpc-3653	51	15	%	%	NOUN
dpc-3653	51	16	reduction	reduction	NOUN
dpc-3653	51	17	in	in	ADP
dpc-3653	51	18	size	size	NOUN
dpc-3653	51	19	)	)	PUNCT
dpc-3653	51	20	.	.	PUNCT
dpc-3653	52	1	patients	patient	NOUN
dpc-3653	52	2	were	be	AUX
dpc-3653	52	3	examined	examine	VERB
dpc-3653	52	4	and	and	CCONJ
dpc-3653	52	5	asked	ask	VERB
dpc-3653	52	6	to	to	PART
dpc-3653	52	7	report	report	VERB
dpc-3653	52	8	any	any	DET
dpc-3653	52	9	local	local	ADJ
dpc-3653	52	10	adverse	adverse	ADJ
dpc-3653	52	11	effects	effect	NOUN
dpc-3653	52	12	such	such	ADJ
dpc-3653	52	13	as	as	ADP
dpc-3653	52	14	erythema	erythema	ADJ
dpc-3653	52	15	,	,	PUNCT
dpc-3653	52	16	pain	pain	NOUN
dpc-3653	52	17	,	,	PUNCT
dpc-3653	52	18	edema	edema	NOUN
dpc-3653	52	19	,	,	PUNCT
dpc-3653	52	20	hypopigmentation	hypopigmentation	NOUN
dpc-3653	52	21	and	and	CCONJ
dpc-3653	52	22	hyperpigmentation	hyperpigmentation	NOUN
dpc-3653	52	23	,	,	PUNCT
dpc-3653	52	24	as	as	ADV
dpc-3653	52	25	well	well	ADV
dpc-3653	52	26	as	as	ADP
dpc-3653	52	27	systemic	systemic	ADJ
dpc-3653	52	28	side	side	NOUN
dpc-3653	52	29	effects	effect	NOUN
dpc-3653	52	30	like	like	ADP
dpc-3653	52	31	fever	fever	NOUN
dpc-3653	52	32	,	,	PUNCT
dpc-3653	52	33	myalgia	myalgia	NOUN
dpc-3653	52	34	,	,	PUNCT
dpc-3653	52	35	headache	headache	NOUN
dpc-3653	52	36	,	,	PUNCT
dpc-3653	52	37	and	and	CCONJ
dpc-3653	52	38	vomiting	vomiting	NOUN
dpc-3653	52	39	.	.	PUNCT
dpc-3653	53	1	follow	follow	VERB
dpc-3653	53	2	-	-	PUNCT
dpc-3653	53	3	up	up	NOUN
dpc-3653	53	4	a	a	DET
dpc-3653	53	5	6	6	NUM
dpc-3653	53	6	-	-	PUNCT
dpc-3653	53	7	month	month	NOUN
dpc-3653	53	8	follow	follow	NOUN
dpc-3653	53	9	-	-	PUNCT
dpc-3653	53	10	up	up	NOUN
dpc-3653	53	11	assessment	assessment	NOUN
dpc-3653	53	12	was	be	AUX
dpc-3653	53	13	performed	perform	VERB
dpc-3653	53	14	every	every	DET
dpc-3653	53	15	month	month	NOUN
dpc-3653	53	16	after	after	SCONJ
dpc-3653	53	17	the	the	DET
dpc-3653	53	18	therapy	therapy	NOUN
dpc-3653	53	19	was	be	AUX
dpc-3653	53	20	completed	complete	VERB
dpc-3653	53	21	to	to	PART
dpc-3653	53	22	detect	detect	VERB
dpc-3653	53	23	any	any	DET
dpc-3653	53	24	recurrence	recurrence	NOUN
dpc-3653	53	25	of	of	ADP
dpc-3653	53	26	warts	wart	NOUN
dpc-3653	53	27	.	.	PUNCT
dpc-3653	54	1	statistical	statistical	ADJ
dpc-3653	54	2	analysis	analysis	NOUN
dpc-3653	54	3	the	the	DET
dpc-3653	54	4	data	datum	NOUN
dpc-3653	54	5	collected	collect	VERB
dpc-3653	54	6	were	be	AUX
dpc-3653	54	7	coded	code	VERB
dpc-3653	54	8	,	,	PUNCT
dpc-3653	54	9	processed	process	VERB
dpc-3653	54	10	and	and	CCONJ
dpc-3653	54	11	analyzed	analyze	VERB
dpc-3653	54	12	with	with	ADP
dpc-3653	54	13	spss	spss	PROPN
dpc-3653	54	14	version	version	NOUN
dpc-3653	54	15	27	27	NUM
dpc-3653	54	16	for	for	ADP
dpc-3653	54	17	windows	window	NOUN
dpc-3653	54	18	®	®	NOUN
dpc-3653	54	19	(	(	PUNCT
dpc-3653	54	20	statistical	statistical	ADJ
dpc-3653	54	21	package	package	NOUN
dpc-3653	54	22	for	for	ADP
dpc-3653	54	23	social	social	ADJ
dpc-3653	54	24	sciences	science	NOUN
dpc-3653	54	25	)	)	PUNCT
dpc-3653	54	26	(	(	PUNCT
dpc-3653	54	27	ibm	ibm	PROPN
dpc-3653	54	28	,	,	PUNCT
dpc-3653	54	29	spss	spss	PROPN
dpc-3653	54	30	inc	inc	PROPN
dpc-3653	54	31	)	)	PUNCT
dpc-3653	54	32	.	.	PUNCT
dpc-3653	55	1	qualitative	qualitative	ADJ
dpc-3653	55	2	data	datum	NOUN
dpc-3653	55	3	as	as	ADP
dpc-3653	55	4	number	number	NOUN
dpc-3653	55	5	(	(	PUNCT
dpc-3653	55	6	frequency	frequency	NOUN
dpc-3653	55	7	)	)	PUNCT
dpc-3653	55	8	and	and	CCONJ
dpc-3653	55	9	percent	percent	NOUN
dpc-3653	55	10	was	be	AUX
dpc-3653	55	11	presented	present	VERB
dpc-3653	55	12	.	.	PUNCT
dpc-3653	56	1	the	the	DET
dpc-3653	56	2	chi	chi	ADJ
dpc-3653	56	3	-	-	PUNCT
dpc-3653	56	4	square	square	ADJ
dpc-3653	56	5	test	test	NOUN
dpc-3653	56	6	(	(	PUNCT
dpc-3653	56	7	or	or	CCONJ
dpc-3653	56	8	monte	monte	PROPN
dpc-3653	56	9	-	-	PUNCT
dpc-3653	56	10	carlo	carlo	PROPN
dpc-3653	56	11	test	test	NOUN
dpc-3653	56	12	)	)	PUNCT
dpc-3653	56	13	made	make	VERB
dpc-3653	56	14	the	the	DET
dpc-3653	56	15	comparison	comparison	NOUN
dpc-3653	56	16	between	between	ADP
dpc-3653	56	17	groups	group	NOUN
dpc-3653	56	18	.	.	PUNCT
dpc-3653	57	1	the	the	DET
dpc-3653	57	2	kolmogorov	kolmogorov	ADJ
dpc-3653	57	3	-	-	PUNCT
dpc-3653	57	4	smirnov	smirnov	ADJ
dpc-3653	57	5	test	test	NOUN
dpc-3653	57	6	tested	test	VERB
dpc-3653	57	7	quantitative	quantitative	ADJ
dpc-3653	57	8	data	datum	NOUN
dpc-3653	57	9	for	for	ADP
dpc-3653	57	10	normality	normality	NOUN
dpc-3653	57	11	.	.	PUNCT
dpc-3653	58	1	parametric	parametric	ADJ
dpc-3653	58	2	data	datum	NOUN
dpc-3653	58	3	were	be	AUX
dpc-3653	58	4	expressed	express	VERB
dpc-3653	58	5	as	as	ADP
dpc-3653	58	6	median	median	PROPN
dpc-3653	58	7	±	±	NUM
dpc-3653	58	8	sd	sd	NOUN
dpc-3653	58	9	while	while	SCONJ
dpc-3653	58	10	the	the	DET
dpc-3653	58	11	non	non	ADJ
dpc-3653	58	12	-	-	ADJ
dpc-3653	58	13	parametric	parametric	ADJ
dpc-3653	58	14	data	datum	NOUN
dpc-3653	58	15	were	be	AUX
dpc-3653	58	16	expressed	express	VERB
dpc-3653	58	17	as	as	ADP
dpc-3653	58	18	median	median	NOUN
dpc-3653	58	19	(	(	PUNCT
dpc-3653	58	20	range	range	NOUN
dpc-3653	58	21	)	)	PUNCT
dpc-3653	58	22	.	.	PUNCT
dpc-3653	59	1	to	to	PART
dpc-3653	59	2	compare	compare	VERB
dpc-3653	59	3	three	three	NUM
dpc-3653	59	4	groups	group	NOUN
dpc-3653	59	5	with	with	ADP
dpc-3653	59	6	normally	normally	ADV
dpc-3653	59	7	distributed	distribute	VERB
dpc-3653	59	8	quantitative	quantitative	ADJ
dpc-3653	59	9	variables	variable	NOUN
dpc-3653	59	10	,	,	PUNCT
dpc-3653	59	11	one	one	NUM
dpc-3653	59	12	-	-	PUNCT
dpc-3653	59	13	way	way	NOUN
dpc-3653	59	14	analysis	analysis	NOUN
dpc-3653	59	15	of	of	ADP
dpc-3653	59	16	the	the	DET
dpc-3653	59	17	variance	variance	NOUN
dpc-3653	59	18	(	(	PUNCT
dpc-3653	59	19	one	one	NUM
dpc-3653	59	20	-	-	PUNCT
dpc-3653	59	21	way	way	NOUN
dpc-3653	59	22	anova	anova	PROPN
dpc-3653	59	23	)	)	PUNCT
dpc-3653	59	24	test	test	NOUN
dpc-3653	59	25	was	be	AUX
dpc-3653	59	26	used	use	VERB
dpc-3653	59	27	and	and	CCONJ
dpc-3653	59	28	kruskal	kruskal	PROPN
dpc-3653	59	29	-	-	PUNCT
dpc-3653	59	30	wallis	wallis	PROPN
dpc-3653	59	31	test	test	NOUN
dpc-3653	59	32	was	be	AUX
dpc-3653	59	33	used	use	VERB
dpc-3653	59	34	if	if	SCONJ
dpc-3653	59	35	the	the	DET
dpc-3653	59	36	data	datum	NOUN
dpc-3653	59	37	were	be	AUX
dpc-3653	59	38	abnormally	abnormally	ADV
dpc-3653	59	39	distributed	distribute	VERB
dpc-3653	59	40	.	.	PUNCT
dpc-3653	60	1	for	for	ADP
dpc-3653	60	2	all	all	DET
dpc-3653	60	3	tests	test	NOUN
dpc-3653	60	4	,	,	PUNCT
dpc-3653	60	5	p	p	NOUN
dpc-3653	60	6	values	value	NOUN
dpc-3653	60	7	<	<	NOUN
dpc-3653	60	8	0.05	0.05	NUM
dpc-3653	60	9	are	be	AUX
dpc-3653	60	10	considered	consider	VERB
dpc-3653	60	11	significant	significant	ADJ
dpc-3653	60	12	.	.	PUNCT
dpc-3653	61	1	results	result	VERB
dpc-3653	61	2	the	the	DET
dpc-3653	61	3	study	study	NOUN
dpc-3653	61	4	included	include	VERB
dpc-3653	61	5	60	60	NUM
dpc-3653	61	6	patients	patient	NOUN
dpc-3653	61	7	with	with	ADP
dpc-3653	61	8	multiple	multiple	ADJ
dpc-3653	61	9	non	non	ADJ
dpc-3653	61	10	-	-	ADJ
dpc-3653	61	11	genital	genital	ADJ
dpc-3653	61	12	warts	wart	NOUN
dpc-3653	61	13	.	.	PUNCT
dpc-3653	62	1	the	the	DET
dpc-3653	62	2	median	median	ADJ
dpc-3653	62	3	age	age	NOUN
dpc-3653	62	4	in	in	ADP
dpc-3653	62	5	group	group	NOUN
dpc-3653	62	6	i	i	PRON
dpc-3653	62	7	was	be	AUX
dpc-3653	62	8	16	16	NUM
dpc-3653	62	9	years	year	NOUN
dpc-3653	62	10	with	with	ADP
dpc-3653	62	11	range	range	NOUN
dpc-3653	62	12	between	between	ADP
dpc-3653	62	13	10	10	NUM
dpc-3653	62	14	and	and	CCONJ
dpc-3653	62	15	39	39	NUM
dpc-3653	62	16	years	year	NOUN
dpc-3653	62	17	,	,	PUNCT
dpc-3653	62	18	the	the	DET
dpc-3653	62	19	median	median	ADJ
dpc-3653	62	20	age	age	NOUN
dpc-3653	62	21	in	in	ADP
dpc-3653	62	22	group	group	PROPN
dpc-3653	62	23	ii	ii	PROPN
dpc-3653	62	24	was	be	AUX
dpc-3653	62	25	14	14	NUM
dpc-3653	62	26	years	year	NOUN
dpc-3653	62	27	with	with	ADP
dpc-3653	62	28	range	range	NOUN
dpc-3653	62	29	between	between	ADP
dpc-3653	62	30	9	9	NUM
dpc-3653	62	31	and	and	CCONJ
dpc-3653	62	32	34	34	NUM
dpc-3653	62	33	years	year	NOUN
dpc-3653	62	34	and	and	CCONJ
dpc-3653	62	35	the	the	DET
dpc-3653	62	36	median	median	ADJ
dpc-3653	62	37	age	age	NOUN
dpc-3653	62	38	in	in	ADP
dpc-3653	62	39	group	group	PROPN
dpc-3653	62	40	iii	iii	PROPN
dpc-3653	62	41	was	be	AUX
dpc-3653	62	42	20	20	NUM
dpc-3653	62	43	years	year	NOUN
dpc-3653	62	44	with	with	ADP
dpc-3653	62	45	range	range	NOUN
dpc-3653	62	46	between	between	ADP
dpc-3653	62	47	10	10	NUM
dpc-3653	62	48	and	and	CCONJ
dpc-3653	62	49	38	38	NUM
dpc-3653	62	50	years	year	NOUN
dpc-3653	62	51	.	.	PUNCT
dpc-3653	63	1	there	there	PRON
dpc-3653	63	2	was	be	VERB
dpc-3653	63	3	no	no	DET
dpc-3653	63	4	statistically	statistically	ADV
dpc-3653	63	5	significant	significant	ADJ
dpc-3653	63	6	difference	difference	NOUN
dpc-3653	63	7	between	between	ADP
dpc-3653	63	8	the	the	DET
dpc-3653	63	9	cases	case	NOUN
dpc-3653	63	10	in	in	ADP
dpc-3653	63	11	the	the	DET
dpc-3653	63	12	different	different	ADJ
dpc-3653	63	13	studied	study	VERB
dpc-3653	63	14	groups	group	NOUN
dpc-3653	63	15	regarding	regard	VERB
dpc-3653	63	16	the	the	DET
dpc-3653	63	17	age	age	NOUN
dpc-3653	63	18	(	(	PUNCT
dpc-3653	63	19	p	p	X
dpc-3653	63	20	=	=	NOUN
dpc-3653	63	21	0.114	0.114	NUM
dpc-3653	63	22	)	)	PUNCT
dpc-3653	63	23	.	.	PUNCT
dpc-3653	64	1	as	as	SCONJ
dpc-3653	64	2	regards	regard	NOUN
dpc-3653	64	3	to	to	ADP
dpc-3653	64	4	the	the	DET
dpc-3653	64	5	sex	sex	NOUN
dpc-3653	64	6	,	,	PUNCT
dpc-3653	64	7	there	there	PRON
dpc-3653	64	8	were	be	VERB
dpc-3653	64	9	40	40	NUM
dpc-3653	64	10	%	%	NOUN
dpc-3653	64	11	males	male	NOUN
dpc-3653	64	12	and	and	CCONJ
dpc-3653	64	13	60	60	NUM
dpc-3653	64	14	%	%	NOUN
dpc-3653	64	15	females	female	NOUN
dpc-3653	64	16	in	in	ADP
dpc-3653	64	17	group	group	NOUN
dpc-3653	64	18	i	i	PRON
dpc-3653	64	19	,	,	PUNCT
dpc-3653	64	20	there	there	PRON
dpc-3653	64	21	were	be	VERB
dpc-3653	64	22	35	35	NUM
dpc-3653	64	23	%	%	NOUN
dpc-3653	64	24	males	male	NOUN
dpc-3653	64	25	and	and	CCONJ
dpc-3653	64	26	65	65	NUM
dpc-3653	64	27	%	%	NOUN
dpc-3653	64	28	females	female	NOUN
dpc-3653	64	29	in	in	ADP
dpc-3653	64	30	group	group	PROPN
dpc-3653	64	31	ii	ii	PROPN
dpc-3653	64	32	and	and	CCONJ
dpc-3653	64	33	there	there	PRON
dpc-3653	64	34	were	be	VERB
dpc-3653	64	35	25	25	NUM
dpc-3653	64	36	%	%	NOUN
dpc-3653	64	37	males	male	NOUN
dpc-3653	64	38	and	and	CCONJ
dpc-3653	64	39	75	75	NUM
dpc-3653	64	40	%	%	NOUN
dpc-3653	64	41	females	female	NOUN
dpc-3653	64	42	in	in	ADP
dpc-3653	64	43	group	group	PROPN
dpc-3653	64	44	iii	iii	PROPN
dpc-3653	64	45	with	with	ADP
dpc-3653	64	46	no	no	DET
dpc-3653	64	47	statistically	statistically	ADV
dpc-3653	64	48	significant	significant	ADJ
dpc-3653	64	49	difference	difference	NOUN
dpc-3653	64	50	between	between	ADP
dpc-3653	64	51	the	the	DET
dpc-3653	64	52	studied	study	VERB
dpc-3653	64	53	groups	group	NOUN
dpc-3653	64	54	regarding	regard	VERB
dpc-3653	64	55	the	the	DET
dpc-3653	64	56	sex	sex	NOUN
dpc-3653	64	57	distribution	distribution	NOUN
dpc-3653	64	58	(	(	PUNCT
dpc-3653	64	59	p	p	NOUN
dpc-3653	64	60	=	=	NOUN
dpc-3653	64	61	0.293	0.293	NUM
dpc-3653	64	62	)	)	PUNCT
dpc-3653	64	63	.	.	PUNCT
dpc-3653	65	1	in	in	ADP
dpc-3653	65	2	regard	regard	NOUN
dpc-3653	65	3	to	to	ADP
dpc-3653	65	4	type	type	NOUN
dpc-3653	65	5	of	of	ADP
dpc-3653	65	6	warts	wart	NOUN
dpc-3653	65	7	,	,	PUNCT
dpc-3653	65	8	in	in	ADP
dpc-3653	65	9	group	group	NOUN
dpc-3653	65	10	i	i	PROPN
dpc-3653	65	11	,	,	PUNCT
dpc-3653	65	12	the	the	DET
dpc-3653	65	13	most	most	ADV
dpc-3653	65	14	common	common	ADJ
dpc-3653	65	15	type	type	NOUN
dpc-3653	65	16	of	of	ADP
dpc-3653	65	17	wart	wart	NOUN
dpc-3653	65	18	was	be	AUX
dpc-3653	65	19	common	common	ADJ
dpc-3653	65	20	warts	wart	NOUN
dpc-3653	65	21	in	in	ADP
dpc-3653	65	22	80	80	NUM
dpc-3653	65	23	%	%	NOUN
dpc-3653	65	24	of	of	ADP
dpc-3653	65	25	the	the	DET
dpc-3653	65	26	cases	case	NOUN
dpc-3653	65	27	followed	follow	VERB
dpc-3653	65	28	by	by	ADP
dpc-3653	65	29	plantar	plantar	NOUN
dpc-3653	65	30	wart	wart	NOUN
dpc-3653	65	31	in	in	ADP
dpc-3653	65	32	20	20	NUM
dpc-3653	65	33	%	%	NOUN
dpc-3653	65	34	with	with	ADP
dpc-3653	65	35	no	no	DET
dpc-3653	65	36	cases	case	NOUN
dpc-3653	65	37	with	with	ADP
dpc-3653	65	38	plane	plane	NOUN
dpc-3653	65	39	warts	wart	NOUN
dpc-3653	65	40	in	in	ADP
dpc-3653	65	41	this	this	DET
dpc-3653	65	42	group	group	NOUN
dpc-3653	65	43	.	.	PUNCT
dpc-3653	66	1	in	in	ADP
dpc-3653	66	2	group	group	PROPN
dpc-3653	66	3	ii	ii	PROPN
dpc-3653	66	4	,	,	PUNCT
dpc-3653	66	5	the	the	DET
dpc-3653	66	6	most	most	ADV
dpc-3653	66	7	common	common	ADJ
dpc-3653	66	8	type	type	NOUN
dpc-3653	66	9	of	of	ADP
dpc-3653	66	10	wart	wart	NOUN
dpc-3653	66	11	was	be	AUX
dpc-3653	66	12	common	common	ADJ
dpc-3653	66	13	warts	wart	NOUN
dpc-3653	66	14	in	in	ADP
dpc-3653	66	15	60	60	NUM
dpc-3653	66	16	%	%	NOUN
dpc-3653	66	17	of	of	ADP
dpc-3653	66	18	the	the	DET
dpc-3653	66	19	cases	case	NOUN
dpc-3653	66	20	followed	follow	VERB
dpc-3653	66	21	by	by	ADP
dpc-3653	66	22	plantar	plantar	NOUN
dpc-3653	66	23	wart	wart	NOUN
dpc-3653	66	24	in	in	ADP
dpc-3653	66	25	30	30	NUM
dpc-3653	66	26	%	%	NOUN
dpc-3653	66	27	and	and	CCONJ
dpc-3653	66	28	plane	plane	NOUN
dpc-3653	66	29	warts	wart	NOUN
dpc-3653	66	30	in	in	ADP
dpc-3653	66	31	10	10	NUM
dpc-3653	66	32	%	%	NOUN
dpc-3653	66	33	of	of	ADP
dpc-3653	66	34	the	the	DET
dpc-3653	66	35	cases	case	NOUN
dpc-3653	66	36	.	.	PUNCT
dpc-3653	67	1	in	in	ADP
dpc-3653	67	2	group	group	PROPN
dpc-3653	67	3	iii	iii	PROPN
dpc-3653	67	4	,	,	PUNCT
dpc-3653	67	5	the	the	DET
dpc-3653	67	6	most	most	ADV
dpc-3653	67	7	common	common	ADJ
dpc-3653	67	8	type	type	NOUN
dpc-3653	67	9	of	of	ADP
dpc-3653	67	10	wart	wart	NOUN
dpc-3653	67	11	was	be	AUX
dpc-3653	67	12	plantar	plantar	NOUN
dpc-3653	67	13	warts	wart	NOUN
dpc-3653	67	14	in	in	ADP
dpc-3653	67	15	85	85	NUM
dpc-3653	67	16	%	%	NOUN
dpc-3653	67	17	of	of	ADP
dpc-3653	67	18	the	the	DET
dpc-3653	67	19	cases	case	NOUN
dpc-3653	67	20	followed	follow	VERB
dpc-3653	67	21	by	by	ADP
dpc-3653	67	22	common	common	ADJ
dpc-3653	67	23	wart	wart	NOUN
dpc-3653	67	24	in	in	ADP
dpc-3653	67	25	15	15	NUM
dpc-3653	67	26	%	%	NOUN
dpc-3653	67	27	with	with	ADP
dpc-3653	67	28	no	no	DET
dpc-3653	67	29	cases	case	NOUN
dpc-3653	67	30	with	with	ADP
dpc-3653	67	31	plane	plane	NOUN
dpc-3653	67	32	warts	wart	NOUN
dpc-3653	67	33	in	in	ADP
dpc-3653	67	34	this	this	DET
dpc-3653	67	35	group	group	NOUN
dpc-3653	67	36	.	.	PUNCT
dpc-3653	68	1	as	as	SCONJ
dpc-3653	68	2	regards	regard	NOUN
dpc-3653	68	3	to	to	ADP
dpc-3653	68	4	number	number	NOUN
dpc-3653	68	5	of	of	ADP
dpc-3653	68	6	warts	wart	NOUN
dpc-3653	68	7	,	,	PUNCT
dpc-3653	68	8	the	the	DET
dpc-3653	68	9	median	median	ADJ
dpc-3653	68	10	number	number	NOUN
dpc-3653	68	11	of	of	ADP
dpc-3653	68	12	warts	wart	NOUN
dpc-3653	68	13	in	in	ADP
dpc-3653	68	14	group	group	NOUN
dpc-3653	68	15	i	i	PRON
dpc-3653	68	16	was	be	AUX
dpc-3653	68	17	3	3	NUM
dpc-3653	68	18	with	with	ADP
dpc-3653	68	19	range	range	NOUN
dpc-3653	68	20	between	between	ADP
dpc-3653	68	21	3	3	NUM
dpc-3653	68	22	and	and	CCONJ
dpc-3653	68	23	13	13	NUM
dpc-3653	68	24	,	,	PUNCT
dpc-3653	68	25	the	the	DET
dpc-3653	68	26	median	median	ADJ
dpc-3653	68	27	number	number	NOUN
dpc-3653	68	28	of	of	ADP
dpc-3653	68	29	warts	wart	NOUN
dpc-3653	68	30	in	in	ADP
dpc-3653	68	31	group	group	PROPN
dpc-3653	68	32	ii	ii	PROPN
dpc-3653	68	33	was	be	AUX
dpc-3653	68	34	4	4	NUM
dpc-3653	68	35	with	with	ADP
dpc-3653	68	36	range	range	NOUN
dpc-3653	68	37	between	between	ADP
dpc-3653	68	38	3	3	NUM
dpc-3653	68	39	and	and	CCONJ
dpc-3653	68	40	12	12	NUM
dpc-3653	68	41	and	and	CCONJ
dpc-3653	68	42	the	the	DET
dpc-3653	68	43	median	median	ADJ
dpc-3653	68	44	number	number	NOUN
dpc-3653	68	45	of	of	ADP
dpc-3653	68	46	warts	wart	NOUN
dpc-3653	68	47	in	in	ADP
dpc-3653	68	48	group	group	PROPN
dpc-3653	68	49	iii	iii	PROPN
dpc-3653	68	50	was	be	AUX
dpc-3653	68	51	3	3	NUM
dpc-3653	68	52	with	with	ADP
dpc-3653	68	53	range	range	NOUN
dpc-3653	68	54	between	between	ADP
dpc-3653	68	55	3	3	NUM
dpc-3653	68	56	and	and	CCONJ
dpc-3653	68	57	7	7	NUM
dpc-3653	68	58	.	.	X
dpc-3653	69	1	there	there	PRON
dpc-3653	69	2	was	be	VERB
dpc-3653	69	3	no	no	DET
dpc-3653	69	4	statistically	statistically	ADV
dpc-3653	69	5	significant	significant	ADJ
dpc-3653	69	6	difference	difference	NOUN
dpc-3653	69	7	between	between	ADP
dpc-3653	69	8	the	the	DET
dpc-3653	69	9	cases	case	NOUN
dpc-3653	69	10	in	in	ADP
dpc-3653	69	11	the	the	DET
dpc-3653	69	12	different	different	ADJ
dpc-3653	69	13	studied	study	VERB
dpc-3653	69	14	groups	group	NOUN
dpc-3653	69	15	regarding	regard	VERB
dpc-3653	69	16	the	the	DET
dpc-3653	69	17	number	number	NOUN
dpc-3653	69	18	of	of	ADP
dpc-3653	69	19	warts	wart	NOUN
dpc-3653	69	20	(	(	PUNCT
dpc-3653	69	21	p	p	X
dpc-3653	69	22	=	=	NOUN
dpc-3653	69	23	0.282	0.282	NUM
dpc-3653	69	24	)	)	PUNCT
dpc-3653	69	25	.	.	PUNCT
dpc-3653	70	1	the	the	DET
dpc-3653	70	2	median	median	ADJ
dpc-3653	70	3	disease	disease	NOUN
dpc-3653	70	4	duration	duration	NOUN
dpc-3653	70	5	in	in	ADP
dpc-3653	70	6	group	group	NOUN
dpc-3653	70	7	i	i	PRON
dpc-3653	70	8	was	be	AUX
dpc-3653	70	9	20	20	NUM
dpc-3653	70	10	months	month	NOUN
dpc-3653	70	11	with	with	ADP
dpc-3653	70	12	range	range	NOUN
dpc-3653	70	13	between	between	ADP
dpc-3653	70	14	18	18	NUM
dpc-3653	70	15	and	and	CCONJ
dpc-3653	70	16	24	24	NUM
dpc-3653	70	17	months	month	NOUN
dpc-3653	70	18	,	,	PUNCT
dpc-3653	70	19	the	the	DET
dpc-3653	70	20	median	median	ADJ
dpc-3653	70	21	disease	disease	NOUN
dpc-3653	70	22	duration	duration	NOUN
dpc-3653	70	23	in	in	ADP
dpc-3653	70	24	group	group	PROPN
dpc-3653	70	25	ii	ii	PROPN
dpc-3653	70	26	was	be	AUX
dpc-3653	70	27	24	24	NUM
dpc-3653	70	28	months	month	NOUN
dpc-3653	70	29	with	with	ADP
dpc-3653	70	30	range	range	NOUN
dpc-3653	70	31	between	between	ADP
dpc-3653	70	32	18	18	NUM
dpc-3653	70	33	 	 	SPACE
dpc-3653	70	34	and	and	CCONJ
dpc-3653	70	35	28	28	NUM
dpc-3653	70	36	months	month	NOUN
dpc-3653	70	37	and	and	CCONJ
dpc-3653	70	38	the	the	DET
dpc-3653	70	39	median	median	ADJ
dpc-3653	70	40	disease	disease	NOUN
dpc-3653	70	41	duration	duration	NOUN
dpc-3653	70	42	in	in	ADP
dpc-3653	70	43	group	group	PROPN
dpc-3653	70	44	iii	iii	PROPN
dpc-3653	70	45	was	be	AUX
dpc-3653	70	46	20	20	NUM
dpc-3653	70	47	months	month	NOUN
dpc-3653	70	48	with	with	ADP
dpc-3653	70	49	range	range	NOUN
dpc-3653	70	50	between	between	ADP
dpc-3653	70	51	12	12	NUM
dpc-3653	70	52	and	and	CCONJ
dpc-3653	70	53	24	24	NUM
dpc-3653	70	54	months	month	NOUN
dpc-3653	70	55	.	.	PUNCT
dpc-3653	71	1	there	there	PRON
dpc-3653	71	2	was	be	VERB
dpc-3653	71	3	no	no	DET
dpc-3653	71	4	statistically	statistically	ADV
dpc-3653	71	5	significant	significant	ADJ
dpc-3653	71	6	difference	difference	NOUN
dpc-3653	71	7	between	between	ADP
dpc-3653	71	8	the	the	DET
dpc-3653	71	9	cases	case	NOUN
dpc-3653	71	10	in	in	ADP
dpc-3653	71	11	the	the	DET
dpc-3653	71	12	different	different	ADJ
dpc-3653	71	13	studied	study	VERB
dpc-3653	71	14	groups	group	NOUN
dpc-3653	71	15	regarding	regard	VERB
dpc-3653	71	16	the	the	DET
dpc-3653	71	17	disease	disease	NOUN
dpc-3653	71	18	duration	duration	NOUN
dpc-3653	71	19	(	(	PUNCT
dpc-3653	71	20	p	p	NOUN
dpc-3653	71	21	=	=	NOUN
dpc-3653	71	22	0.059	0.059	NUM
dpc-3653	71	23	)	)	PUNCT
dpc-3653	71	24	.	.	PUNCT
dpc-3653	72	1	presence	presence	NOUN
dpc-3653	72	2	of	of	ADP
dpc-3653	72	3	distant	distant	ADJ
dpc-3653	72	4	warts	wart	NOUN
dpc-3653	72	5	was	be	AUX
dpc-3653	72	6	reported	report	VERB
dpc-3653	72	7	in	in	ADP
dpc-3653	72	8	30	30	NUM
dpc-3653	72	9	%	%	NOUN
dpc-3653	72	10	,	,	PUNCT
dpc-3653	72	11	55	55	NUM
dpc-3653	72	12	%	%	NOUN
dpc-3653	72	13	and	and	CCONJ
dpc-3653	72	14	15	15	NUM
dpc-3653	72	15	%	%	NOUN
dpc-3653	72	16	in	in	ADP
dpc-3653	72	17	group	group	NOUN
dpc-3653	72	18	i	i	PROPN
dpc-3653	72	19	,	,	PUNCT
dpc-3653	72	20	ii	ii	PROPN
dpc-3653	72	21	and	and	CCONJ
dpc-3653	72	22	iii	iii	NOUN
dpc-3653	72	23	respectively	respectively	ADV
dpc-3653	72	24	with	with	ADP
dpc-3653	72	25	statistically	statistically	ADV
dpc-3653	72	26	significant	significant	ADJ
dpc-3653	72	27	difference	difference	NOUN
dpc-3653	72	28	between	between	ADP
dpc-3653	72	29	the	the	DET
dpc-3653	72	30	studied	study	VERB
dpc-3653	72	31	groups	group	NOUN
dpc-3653	72	32	(	(	PUNCT
dpc-3653	72	33	p	p	X
dpc-3653	72	34	=	=	PUNCT
dpc-3653	72	35	0.025	0.025	NUM
dpc-3653	72	36	,	,	PUNCT
dpc-3653	72	37	table	table	NOUN
dpc-3653	72	38	1	1	NUM
dpc-3653	72	39	)	)	PUNCT
dpc-3653	72	40	.	.	PUNCT
dpc-3653	73	1	regarding	regard	VERB
dpc-3653	73	2	the	the	DET
dpc-3653	73	3	therapeutic	therapeutic	ADJ
dpc-3653	73	4	response	response	NOUN
dpc-3653	73	5	within	within	ADP
dpc-3653	73	6	the	the	DET
dpc-3653	73	7	three	three	NUM
dpc-3653	73	8	studied	study	VERB
dpc-3653	73	9	groups	group	NOUN
dpc-3653	73	10	,	,	PUNCT
dpc-3653	73	11	in	in	ADP
dpc-3653	73	12	group	group	NOUN
dpc-3653	73	13	i	i	NOUN
dpc-3653	73	14	,	,	PUNCT
dpc-3653	73	15	complete	complete	ADJ
dpc-3653	73	16	response	response	NOUN
dpc-3653	73	17	was	be	AUX
dpc-3653	73	18	reported	report	VERB
dpc-3653	73	19	in	in	ADP
dpc-3653	73	20	(	(	PUNCT
dpc-3653	73	21	40	40	NUM
dpc-3653	73	22	%	%	NOUN
dpc-3653	73	23	)	)	PUNCT
dpc-3653	73	24	of	of	ADP
dpc-3653	73	25	the	the	DET
dpc-3653	73	26	cases	case	NOUN
dpc-3653	73	27	,	,	PUNCT
dpc-3653	73	28	partial	partial	ADJ
dpc-3653	73	29	response	response	NOUN
dpc-3653	73	30	in	in	ADP
dpc-3653	73	31	(	(	PUNCT
dpc-3653	73	32	15	15	NUM
dpc-3653	73	33	%	%	NOUN
dpc-3653	73	34	)	)	PUNCT
dpc-3653	73	35	and	and	CCONJ
dpc-3653	73	36	no	no	DET
dpc-3653	73	37	response	response	NOUN
dpc-3653	73	38	in	in	ADP
dpc-3653	73	39	(	(	PUNCT
dpc-3653	73	40	45	45	NUM
dpc-3653	73	41	%	%	NOUN
dpc-3653	73	42	)	)	PUNCT
dpc-3653	73	43	.	.	PUNCT
dpc-3653	74	1	in	in	ADP
dpc-3653	74	2	group	group	PROPN
dpc-3653	74	3	ii	ii	PROPN
dpc-3653	74	4	,	,	PUNCT
dpc-3653	74	5	complete	complete	ADJ
dpc-3653	74	6	response	response	NOUN
dpc-3653	74	7	was	be	AUX
dpc-3653	74	8	detected	detect	VERB
dpc-3653	74	9	(	(	PUNCT
dpc-3653	74	10	75	75	NUM
dpc-3653	74	11	%	%	NOUN
dpc-3653	74	12	)	)	PUNCT
dpc-3653	74	13	of	of	ADP
dpc-3653	74	14	the	the	DET
dpc-3653	74	15	cases	case	NOUN
dpc-3653	74	16	and	and	CCONJ
dpc-3653	74	17	no	no	DET
dpc-3653	74	18	response	response	NOUN
dpc-3653	74	19	in	in	ADP
dpc-3653	74	20	(	(	PUNCT
dpc-3653	74	21	25	25	NUM
dpc-3653	74	22	%	%	NOUN
dpc-3653	74	23	)	)	PUNCT
dpc-3653	74	24	.	.	PUNCT
dpc-3653	75	1	in	in	ADP
dpc-3653	75	2	group	group	PROPN
dpc-3653	75	3	iii	iii	PROPN
dpc-3653	75	4	,	,	PUNCT
dpc-3653	75	5	partial	partial	ADJ
dpc-3653	75	6	response	response	NOUN
dpc-3653	75	7	in	in	ADP
dpc-3653	75	8	(	(	PUNCT
dpc-3653	75	9	10	10	NUM
dpc-3653	75	10	%	%	NOUN
dpc-3653	75	11	)	)	PUNCT
dpc-3653	75	12	of	of	ADP
dpc-3653	75	13	the	the	DET
dpc-3653	75	14	cases	case	NOUN
dpc-3653	75	15	and	and	CCONJ
dpc-3653	75	16	no	no	DET
dpc-3653	75	17	response	response	NOUN
dpc-3653	75	18	in	in	ADP
dpc-3653	75	19	(	(	PUNCT
dpc-3653	75	20	90	90	NUM
dpc-3653	75	21	%	%	NOUN
dpc-3653	75	22	)	)	PUNCT
dpc-3653	75	23	there	there	PRON
dpc-3653	75	24	was	be	VERB
dpc-3653	75	25	a	a	DET
dpc-3653	75	26	statistically	statistically	ADV
dpc-3653	75	27	significant	significant	ADJ
dpc-3653	75	28	difference	difference	NOUN
dpc-3653	75	29	as	as	ADP
dpc-3653	75	30	regarding	regard	VERB
dpc-3653	75	31	the	the	DET
dpc-3653	75	32	local	local	ADJ
dpc-3653	75	33	response	response	NOUN
dpc-3653	75	34	between	between	ADP
dpc-3653	75	35	the	the	DET
dpc-3653	75	36	three	three	NUM
dpc-3653	75	37	studied	study	VERB
dpc-3653	75	38	groups	group	NOUN
dpc-3653	75	39	with	with	ADP
dpc-3653	75	40	the	the	DET
dpc-3653	75	41	highest	high	ADJ
dpc-3653	75	42	response	response	NOUN
dpc-3653	75	43	in	in	ADP
dpc-3653	75	44	group	group	PROPN
dpc-3653	75	45	ii	ii	PROPN
dpc-3653	75	46	(	(	PUNCT
dpc-3653	75	47	quadrivalent	quadrivalent	NOUN
dpc-3653	75	48	hpv	hpv	NOUN
dpc-3653	75	49	vaccine	vaccine	NOUN
dpc-3653	75	50	)	)	PUNCT
dpc-3653	75	51	followed	follow	VERB
dpc-3653	75	52	by	by	ADP
dpc-3653	75	53	group	group	NOUN
dpc-3653	75	54	i	i	PROPN
dpc-3653	75	55	(	(	PUNCT
dpc-3653	75	56	candida	candida	PROPN
dpc-3653	75	57	antigen	antigen	ADV
dpc-3653	75	58	)	)	PUNCT
dpc-3653	75	59	.	.	PUNCT
dpc-3653	76	1	regarding	regard	VERB
dpc-3653	76	2	the	the	DET
dpc-3653	76	3	response	response	NOUN
dpc-3653	76	4	in	in	ADP
dpc-3653	76	5	the	the	DET
dpc-3653	76	6	distant	distant	ADJ
dpc-3653	76	7	warts	wart	NOUN
dpc-3653	76	8	within	within	ADP
dpc-3653	76	9	the	the	DET
dpc-3653	76	10	three	three	NUM
dpc-3653	76	11	studied	study	VERB
dpc-3653	76	12	groups	group	NOUN
dpc-3653	76	13	,	,	PUNCT
dpc-3653	76	14	in	in	ADP
dpc-3653	76	15	group	group	NOUN
dpc-3653	76	16	i	i	NOUN
dpc-3653	76	17	,	,	PUNCT
dpc-3653	76	18	complete	complete	ADJ
dpc-3653	76	19	response	response	NOUN
dpc-3653	76	20	was	be	AUX
dpc-3653	76	21	detected	detect	VERB
dpc-3653	76	22	in	in	ADP
dpc-3653	76	23	2	2	NUM
dpc-3653	76	24	out	out	ADP
dpc-3653	76	25	of	of	ADP
dpc-3653	76	26	6	6	NUM
dpc-3653	76	27	patients	patient	NOUN
dpc-3653	76	28	(	(	PUNCT
dpc-3653	76	29	33.3	33.3	NUM
dpc-3653	76	30	%	%	NOUN
dpc-3653	76	31	)	)	PUNCT
dpc-3653	76	32	,	,	PUNCT
dpc-3653	76	33	partial	partial	ADJ
dpc-3653	76	34	response	response	NOUN
dpc-3653	76	35	in	in	ADP
dpc-3653	76	36	3	3	NUM
dpc-3653	76	37	 	 	SPACE
dpc-3653	76	38	out	out	ADP
dpc-3653	76	39	of	of	ADP
dpc-3653	76	40	6	6	NUM
dpc-3653	76	41	patients	patient	NOUN
dpc-3653	76	42	(	(	PUNCT
dpc-3653	76	43	50	50	NUM
dpc-3653	76	44	%	%	NOUN
dpc-3653	76	45	)	)	PUNCT
dpc-3653	76	46	and	and	CCONJ
dpc-3653	76	47	no	no	DET
dpc-3653	76	48	response	response	NOUN
dpc-3653	76	49	in	in	ADP
dpc-3653	76	50	1	1	NUM
dpc-3653	76	51	out	out	ADP
dpc-3653	76	52	of	of	ADP
dpc-3653	76	53	6	6	NUM
dpc-3653	76	54	patients	patient	NOUN
dpc-3653	76	55	(	(	PUNCT
dpc-3653	76	56	16.7	16.7	NUM
dpc-3653	76	57	%	%	NOUN
dpc-3653	76	58	)	)	PUNCT
dpc-3653	76	59	.	.	PUNCT
dpc-3653	77	1	in	in	ADP
dpc-3653	77	2	group	group	PROPN
dpc-3653	77	3	ii	ii	PROPN
dpc-3653	77	4	,	,	PUNCT
dpc-3653	77	5	complete	complete	ADJ
dpc-3653	77	6	response	response	NOUN
dpc-3653	77	7	was	be	AUX
dpc-3653	77	8	detected	detect	VERB
dpc-3653	77	9	in	in	ADP
dpc-3653	77	10	8	8	NUM
dpc-3653	77	11	out	out	ADP
dpc-3653	77	12	of	of	ADP
dpc-3653	77	13	11	11	NUM
dpc-3653	77	14	patients	patient	NOUN
dpc-3653	77	15	(	(	PUNCT
dpc-3653	77	16	72.7	72.7	NUM
dpc-3653	77	17	%	%	NOUN
dpc-3653	77	18	)	)	PUNCT
dpc-3653	77	19	and	and	CCONJ
dpc-3653	77	20	partial	partial	ADJ
dpc-3653	77	21	response	response	NOUN
dpc-3653	77	22	in	in	ADP
dpc-3653	77	23	3	3	NUM
dpc-3653	77	24	out	out	ADP
dpc-3653	77	25	of	of	ADP
dpc-3653	77	26	11	11	NUM
dpc-3653	77	27	patients	patient	NOUN
dpc-3653	77	28	(	(	PUNCT
dpc-3653	77	29	27.3	27.3	NUM
dpc-3653	77	30	%	%	NOUN
dpc-3653	77	31	)	)	PUNCT
dpc-3653	77	32	.	.	PUNCT
dpc-3653	78	1	in	in	ADP
dpc-3653	78	2	group	group	PROPN
dpc-3653	78	3	iii	iii	PROPN
dpc-3653	78	4	,	,	PUNCT
dpc-3653	78	5	no	no	DET
dpc-3653	78	6	distant	distant	ADJ
dpc-3653	78	7	partial	partial	ADJ
dpc-3653	78	8	or	or	CCONJ
dpc-3653	78	9	complete	complete	ADJ
dpc-3653	78	10	local	local	ADJ
dpc-3653	78	11	response	response	NOUN
dpc-3653	78	12	was	be	AUX
dpc-3653	78	13	detected	detect	VERB
dpc-3653	78	14	.	.	PUNCT
dpc-3653	79	1	there	there	PRON
dpc-3653	79	2	was	be	VERB
dpc-3653	79	3	a	a	DET
dpc-3653	79	4	statistically	statistically	ADV
dpc-3653	79	5	significant	significant	ADJ
dpc-3653	79	6	difference	difference	NOUN
dpc-3653	79	7	as	as	ADP
dpc-3653	79	8	regarding	regard	VERB
dpc-3653	79	9	the	the	DET
dpc-3653	79	10	response	response	NOUN
dpc-3653	79	11	between	between	ADP
dpc-3653	79	12	the	the	DET
dpc-3653	79	13	three	three	NUM
dpc-3653	79	14	studied	study	VERB
dpc-3653	79	15	groups	group	NOUN
dpc-3653	79	16	with	with	ADP
dpc-3653	79	17	the	the	DET
dpc-3653	79	18	highest	high	ADJ
dpc-3653	79	19	response	response	NOUN
dpc-3653	79	20	in	in	ADP
dpc-3653	79	21	group	group	PROPN
dpc-3653	79	22	ii	ii	PROPN
dpc-3653	79	23	(	(	PUNCT
dpc-3653	79	24	quadrivalent	quadrivalent	NOUN
dpc-3653	79	25	hpv	hpv	NOUN
dpc-3653	79	26	vaccine	vaccine	NOUN
dpc-3653	79	27	)	)	PUNCT
dpc-3653	79	28	followed	follow	VERB
dpc-3653	79	29	by	by	ADP
dpc-3653	79	30	group	group	NOUN
dpc-3653	79	31	i	i	PRON
dpc-3653	79	32	(	(	PUNCT
dpc-3653	79	33	candida	candida	PROPN
dpc-3653	79	34	antigen	antigen	PROPN
dpc-3653	79	35	,	,	PUNCT
dpc-3653	79	36	table	table	NOUN
dpc-3653	79	37	2	2	NUM
dpc-3653	79	38	)	)	PUNCT
dpc-3653	79	39	.	.	PUNCT
dpc-3653	80	1	regarding	regard	VERB
dpc-3653	80	2	the	the	DET
dpc-3653	80	3	local	local	ADJ
dpc-3653	80	4	side	side	NOUN
dpc-3653	80	5	effects	effect	NOUN
dpc-3653	80	6	,	,	PUNCT
dpc-3653	80	7	tolerable	tolerable	ADJ
dpc-3653	80	8	pain	pain	NOUN
dpc-3653	80	9	during	during	ADP
dpc-3653	80	10	injection	injection	NOUN
dpc-3653	80	11	was	be	AUX
dpc-3653	80	12	reported	report	VERB
dpc-3653	80	13	in	in	ADP
dpc-3653	80	14	all	all	DET
dpc-3653	80	15	the	the	DET
dpc-3653	80	16	included	include	VERB
dpc-3653	80	17	cases	case	NOUN
dpc-3653	80	18	.	.	PUNCT
dpc-3653	81	1	in	in	ADP
dpc-3653	81	2	group	group	NOUN
dpc-3653	81	3	i	i	PROPN
dpc-3653	81	4	,	,	PUNCT
dpc-3653	81	5	other	other	ADJ
dpc-3653	81	6	local	local	ADJ
dpc-3653	81	7	side	side	NOUN
dpc-3653	81	8	effects	effect	NOUN
dpc-3653	81	9	included	include	VERB
dpc-3653	81	10	erythema	erythema	NOUN
dpc-3653	81	11	in	in	ADP
dpc-3653	81	12	30	30	NUM
dpc-3653	81	13	%	%	NOUN
dpc-3653	81	14	,	,	PUNCT
dpc-3653	81	15	swelling	swell	VERB
dpc-3653	81	16	in	in	ADP
dpc-3653	81	17	30	30	NUM
dpc-3653	81	18	%	%	NOUN
dpc-3653	81	19	and	and	CCONJ
dpc-3653	81	20	tenderness	tenderness	NOUN
dpc-3653	81	21	in	in	ADP
dpc-3653	81	22	15	15	NUM
dpc-3653	81	23	%	%	NOUN
dpc-3653	81	24	of	of	ADP
dpc-3653	81	25	the	the	DET
dpc-3653	81	26	cases	case	NOUN
dpc-3653	81	27	while	while	SCONJ
dpc-3653	81	28	in	in	ADP
dpc-3653	81	29	group	group	PROPN
dpc-3653	81	30	ii	ii	PROPN
dpc-3653	81	31	,	,	PUNCT
dpc-3653	81	32	erythema	erythema	VERB
dpc-3653	81	33	was	be	AUX
dpc-3653	81	34	detected	detect	VERB
dpc-3653	81	35	in	in	ADP
dpc-3653	81	36	25	25	NUM
dpc-3653	81	37	%	%	NOUN
dpc-3653	81	38	of	of	ADP
dpc-3653	81	39	the	the	DET
dpc-3653	81	40	cases	case	NOUN
dpc-3653	81	41	.	.	PUNCT
dpc-3653	82	1	regarding	regard	VERB
dpc-3653	82	2	the	the	DET
dpc-3653	82	3	distant	distant	ADJ
dpc-3653	82	4	side	side	NOUN
dpc-3653	82	5	effects	effect	NOUN
dpc-3653	82	6	,	,	PUNCT
dpc-3653	82	7	fever	fever	NOUN
dpc-3653	82	8	was	be	AUX
dpc-3653	82	9	detected	detect	VERB
dpc-3653	82	10	in	in	ADP
dpc-3653	82	11	55	55	NUM
dpc-3653	82	12	%	%	NOUN
dpc-3653	82	13	and	and	CCONJ
dpc-3653	82	14	10	10	NUM
dpc-3653	82	15	%	%	NOUN
dpc-3653	82	16	in	in	ADP
dpc-3653	82	17	group	group	NOUN
dpc-3653	82	18	i	i	PROPN
dpc-3653	82	19	and	and	CCONJ
dpc-3653	82	20	group	group	PROPN
dpc-3653	82	21	ii	ii	PROPN
dpc-3653	82	22	respectively	respectively	ADV
dpc-3653	82	23	while	while	SCONJ
dpc-3653	82	24	bone	bone	NOUN
dpc-3653	82	25	ache	ache	ADV
dpc-3653	82	26	was	be	AUX
dpc-3653	82	27	reported	report	VERB
dpc-3653	82	28	in	in	ADP
dpc-3653	82	29	15	15	NUM
dpc-3653	82	30	%	%	NOUN
dpc-3653	82	31	of	of	ADP
dpc-3653	82	32	the	the	DET
dpc-3653	82	33	cases	case	NOUN
dpc-3653	82	34	in	in	ADP
dpc-3653	82	35	group	group	NOUN
dpc-3653	82	36	i	i	PRON
dpc-3653	82	37	only	only	ADV
dpc-3653	82	38	(	(	PUNCT
dpc-3653	82	39	table	table	NOUN
dpc-3653	82	40	3	3	NUM
dpc-3653	82	41	)	)	PUNCT
dpc-3653	82	42	.	.	PUNCT
dpc-3653	83	1	no	no	DET
dpc-3653	83	2	statistically	statistically	ADV
dpc-3653	83	3	significant	significant	ADJ
dpc-3653	83	4	difference	difference	NOUN
dpc-3653	83	5	in	in	ADP
dpc-3653	83	6	the	the	DET
dpc-3653	83	7	adverse	adverse	ADJ
dpc-3653	83	8	effects	effect	NOUN
dpc-3653	83	9	was	be	AUX
dpc-3653	83	10	observed	observe	VERB
dpc-3653	83	11	between	between	ADP
dpc-3653	83	12	all	all	DET
dpc-3653	83	13	studied	studied	ADJ
dpc-3653	83	14	groups	group	NOUN
dpc-3653	83	15	.	.	PUNCT
dpc-3653	84	1	no	no	DET
dpc-3653	84	2	recurrence	recurrence	NOUN
dpc-3653	84	3	of	of	ADP
dpc-3653	84	4	warts	wart	NOUN
dpc-3653	84	5	was	be	AUX
dpc-3653	84	6	reported	report	VERB
dpc-3653	84	7	during	during	ADP
dpc-3653	84	8	the	the	DET
dpc-3653	84	9	6	6	NUM
dpc-3653	84	10	-	-	PUNCT
dpc-3653	84	11	month	month	NOUN
dpc-3653	84	12	follow	follow	NOUN
dpc-3653	84	13	-	-	PUNCT
dpc-3653	84	14	up	up	NOUN
dpc-3653	84	15	period	period	NOUN
dpc-3653	84	16	in	in	ADP
dpc-3653	84	17	both	both	DET
dpc-3653	84	18	groups	group	NOUN
dpc-3653	84	19	.	.	PUNCT
dpc-3653	85	1	4	4	NUM
dpc-3653	85	2	original	original	ADJ
dpc-3653	85	3	article	article	NOUN
dpc-3653	85	4	|	|	ADV
dpc-3653	85	5	dermatol	dermatol	ADJ
dpc-3653	85	6	pract	pract	NOUN
dpc-3653	85	7	concept	concept	NOUN
dpc-3653	85	8	.	.	PUNCT
dpc-3653	86	1	2024;14(2):e2024066	2024;14(2):e2024066	NUM
dpc-3653	86	2	table	table	NOUN
dpc-3653	86	3	1	1	NUM
dpc-3653	86	4	.	.	PUNCT
dpc-3653	86	5	baseline	baseline	PROPN
dpc-3653	86	6	characteristics	characteristic	NOUN
dpc-3653	86	7	of	of	ADP
dpc-3653	86	8	the	the	DET
dpc-3653	86	9	studied	study	VERB
dpc-3653	86	10	patients	patient	NOUN
dpc-3653	86	11	variable	variable	ADJ
dpc-3653	86	12	group	group	NOUN
dpc-3653	86	13	i	i	PRON
dpc-3653	86	14	candida	candida	VERB
dpc-3653	86	15	antigen	antigen	ADV
dpc-3653	86	16	(	(	PUNCT
dpc-3653	86	17	n	n	NOUN
dpc-3653	86	18	=	=	SYM
dpc-3653	86	19	20	20	NUM
dpc-3653	86	20	)	)	PUNCT
dpc-3653	86	21	group	group	NOUN
dpc-3653	86	22	ii	ii	PROPN
dpc-3653	86	23	quadrivalent	quadrivalent	PROPN
dpc-3653	86	24	hpv	hpv	NOUN
dpc-3653	86	25	vaccine	vaccine	NOUN
dpc-3653	86	26	(	(	PUNCT
dpc-3653	86	27	n	n	NOUN
dpc-3653	86	28	=	=	SYM
dpc-3653	86	29	20	20	NUM
dpc-3653	86	30	)	)	PUNCT
dpc-3653	86	31	group	group	NOUN
dpc-3653	86	32	iii	iii	NUM
dpc-3653	86	33	normal	normal	ADJ
dpc-3653	86	34	saline	saline	NOUN
dpc-3653	86	35	(	(	PUNCT
dpc-3653	86	36	n	n	NOUN
dpc-3653	86	37	=	=	SYM
dpc-3653	86	38	20	20	NUM
dpc-3653	86	39	)	)	PUNCT
dpc-3653	86	40	p	p	NOUN
dpc-3653	86	41	value	value	NOUN
dpc-3653	86	42	sex	sex	NOUN
dpc-3653	86	43	males	male	NOUN
dpc-3653	86	44	8	8	NUM
dpc-3653	86	45	(	(	PUNCT
dpc-3653	86	46	40	40	NUM
dpc-3653	86	47	%	%	NOUN
dpc-3653	86	48	)	)	PUNCT
dpc-3653	86	49	7	7	NUM
dpc-3653	86	50	(	(	PUNCT
dpc-3653	86	51	35	35	NUM
dpc-3653	86	52	%	%	NOUN
dpc-3653	86	53	)	)	PUNCT
dpc-3653	86	54	5	5	NUM
dpc-3653	86	55	(	(	PUNCT
dpc-3653	86	56	25	25	NUM
dpc-3653	86	57	%	%	NOUN
dpc-3653	86	58	)	)	PUNCT
dpc-3653	86	59	0.293	0.293	NUM
dpc-3653	86	60	females	female	NOUN
dpc-3653	86	61	12	12	NUM
dpc-3653	86	62	(	(	PUNCT
dpc-3653	86	63	60	60	NUM
dpc-3653	86	64	%	%	NOUN
dpc-3653	86	65	)	)	PUNCT
dpc-3653	86	66	13	13	NUM
dpc-3653	86	67	(	(	PUNCT
dpc-3653	86	68	65	65	NUM
dpc-3653	86	69	%	%	NOUN
dpc-3653	86	70	)	)	PUNCT
dpc-3653	86	71	15	15	NUM
dpc-3653	86	72	(	(	PUNCT
dpc-3653	86	73	75	75	NUM
dpc-3653	86	74	%	%	NOUN
dpc-3653	86	75	)	)	PUNCT
dpc-3653	86	76	age	age	NOUN
dpc-3653	86	77	(	(	PUNCT
dpc-3653	86	78	years	year	NOUN
dpc-3653	86	79	)	)	PUNCT
dpc-3653	86	80	16	16	NUM
dpc-3653	86	81	(	(	PUNCT
dpc-3653	86	82	10	10	NUM
dpc-3653	86	83	-	-	NUM
dpc-3653	86	84	39	39	NUM
dpc-3653	86	85	)	)	PUNCT
dpc-3653	86	86	14	14	NUM
dpc-3653	86	87	(	(	PUNCT
dpc-3653	86	88	9	9	NUM
dpc-3653	86	89	-	-	SYM
dpc-3653	86	90	34	34	NUM
dpc-3653	86	91	)	)	PUNCT
dpc-3653	86	92	20	20	NUM
dpc-3653	86	93	(	(	PUNCT
dpc-3653	86	94	10	10	NUM
dpc-3653	86	95	-	-	SYM
dpc-3653	86	96	38	38	NUM
dpc-3653	86	97	)	)	PUNCT
dpc-3653	86	98	0.114	0.114	NUM
dpc-3653	86	99	number	number	NOUN
dpc-3653	86	100	of	of	ADP
dpc-3653	86	101	warts	wart	NOUN
dpc-3653	86	102	median	median	NOUN
dpc-3653	86	103	(	(	PUNCT
dpc-3653	86	104	range	range	NOUN
dpc-3653	86	105	)	)	PUNCT
dpc-3653	86	106	3	3	NUM
dpc-3653	86	107	(	(	PUNCT
dpc-3653	86	108	3	3	NUM
dpc-3653	86	109	-	-	SYM
dpc-3653	86	110	13	13	NUM
dpc-3653	86	111	)	)	PUNCT
dpc-3653	86	112	4	4	NUM
dpc-3653	86	113	(	(	PUNCT
dpc-3653	86	114	3	3	NUM
dpc-3653	86	115	-	-	SYM
dpc-3653	86	116	12	12	NUM
dpc-3653	86	117	)	)	PUNCT
dpc-3653	86	118	3	3	NUM
dpc-3653	86	119	(	(	PUNCT
dpc-3653	86	120	3	3	NUM
dpc-3653	86	121	-	-	SYM
dpc-3653	86	122	7	7	NUM
dpc-3653	86	123	)	)	PUNCT
dpc-3653	86	124	0.282	0.282	NUM
dpc-3653	86	125	duration	duration	NOUN
dpc-3653	86	126	of	of	ADP
dpc-3653	86	127	warts	wart	NOUN
dpc-3653	86	128	(	(	PUNCT
dpc-3653	86	129	months	month	NOUN
dpc-3653	86	130	)	)	PUNCT
dpc-3653	86	131	median	median	NOUN
dpc-3653	86	132	(	(	PUNCT
dpc-3653	86	133	range	range	NOUN
dpc-3653	86	134	)	)	PUNCT
dpc-3653	86	135	20	20	NUM
dpc-3653	86	136	(	(	PUNCT
dpc-3653	86	137	18	18	NUM
dpc-3653	86	138	-	-	SYM
dpc-3653	86	139	24	24	NUM
dpc-3653	86	140	)	)	PUNCT
dpc-3653	86	141	24	24	NUM
dpc-3653	86	142	(	(	PUNCT
dpc-3653	86	143	18	18	NUM
dpc-3653	86	144	-	-	SYM
dpc-3653	86	145	28	28	NUM
dpc-3653	86	146	)	)	PUNCT
dpc-3653	86	147	20	20	NUM
dpc-3653	86	148	(	(	PUNCT
dpc-3653	86	149	12	12	NUM
dpc-3653	86	150	-	-	SYM
dpc-3653	86	151	24	24	NUM
dpc-3653	86	152	)	)	PUNCT
dpc-3653	86	153	0.059	0.059	NUM
dpc-3653	86	154	distant	distant	ADJ
dpc-3653	86	155	warts	wart	NOUN
dpc-3653	86	156	6	6	NUM
dpc-3653	86	157	(	(	PUNCT
dpc-3653	86	158	30	30	NUM
dpc-3653	86	159	%	%	NOUN
dpc-3653	86	160	)	)	PUNCT
dpc-3653	86	161	11	11	NUM
dpc-3653	86	162	(	(	PUNCT
dpc-3653	86	163	55	55	NUM
dpc-3653	86	164	%	%	NOUN
dpc-3653	86	165	)	)	PUNCT
dpc-3653	86	166	3	3	NUM
dpc-3653	86	167	(	(	PUNCT
dpc-3653	86	168	15	15	NUM
dpc-3653	86	169	%	%	NOUN
dpc-3653	86	170	)	)	PUNCT
dpc-3653	86	171	0.025	0.025	NUM
dpc-3653	86	172	type	type	NOUN
dpc-3653	86	173	of	of	ADP
dpc-3653	86	174	warts	wart	NOUN
dpc-3653	86	175	common	common	ADJ
dpc-3653	86	176	warts	wart	NOUN
dpc-3653	86	177	16	16	NUM
dpc-3653	86	178	(	(	PUNCT
dpc-3653	86	179	80	80	NUM
dpc-3653	86	180	%	%	NOUN
dpc-3653	86	181	)	)	PUNCT
dpc-3653	86	182	12	12	NUM
dpc-3653	86	183	(	(	PUNCT
dpc-3653	86	184	60	60	NUM
dpc-3653	86	185	%	%	NOUN
dpc-3653	86	186	)	)	PUNCT
dpc-3653	86	187	3	3	NUM
dpc-3653	86	188	(	(	PUNCT
dpc-3653	86	189	15	15	NUM
dpc-3653	86	190	%	%	NOUN
dpc-3653	86	191	)	)	PUNCT
dpc-3653	86	192	<	<	X
dpc-3653	86	193	0.001	0.001	NUM
dpc-3653	86	194	plantar	plantar	NOUN
dpc-3653	86	195	warts	wart	NOUN
dpc-3653	86	196	4	4	NUM
dpc-3653	86	197	(	(	PUNCT
dpc-3653	86	198	20	20	NUM
dpc-3653	86	199	%	%	NOUN
dpc-3653	86	200	)	)	PUNCT
dpc-3653	86	201	6	6	NUM
dpc-3653	86	202	(	(	PUNCT
dpc-3653	86	203	30	30	NUM
dpc-3653	86	204	%	%	NOUN
dpc-3653	86	205	)	)	PUNCT
dpc-3653	86	206	17	17	NUM
dpc-3653	86	207	(	(	PUNCT
dpc-3653	86	208	85	85	NUM
dpc-3653	86	209	%	%	NOUN
dpc-3653	86	210	)	)	PUNCT
dpc-3653	86	211	plane	plane	NOUN
dpc-3653	86	212	wart	wart	NOUN
dpc-3653	86	213	0	0	PUNCT
dpc-3653	87	1	(	(	PUNCT
dpc-3653	87	2	0	0	NUM
dpc-3653	87	3	%	%	NOUN
dpc-3653	87	4	)	)	PUNCT
dpc-3653	87	5	2	2	NUM
dpc-3653	87	6	(	(	PUNCT
dpc-3653	87	7	10	10	NUM
dpc-3653	87	8	%	%	NOUN
dpc-3653	87	9	)	)	PUNCT
dpc-3653	87	10	0	0	NUM
dpc-3653	88	1	(	(	PUNCT
dpc-3653	88	2	0	0	NUM
dpc-3653	88	3	%	%	NOUN
dpc-3653	88	4	)	)	PUNCT
dpc-3653	88	5	0.468	0.468	NUM
dpc-3653	88	6	distant	distant	ADJ
dpc-3653	88	7	warts	wart	NOUN
dpc-3653	88	8	6(30	6(30	NUM
dpc-3653	88	9	%	%	NOUN
dpc-3653	88	10	)	)	PUNCT
dpc-3653	88	11	11	11	NUM
dpc-3653	88	12	(	(	PUNCT
dpc-3653	88	13	55	55	NUM
dpc-3653	88	14	%	%	NOUN
dpc-3653	88	15	)	)	PUNCT
dpc-3653	88	16	3	3	NUM
dpc-3653	88	17	(	(	PUNCT
dpc-3653	88	18	15	15	NUM
dpc-3653	88	19	%	%	NOUN
dpc-3653	88	20	)	)	PUNCT
dpc-3653	88	21	0.025	0.025	NUM
dpc-3653	88	22	previous	previous	ADJ
dpc-3653	88	23	treatment	treatment	NOUN
dpc-3653	88	24	cryotherapy	cryotherapy	NOUN
dpc-3653	88	25	17	17	NUM
dpc-3653	88	26	(	(	PUNCT
dpc-3653	88	27	85	85	NUM
dpc-3653	88	28	%	%	NOUN
dpc-3653	88	29	)	)	PUNCT
dpc-3653	88	30	18	18	NUM
dpc-3653	88	31	(	(	PUNCT
dpc-3653	88	32	90	90	NUM
dpc-3653	88	33	%	%	NOUN
dpc-3653	88	34	)	)	PUNCT
dpc-3653	88	35	20	20	NUM
dpc-3653	88	36	(	(	PUNCT
dpc-3653	88	37	100	100	NUM
dpc-3653	88	38	%	%	NOUN
dpc-3653	88	39	)	)	PUNCT
dpc-3653	88	40	0.236	0.236	NUM
dpc-3653	88	41	salicylic	salicylic	NOUN
dpc-3653	88	42	acid	acid	NOUN
dpc-3653	88	43	19	19	NUM
dpc-3653	88	44	(	(	PUNCT
dpc-3653	88	45	95	95	NUM
dpc-3653	88	46	%	%	NOUN
dpc-3653	88	47	)	)	PUNCT
dpc-3653	88	48	16	16	NUM
dpc-3653	88	49	(	(	PUNCT
dpc-3653	88	50	80	80	NUM
dpc-3653	88	51	%	%	NOUN
dpc-3653	88	52	)	)	PUNCT
dpc-3653	88	53	18	18	NUM
dpc-3653	88	54	(	(	PUNCT
dpc-3653	88	55	90	90	NUM
dpc-3653	88	56	%	%	NOUN
dpc-3653	88	57	)	)	PUNCT
dpc-3653	88	58	laser	laser	NOUN
dpc-3653	88	59	1	1	NUM
dpc-3653	88	60	(	(	PUNCT
dpc-3653	88	61	5	5	NUM
dpc-3653	88	62	%	%	NOUN
dpc-3653	88	63	)	)	PUNCT
dpc-3653	88	64	0	0	NUM
dpc-3653	89	1	(	(	PUNCT
dpc-3653	89	2	0	0	NUM
dpc-3653	89	3	%	%	NOUN
dpc-3653	89	4	)	)	PUNCT
dpc-3653	89	5	0	0	NUM
dpc-3653	90	1	(	(	PUNCT
dpc-3653	90	2	0	0	NUM
dpc-3653	90	3	%	%	NOUN
dpc-3653	90	4	)	)	PUNCT
dpc-3653	90	5	topical	topical	ADJ
dpc-3653	90	6	retinoid	retinoid	NOUN
dpc-3653	90	7	0	0	SYM
dpc-3653	90	8	(	(	PUNCT
dpc-3653	90	9	0	0	NUM
dpc-3653	90	10	%	%	NOUN
dpc-3653	90	11	)	)	PUNCT
dpc-3653	90	12	1	1	NUM
dpc-3653	90	13	(	(	PUNCT
dpc-3653	90	14	5	5	NUM
dpc-3653	90	15	%	%	NOUN
dpc-3653	90	16	)	)	PUNCT
dpc-3653	90	17	0	0	NUM
dpc-3653	91	1	(	(	PUNCT
dpc-3653	91	2	0	0	NUM
dpc-3653	91	3	%	%	NOUN
dpc-3653	91	4	)	)	PUNCT
dpc-3653	91	5	electrotherapy	electrotherapy	NOUN
dpc-3653	91	6	1	1	NUM
dpc-3653	91	7	(	(	PUNCT
dpc-3653	91	8	5	5	NUM
dpc-3653	91	9	%	%	NOUN
dpc-3653	91	10	)	)	PUNCT
dpc-3653	91	11	2	2	NUM
dpc-3653	91	12	(	(	PUNCT
dpc-3653	91	13	10	10	NUM
dpc-3653	91	14	%	%	NOUN
dpc-3653	91	15	)	)	PUNCT
dpc-3653	91	16	2	2	NUM
dpc-3653	91	17	(	(	PUNCT
dpc-3653	91	18	10	10	NUM
dpc-3653	91	19	%	%	NOUN
dpc-3653	91	20	)	)	PUNCT
dpc-3653	91	21	mmr	mmr	PROPN
dpc-3653	91	22	intralesional	intralesional	ADJ
dpc-3653	91	23	injection	injection	NOUN
dpc-3653	91	24	0	0	NUM
dpc-3653	92	1	(	(	PUNCT
dpc-3653	92	2	0	0	NUM
dpc-3653	92	3	%	%	NOUN
dpc-3653	92	4	)	)	PUNCT
dpc-3653	92	5	1	1	NUM
dpc-3653	92	6	(	(	PUNCT
dpc-3653	92	7	5	5	NUM
dpc-3653	92	8	%	%	NOUN
dpc-3653	92	9	)	)	PUNCT
dpc-3653	92	10	0	0	NUM
dpc-3653	93	1	(	(	PUNCT
dpc-3653	93	2	0	0	NUM
dpc-3653	93	3	%	%	NOUN
dpc-3653	93	4	)	)	PUNCT
dpc-3653	93	5	hpv	hpv	NOUN
dpc-3653	93	6	=	=	SYM
dpc-3653	93	7	human	human	ADJ
dpc-3653	93	8	papilloma	papilloma	PROPN
dpc-3653	93	9	virus	virus	NOUN
dpc-3653	93	10	.	.	PUNCT
dpc-3653	94	1	table	table	NOUN
dpc-3653	94	2	2	2	NUM
dpc-3653	94	3	.	.	PUNCT
dpc-3653	95	1	therapeutic	therapeutic	ADJ
dpc-3653	95	2	response	response	NOUN
dpc-3653	95	3	among	among	ADP
dpc-3653	95	4	the	the	DET
dpc-3653	95	5	studied	study	VERB
dpc-3653	95	6	patients	patient	NOUN
dpc-3653	95	7	variable	variable	ADJ
dpc-3653	95	8	group	group	NOUN
dpc-3653	95	9	i	i	PRON
dpc-3653	95	10	candida	candida	VERB
dpc-3653	95	11	antigen	antigen	ADV
dpc-3653	95	12	(	(	PUNCT
dpc-3653	95	13	n	n	NOUN
dpc-3653	95	14	=	=	SYM
dpc-3653	95	15	20	20	NUM
dpc-3653	95	16	)	)	PUNCT
dpc-3653	95	17	group	group	NOUN
dpc-3653	95	18	ii	ii	PROPN
dpc-3653	95	19	quadrivalent	quadrivalent	PROPN
dpc-3653	95	20	hpv	hpv	NOUN
dpc-3653	95	21	vaccine	vaccine	NOUN
dpc-3653	95	22	(	(	PUNCT
dpc-3653	95	23	n	n	NOUN
dpc-3653	95	24	=	=	SYM
dpc-3653	95	25	20	20	NUM
dpc-3653	95	26	)	)	PUNCT
dpc-3653	95	27	group	group	NOUN
dpc-3653	95	28	iii	iii	NUM
dpc-3653	95	29	normal	normal	ADJ
dpc-3653	95	30	saline	saline	NOUN
dpc-3653	95	31	(	(	PUNCT
dpc-3653	95	32	n	n	NOUN
dpc-3653	95	33	=	=	SYM
dpc-3653	95	34	20	20	NUM
dpc-3653	95	35	)	)	PUNCT
dpc-3653	95	36	p	p	NOUN
dpc-3653	95	37	value	value	NOUN
dpc-3653	95	38	complete	complete	ADJ
dpc-3653	95	39	response	response	NOUN
dpc-3653	95	40	8	8	NUM
dpc-3653	95	41	(	(	PUNCT
dpc-3653	95	42	40	40	NUM
dpc-3653	95	43	%	%	NOUN
dpc-3653	95	44	)	)	PUNCT
dpc-3653	95	45	15	15	NUM
dpc-3653	95	46	(	(	PUNCT
dpc-3653	95	47	75	75	NUM
dpc-3653	95	48	%	%	NOUN
dpc-3653	95	49	)	)	PUNCT
dpc-3653	95	50	0	0	NUM
dpc-3653	96	1	(	(	PUNCT
dpc-3653	96	2	0	0	NUM
dpc-3653	96	3	%	%	NOUN
dpc-3653	96	4	)	)	PUNCT
dpc-3653	97	1	<	<	X
dpc-3653	97	2	0.001partial	0.001partial	ADJ
dpc-3653	97	3	response	response	NOUN
dpc-3653	97	4	3	3	NUM
dpc-3653	97	5	(	(	PUNCT
dpc-3653	97	6	15	15	NUM
dpc-3653	97	7	%	%	NOUN
dpc-3653	97	8	)	)	PUNCT
dpc-3653	97	9	0	0	NUM
dpc-3653	98	1	(	(	PUNCT
dpc-3653	98	2	0	0	NUM
dpc-3653	98	3	%	%	NOUN
dpc-3653	98	4	)	)	PUNCT
dpc-3653	98	5	2	2	NUM
dpc-3653	98	6	(	(	PUNCT
dpc-3653	98	7	10	10	NUM
dpc-3653	98	8	%	%	NOUN
dpc-3653	98	9	)	)	PUNCT
dpc-3653	99	1	no	no	DET
dpc-3653	99	2	response	response	NOUN
dpc-3653	99	3	9	9	NUM
dpc-3653	99	4	(	(	PUNCT
dpc-3653	99	5	45	45	NUM
dpc-3653	99	6	%	%	NOUN
dpc-3653	99	7	)	)	PUNCT
dpc-3653	99	8	5	5	NUM
dpc-3653	99	9	(	(	PUNCT
dpc-3653	99	10	25	25	NUM
dpc-3653	99	11	%	%	NOUN
dpc-3653	99	12	)	)	PUNCT
dpc-3653	99	13	18	18	NUM
dpc-3653	99	14	(	(	PUNCT
dpc-3653	99	15	90	90	NUM
dpc-3653	99	16	%	%	NOUN
dpc-3653	99	17	)	)	PUNCT
dpc-3653	99	18	distant	distant	ADJ
dpc-3653	99	19	response	response	NOUN
dpc-3653	99	20	group	group	NOUN
dpc-3653	99	21	i	i	PRON
dpc-3653	99	22	candida	candida	VERB
dpc-3653	99	23	antigen	antigen	ADV
dpc-3653	99	24	(	(	PUNCT
dpc-3653	99	25	n	n	NOUN
dpc-3653	99	26	=	=	SYM
dpc-3653	99	27	6	6	NUM
dpc-3653	99	28	)	)	PUNCT
dpc-3653	99	29	group	group	NOUN
dpc-3653	99	30	ii	ii	PROPN
dpc-3653	99	31	quadrivalent	quadrivalent	PROPN
dpc-3653	99	32	hpv	hpv	NOUN
dpc-3653	99	33	vaccine	vaccine	NOUN
dpc-3653	99	34	(	(	PUNCT
dpc-3653	99	35	n	n	NOUN
dpc-3653	99	36	=	=	SYM
dpc-3653	99	37	11	11	NUM
dpc-3653	99	38	)	)	PUNCT
dpc-3653	99	39	group	group	NOUN
dpc-3653	99	40	iii	iii	NUM
dpc-3653	99	41	normal	normal	ADJ
dpc-3653	99	42	saline	saline	NOUN
dpc-3653	99	43	(	(	PUNCT
dpc-3653	99	44	n	n	NOUN
dpc-3653	99	45	=	=	SYM
dpc-3653	99	46	3	3	NUM
dpc-3653	99	47	)	)	PUNCT
dpc-3653	99	48	complete	complete	ADJ
dpc-3653	99	49	response	response	NOUN
dpc-3653	99	50	2	2	NUM
dpc-3653	99	51	(	(	PUNCT
dpc-3653	99	52	33	33	NUM
dpc-3653	99	53	%	%	NOUN
dpc-3653	99	54	)	)	PUNCT
dpc-3653	99	55	8	8	NUM
dpc-3653	99	56	(	(	PUNCT
dpc-3653	99	57	72.7	72.7	NUM
dpc-3653	99	58	%	%	NOUN
dpc-3653	99	59	)	)	PUNCT
dpc-3653	99	60	0	0	NUM
dpc-3653	100	1	(	(	PUNCT
dpc-3653	100	2	0	0	NUM
dpc-3653	100	3	%	%	NOUN
dpc-3653	100	4	)	)	PUNCT
dpc-3653	100	5	0.002partial	0.002partial	ADJ
dpc-3653	100	6	response	response	NOUN
dpc-3653	100	7	3	3	NUM
dpc-3653	100	8	(	(	PUNCT
dpc-3653	100	9	50	50	NUM
dpc-3653	100	10	%	%	NOUN
dpc-3653	100	11	)	)	PUNCT
dpc-3653	100	12	3	3	NUM
dpc-3653	100	13	(	(	PUNCT
dpc-3653	100	14	27.3	27.3	NUM
dpc-3653	100	15	%	%	NOUN
dpc-3653	100	16	)	)	PUNCT
dpc-3653	100	17	0	0	NUM
dpc-3653	101	1	(	(	PUNCT
dpc-3653	101	2	0	0	NUM
dpc-3653	101	3	%	%	NOUN
dpc-3653	101	4	)	)	PUNCT
dpc-3653	102	1	no	no	DET
dpc-3653	102	2	response	response	NOUN
dpc-3653	102	3	1	1	NUM
dpc-3653	102	4	(	(	PUNCT
dpc-3653	102	5	16	16	NUM
dpc-3653	102	6	%	%	NOUN
dpc-3653	102	7	)	)	PUNCT
dpc-3653	102	8	0	0	NUM
dpc-3653	103	1	(	(	PUNCT
dpc-3653	103	2	0	0	NUM
dpc-3653	103	3	%	%	NOUN
dpc-3653	103	4	)	)	PUNCT
dpc-3653	103	5	3	3	NUM
dpc-3653	103	6	(	(	PUNCT
dpc-3653	103	7	100	100	NUM
dpc-3653	103	8	%	%	NOUN
dpc-3653	103	9	)	)	PUNCT
dpc-3653	103	10	hpv	hpv	NOUN
dpc-3653	103	11	=	=	SYM
dpc-3653	103	12	human	human	ADJ
dpc-3653	103	13	papilloma	papilloma	PROPN
dpc-3653	103	14	virus	virus	NOUN
dpc-3653	103	15	.	.	PUNCT
dpc-3653	104	1	original	original	ADJ
dpc-3653	104	2	article	article	NOUN
dpc-3653	104	3	|	|	ADV
dpc-3653	104	4	dermatol	dermatol	ADJ
dpc-3653	104	5	pract	pract	NOUN
dpc-3653	104	6	concept	concept	NOUN
dpc-3653	104	7	.	.	PUNCT
dpc-3653	105	1	2024;14(2):e2024066	2024;14(2):e2024066	NUM
dpc-3653	105	2	5	5	NUM
dpc-3653	105	3	table	table	NOUN
dpc-3653	105	4	3	3	NUM
dpc-3653	105	5	.	.	PUNCT
dpc-3653	105	6	local	local	ADJ
dpc-3653	105	7	and	and	CCONJ
dpc-3653	105	8	distant	distant	ADJ
dpc-3653	105	9	side	side	NOUN
dpc-3653	105	10	effects	effect	NOUN
dpc-3653	105	11	among	among	ADP
dpc-3653	105	12	the	the	DET
dpc-3653	105	13	studied	study	VERB
dpc-3653	105	14	patients	patient	NOUN
dpc-3653	105	15	variable	variable	ADJ
dpc-3653	105	16	group	group	NOUN
dpc-3653	105	17	i	i	PRON
dpc-3653	105	18	candida	candida	VERB
dpc-3653	105	19	antigen	antigen	ADV
dpc-3653	105	20	(	(	PUNCT
dpc-3653	105	21	n	n	NOUN
dpc-3653	105	22	=	=	SYM
dpc-3653	105	23	20	20	NUM
dpc-3653	105	24	)	)	PUNCT
dpc-3653	105	25	group	group	NOUN
dpc-3653	105	26	ii	ii	PROPN
dpc-3653	105	27	quadrivalent	quadrivalent	PROPN
dpc-3653	105	28	hpv	hpv	NOUN
dpc-3653	105	29	vaccine	vaccine	NOUN
dpc-3653	105	30	(	(	PUNCT
dpc-3653	105	31	n	n	NOUN
dpc-3653	105	32	=	=	SYM
dpc-3653	105	33	20	20	NUM
dpc-3653	105	34	)	)	PUNCT
dpc-3653	105	35	group	group	NOUN
dpc-3653	105	36	iii	iii	NUM
dpc-3653	105	37	normal	normal	ADJ
dpc-3653	105	38	saline	saline	NOUN
dpc-3653	105	39	(	(	PUNCT
dpc-3653	105	40	n	n	NOUN
dpc-3653	105	41	=	=	SYM
dpc-3653	105	42	20	20	NUM
dpc-3653	105	43	)	)	PUNCT
dpc-3653	105	44	p	p	NOUN
dpc-3653	105	45	value	value	NOUN
dpc-3653	105	46	local	local	ADJ
dpc-3653	105	47	side	side	NOUN
dpc-3653	105	48	effects	effect	NOUN
dpc-3653	105	49	tolerable	tolerable	ADJ
dpc-3653	105	50	pain	pain	NOUN
dpc-3653	105	51	during	during	ADP
dpc-3653	105	52	injection	injection	NOUN
dpc-3653	105	53	20	20	NUM
dpc-3653	105	54	(	(	PUNCT
dpc-3653	105	55	100	100	NUM
dpc-3653	105	56	%	%	NOUN
dpc-3653	105	57	)	)	PUNCT
dpc-3653	105	58	20	20	NUM
dpc-3653	105	59	(	(	PUNCT
dpc-3653	105	60	100	100	NUM
dpc-3653	105	61	%	%	NOUN
dpc-3653	105	62	)	)	PUNCT
dpc-3653	105	63	20	20	NUM
dpc-3653	105	64	(	(	PUNCT
dpc-3653	105	65	100	100	NUM
dpc-3653	105	66	%	%	NOUN
dpc-3653	105	67	)	)	PUNCT
dpc-3653	105	68	0.011	0.011	NUM
dpc-3653	105	69	*	*	NOUN
dpc-3653	105	70	erythema	erythema	ADJ
dpc-3653	105	71	6	6	NUM
dpc-3653	105	72	(	(	PUNCT
dpc-3653	105	73	30	30	NUM
dpc-3653	105	74	%	%	NOUN
dpc-3653	105	75	)	)	PUNCT
dpc-3653	105	76	5	5	NUM
dpc-3653	105	77	(	(	PUNCT
dpc-3653	105	78	25	25	NUM
dpc-3653	105	79	%	%	NOUN
dpc-3653	105	80	)	)	PUNCT
dpc-3653	105	81	0	0	NUM
dpc-3653	106	1	(	(	PUNCT
dpc-3653	106	2	0	0	NUM
dpc-3653	106	3	%	%	NOUN
dpc-3653	106	4	)	)	PUNCT
dpc-3653	106	5	swelling	swell	VERB
dpc-3653	106	6	6	6	NUM
dpc-3653	106	7	(	(	PUNCT
dpc-3653	106	8	30	30	NUM
dpc-3653	106	9	%	%	NOUN
dpc-3653	106	10	)	)	PUNCT
dpc-3653	106	11	0	0	NUM
dpc-3653	107	1	(	(	PUNCT
dpc-3653	107	2	0	0	NUM
dpc-3653	107	3	%	%	NOUN
dpc-3653	107	4	)	)	PUNCT
dpc-3653	107	5	0	0	NUM
dpc-3653	108	1	(	(	PUNCT
dpc-3653	108	2	0	0	NUM
dpc-3653	108	3	%	%	NOUN
dpc-3653	108	4	)	)	PUNCT
dpc-3653	108	5	tenderness	tenderness	NOUN
dpc-3653	108	6	3	3	NUM
dpc-3653	108	7	(	(	PUNCT
dpc-3653	108	8	15	15	NUM
dpc-3653	108	9	%	%	NOUN
dpc-3653	108	10	)	)	PUNCT
dpc-3653	108	11	0	0	NUM
dpc-3653	109	1	(	(	PUNCT
dpc-3653	109	2	0	0	NUM
dpc-3653	109	3	%	%	NOUN
dpc-3653	109	4	)	)	PUNCT
dpc-3653	109	5	0	0	NUM
dpc-3653	110	1	(	(	PUNCT
dpc-3653	110	2	0	0	NUM
dpc-3653	110	3	%	%	NOUN
dpc-3653	110	4	)	)	PUNCT
dpc-3653	110	5	distant	distant	ADJ
dpc-3653	110	6	side	side	NOUN
dpc-3653	110	7	effects	effect	NOUN
dpc-3653	110	8	no	no	DET
dpc-3653	110	9	distant	distant	ADJ
dpc-3653	110	10	lesions	lesion	NOUN
dpc-3653	110	11	9	9	NUM
dpc-3653	110	12	(	(	PUNCT
dpc-3653	110	13	45	45	NUM
dpc-3653	110	14	%	%	NOUN
dpc-3653	110	15	)	)	PUNCT
dpc-3653	110	16	18	18	NUM
dpc-3653	110	17	(	(	PUNCT
dpc-3653	110	18	90	90	NUM
dpc-3653	110	19	%	%	NOUN
dpc-3653	110	20	)	)	PUNCT
dpc-3653	110	21	20	20	NUM
dpc-3653	110	22	(	(	PUNCT
dpc-3653	110	23	100	100	NUM
dpc-3653	110	24	%	%	NOUN
dpc-3653	110	25	)	)	PUNCT
dpc-3653	110	26	<	<	X
dpc-3653	111	1	0.001*fever	0.001*fever	PUNCT
dpc-3653	111	2	11	11	NUM
dpc-3653	111	3	(	(	PUNCT
dpc-3653	111	4	55	55	NUM
dpc-3653	111	5	%	%	NOUN
dpc-3653	111	6	)	)	PUNCT
dpc-3653	111	7	2	2	NUM
dpc-3653	111	8	(	(	PUNCT
dpc-3653	111	9	10	10	NUM
dpc-3653	111	10	%	%	NOUN
dpc-3653	111	11	)	)	PUNCT
dpc-3653	111	12	0	0	NUM
dpc-3653	112	1	(	(	PUNCT
dpc-3653	112	2	0	0	NUM
dpc-3653	112	3	%	%	NOUN
dpc-3653	112	4	)	)	PUNCT
dpc-3653	112	5	bone	bone	NOUN
dpc-3653	112	6	ache	ache	NOUN
dpc-3653	112	7	3	3	NUM
dpc-3653	112	8	(	(	PUNCT
dpc-3653	112	9	15	15	NUM
dpc-3653	112	10	%	%	NOUN
dpc-3653	112	11	)	)	PUNCT
dpc-3653	112	12	0	0	NUM
dpc-3653	113	1	(	(	PUNCT
dpc-3653	113	2	0	0	NUM
dpc-3653	113	3	%	%	NOUN
dpc-3653	113	4	)	)	PUNCT
dpc-3653	113	5	0	0	NUM
dpc-3653	114	1	(	(	PUNCT
dpc-3653	114	2	0	0	NUM
dpc-3653	114	3	%	%	NOUN
dpc-3653	114	4	)	)	PUNCT
dpc-3653	114	5	hpv	hpv	NOUN
dpc-3653	114	6	=	=	SYM
dpc-3653	114	7	human	human	ADJ
dpc-3653	114	8	papilloma	papilloma	PROPN
dpc-3653	114	9	virus	virus	NOUN
dpc-3653	114	10	.	.	PUNCT
dpc-3653	115	1	conclusions	conclusion	NOUN
dpc-3653	115	2	in	in	ADP
dpc-3653	115	3	general	general	ADJ
dpc-3653	115	4	,	,	PUNCT
dpc-3653	115	5	practice	practice	NOUN
dpc-3653	115	6	,	,	PUNCT
dpc-3653	115	7	non	non	ADJ
dpc-3653	115	8	-	-	ADJ
dpc-3653	115	9	genital	genital	ADJ
dpc-3653	115	10	warts	wart	NOUN
dpc-3653	115	11	are	be	AUX
dpc-3653	115	12	a	a	DET
dpc-3653	115	13	common	common	ADJ
dpc-3653	115	14	.	.	PUNCT
dpc-3653	116	1	despite	despite	SCONJ
dpc-3653	116	2	following	follow	VERB
dpc-3653	116	3	evidence	evidence	NOUN
dpc-3653	116	4	-	-	PUNCT
dpc-3653	116	5	based	base	VERB
dpc-3653	116	6	treatment	treatment	NOUN
dpc-3653	116	7	guidelines	guideline	NOUN
dpc-3653	116	8	,	,	PUNCT
dpc-3653	116	9	a	a	DET
dpc-3653	116	10	significant	significant	ADJ
dpc-3653	116	11	percentage	percentage	NOUN
dpc-3653	116	12	of	of	ADP
dpc-3653	116	13	warts	wart	NOUN
dpc-3653	116	14	do	do	AUX
dpc-3653	116	15	not	not	PART
dpc-3653	116	16	cure	cure	VERB
dpc-3653	116	17	and	and	CCONJ
dpc-3653	116	18	become	become	VERB
dpc-3653	116	19	recalcitrant	recalcitrant	ADJ
dpc-3653	116	20	.	.	PUNCT
dpc-3653	117	1	this	this	DET
dpc-3653	117	2	current	current	ADJ
dpc-3653	117	3	study	study	NOUN
dpc-3653	117	4	was	be	AUX
dpc-3653	117	5	conducted	conduct	VERB
dpc-3653	117	6	to	to	PART
dpc-3653	117	7	evaluate	evaluate	VERB
dpc-3653	117	8	the	the	DET
dpc-3653	117	9	efficacy	efficacy	NOUN
dpc-3653	117	10	of	of	ADP
dpc-3653	117	11	intralesional	intralesional	ADJ
dpc-3653	117	12	quadrivalent	quadrivalent	NOUN
dpc-3653	117	13	human	human	ADJ
dpc-3653	117	14	papillomavirus	papillomavirus	NOUN
dpc-3653	117	15	(	(	PUNCT
dpc-3653	117	16	hpv	hpv	NOUN
dpc-3653	117	17	)	)	PUNCT
dpc-3653	117	18	vaccine	vaccine	NOUN
dpc-3653	117	19	versus	versus	ADP
dpc-3653	117	20	candida	candida	PROPN
dpc-3653	117	21	antigen	antigen	ADV
dpc-3653	117	22	in	in	ADP
dpc-3653	117	23	treatment	treatment	NOUN
dpc-3653	117	24	of	of	ADP
dpc-3653	117	25	multiple	multiple	ADJ
dpc-3653	117	26	recalcitrant	recalcitrant	ADJ
dpc-3653	117	27	non	non	ADJ
dpc-3653	117	28	-	-	ADJ
dpc-3653	117	29	genital	genital	ADJ
dpc-3653	117	30	warts	wart	NOUN
dpc-3653	117	31	.	.	PUNCT
dpc-3653	118	1	the	the	DET
dpc-3653	118	2	current	current	ADJ
dpc-3653	118	3	study	study	NOUN
dpc-3653	118	4	included	include	VERB
dpc-3653	118	5	60	60	NUM
dpc-3653	118	6	cases	case	NOUN
dpc-3653	118	7	with	with	ADP
dpc-3653	118	8	multiple	multiple	ADJ
dpc-3653	118	9	recalcitrant	recalcitrant	ADJ
dpc-3653	118	10	non	non	ADJ
dpc-3653	118	11	-	-	ADJ
dpc-3653	118	12	genital	genital	ADJ
dpc-3653	118	13	warts	wart	NOUN
dpc-3653	118	14	who	who	PRON
dpc-3653	118	15	were	be	AUX
dpc-3653	118	16	randomly	randomly	ADV
dpc-3653	118	17	distributed	distribute	VERB
dpc-3653	118	18	according	accord	VERB
dpc-3653	118	19	to	to	ADP
dpc-3653	118	20	the	the	DET
dpc-3653	118	21	treatment	treatment	NOUN
dpc-3653	118	22	regimen	regiman	NOUN
dpc-3653	118	23	into	into	ADP
dpc-3653	118	24	three	three	NUM
dpc-3653	118	25	groups	group	NOUN
dpc-3653	118	26	;	;	PUNCT
dpc-3653	118	27	group	group	NOUN
dpc-3653	118	28	i	i	PRON
dpc-3653	118	29	that	that	PRON
dpc-3653	118	30	included	include	VERB
dpc-3653	118	31	cases	case	NOUN
dpc-3653	118	32	who	who	PRON
dpc-3653	118	33	received	receive	VERB
dpc-3653	118	34	intralesional	intralesional	ADJ
dpc-3653	118	35	treatment	treatment	NOUN
dpc-3653	118	36	with	with	ADP
dpc-3653	118	37	candida	candida	PROPN
dpc-3653	118	38	antigen	antigen	PROPN
dpc-3653	118	39	,	,	PUNCT
dpc-3653	118	40	group	group	NOUN
dpc-3653	118	41	ii	ii	PROPN
dpc-3653	118	42	that	that	PRON
dpc-3653	118	43	included	include	VERB
dpc-3653	118	44	cases	case	NOUN
dpc-3653	118	45	received	receive	VERB
dpc-3653	118	46	intralesional	intralesional	ADJ
dpc-3653	118	47	treatment	treatment	NOUN
dpc-3653	118	48	with	with	ADP
dpc-3653	118	49	quadrivalent	quadrivalent	NOUN
dpc-3653	118	50	hpv	hpv	NOUN
dpc-3653	118	51	vaccine	vaccine	NOUN
dpc-3653	118	52	and	and	CCONJ
dpc-3653	118	53	group	group	PROPN
dpc-3653	118	54	iii	iii	PROPN
dpc-3653	118	55	that	that	PRON
dpc-3653	118	56	included	include	VERB
dpc-3653	118	57	cases	case	NOUN
dpc-3653	118	58	received	receive	VERB
dpc-3653	118	59	normal	normal	ADJ
dpc-3653	118	60	saline	saline	NOUN
dpc-3653	118	61	as	as	ADP
dpc-3653	118	62	a	a	DET
dpc-3653	118	63	control	control	NOUN
dpc-3653	118	64	group	group	NOUN
dpc-3653	118	65	.	.	PUNCT
dpc-3653	119	1	in	in	ADP
dpc-3653	119	2	the	the	DET
dpc-3653	119	3	current	current	ADJ
dpc-3653	119	4	study	study	NOUN
dpc-3653	119	5	,	,	PUNCT
dpc-3653	119	6	the	the	DET
dpc-3653	119	7	incidence	incidence	NOUN
dpc-3653	119	8	of	of	ADP
dpc-3653	119	9	complete	complete	ADJ
dpc-3653	119	10	response	response	NOUN
dpc-3653	119	11	after	after	ADP
dpc-3653	119	12	intralesional	intralesional	ADJ
dpc-3653	119	13	candida	candida	PROPN
dpc-3653	119	14	antigen	antigen	NOUN
dpc-3653	119	15	was	be	AUX
dpc-3653	119	16	40	40	NUM
dpc-3653	119	17	%	%	NOUN
dpc-3653	119	18	and	and	CCONJ
dpc-3653	119	19	after	after	ADP
dpc-3653	119	20	intralesional	intralesional	ADJ
dpc-3653	119	21	injection	injection	NOUN
dpc-3653	119	22	of	of	ADP
dpc-3653	119	23	quadrivalent	quadrivalent	NOUN
dpc-3653	119	24	hpv	hpv	NOUN
dpc-3653	119	25	vaccine	vaccine	NOUN
dpc-3653	119	26	was	be	AUX
dpc-3653	119	27	75	75	NUM
dpc-3653	119	28	%	%	NOUN
dpc-3653	119	29	with	with	ADP
dpc-3653	119	30	no	no	DET
dpc-3653	119	31	cases	case	NOUN
dpc-3653	119	32	with	with	ADP
dpc-3653	119	33	complete	complete	ADJ
dpc-3653	119	34	response	response	NOUN
dpc-3653	119	35	in	in	ADP
dpc-3653	119	36	the	the	DET
dpc-3653	119	37	control	control	NOUN
dpc-3653	119	38	group	group	NOUN
dpc-3653	119	39	.	.	PUNCT
dpc-3653	120	1	also	also	ADV
dpc-3653	120	2	,	,	PUNCT
dpc-3653	120	3	partial	partial	ADJ
dpc-3653	120	4	response	response	NOUN
dpc-3653	120	5	was	be	AUX
dpc-3653	120	6	noticed	notice	VERB
dpc-3653	120	7	in	in	ADP
dpc-3653	120	8	15	15	NUM
dpc-3653	120	9	%	%	NOUN
dpc-3653	120	10	and	and	CCONJ
dpc-3653	120	11	20	20	NUM
dpc-3653	120	12	%	%	NOUN
dpc-3653	120	13	in	in	ADP
dpc-3653	120	14	the	the	DET
dpc-3653	120	15	candida	candida	PROPN
dpc-3653	120	16	antigen	antigen	NOUN
dpc-3653	120	17	group	group	NOUN
dpc-3653	120	18	and	and	CCONJ
dpc-3653	120	19	control	control	NOUN
dpc-3653	120	20	group	group	NOUN
dpc-3653	120	21	respectively	respectively	ADV
dpc-3653	120	22	.	.	PUNCT
dpc-3653	121	1	the	the	DET
dpc-3653	121	2	rate	rate	NOUN
dpc-3653	121	3	of	of	ADP
dpc-3653	121	4	response	response	NOUN
dpc-3653	121	5	to	to	ADP
dpc-3653	121	6	candida	candida	PROPN
dpc-3653	121	7	antigen	antigen	NOUN
dpc-3653	121	8	was	be	AUX
dpc-3653	121	9	similar	similar	ADJ
dpc-3653	121	10	to	to	ADP
dpc-3653	121	11	an	an	DET
dpc-3653	121	12	egyptian	egyptian	ADJ
dpc-3653	121	13	study	study	NOUN
dpc-3653	121	14	conducted	conduct	VERB
dpc-3653	121	15	by	by	ADP
dpc-3653	121	16	marei	marei	NOUN
dpc-3653	121	17	et	et	PROPN
dpc-3653	121	18	al	al	PROPN
dpc-3653	121	19	who	who	PRON
dpc-3653	121	20	showed	show	VERB
dpc-3653	121	21	that	that	SCONJ
dpc-3653	121	22	58.3	58.3	NUM
dpc-3653	121	23	%	%	NOUN
dpc-3653	121	24	of	of	ADP
dpc-3653	121	25	studied	study	VERB
dpc-3653	121	26	patients	patient	NOUN
dpc-3653	121	27	showed	show	VERB
dpc-3653	121	28	complete	complete	ADJ
dpc-3653	121	29	response	response	NOUN
dpc-3653	121	30	[	[	X
dpc-3653	121	31	15	15	NUM
dpc-3653	121	32	]	]	PUNCT
dpc-3653	121	33	.	.	PUNCT
dpc-3653	122	1	however	however	ADV
dpc-3653	122	2	,	,	PUNCT
dpc-3653	122	3	although	although	SCONJ
dpc-3653	122	4	nassar	nassar	PROPN
dpc-3653	122	5	and	and	CCONJ
dpc-3653	122	6	her	her	PRON
dpc-3653	122	7	colleagues	colleague	NOUN
dpc-3653	122	8	showed	show	VERB
dpc-3653	122	9	superiority	superiority	NOUN
dpc-3653	122	10	of	of	ADP
dpc-3653	122	11	both	both	PRON
dpc-3653	122	12	candida	candida	NOUN
dpc-3653	122	13	antigen	antigen	NOUN
dpc-3653	122	14	and	and	CCONJ
dpc-3653	122	15	hpv	hpv	ADJ
dpc-3653	122	16	vaccine	vaccine	NOUN
dpc-3653	122	17	over	over	ADP
dpc-3653	122	18	control	control	PROPN
dpc-3653	122	19	,	,	PUNCT
dpc-3653	122	20	the	the	DET
dpc-3653	122	21	rate	rate	NOUN
dpc-3653	122	22	of	of	ADP
dpc-3653	122	23	response	response	NOUN
dpc-3653	122	24	was	be	AUX
dpc-3653	122	25	different	different	ADJ
dpc-3653	122	26	form	form	NOUN
dpc-3653	122	27	our	our	PRON
dpc-3653	122	28	study	study	NOUN
dpc-3653	122	29	.	.	PUNCT
dpc-3653	123	1	in	in	ADP
dpc-3653	123	2	their	their	PRON
dpc-3653	123	3	study	study	NOUN
dpc-3653	123	4	,	,	PUNCT
dpc-3653	123	5	complete	complete	ADJ
dpc-3653	123	6	clearance	clearance	NOUN
dpc-3653	123	7	of	of	ADP
dpc-3653	123	8	warts	wart	NOUN
dpc-3653	123	9	was	be	AUX
dpc-3653	123	10	reported	report	VERB
dpc-3653	123	11	in	in	ADP
dpc-3653	123	12	63.3	63.3	NUM
dpc-3653	123	13	%	%	NOUN
dpc-3653	123	14	of	of	ADP
dpc-3653	123	15	the	the	DET
dpc-3653	123	16	candida	candida	PROPN
dpc-3653	123	17	antigen	antigen	NOUN
dpc-3653	123	18	group	group	NOUN
dpc-3653	123	19	,	,	PUNCT
dpc-3653	123	20	50	50	NUM
dpc-3653	123	21	%	%	NOUN
dpc-3653	123	22	of	of	ADP
dpc-3653	123	23	the	the	DET
dpc-3653	123	24	bivalent	bivalent	ADJ
dpc-3653	123	25	hpv	hpv	ADJ
dpc-3653	123	26	vaccine	vaccine	NOUN
dpc-3653	123	27	group	group	NOUN
dpc-3653	123	28	and	and	CCONJ
dpc-3653	123	29	0	0	NUM
dpc-3653	123	30	%	%	NOUN
dpc-3653	123	31	of	of	ADP
dpc-3653	123	32	the	the	DET
dpc-3653	123	33	control	control	NOUN
dpc-3653	123	34	group	group	NOUN
dpc-3653	123	35	.	.	PUNCT
dpc-3653	124	1	a	a	DET
dpc-3653	124	2	statistically	statistically	ADV
dpc-3653	124	3	significant	significant	ADJ
dpc-3653	124	4	difference	difference	NOUN
dpc-3653	124	5	in	in	ADP
dpc-3653	124	6	the	the	DET
dpc-3653	124	7	therapeutic	therapeutic	ADJ
dpc-3653	124	8	responses	response	NOUN
dpc-3653	124	9	was	be	AUX
dpc-3653	124	10	found	find	VERB
dpc-3653	124	11	between	between	ADP
dpc-3653	124	12	the	the	DET
dpc-3653	124	13	treatment	treatment	NOUN
dpc-3653	124	14	and	and	CCONJ
dpc-3653	124	15	control	control	NOUN
dpc-3653	124	16	groups	group	NOUN
dpc-3653	124	17	and	and	CCONJ
dpc-3653	124	18	between	between	ADP
dpc-3653	124	19	both	both	CCONJ
dpc-3653	124	20	the	the	DET
dpc-3653	124	21	candida	candida	PROPN
dpc-3653	124	22	antigen	antigen	NOUN
dpc-3653	124	23	and	and	CCONJ
dpc-3653	124	24	bivalent	bivalent	VERB
dpc-3653	124	25	hpv	hpv	ADJ
dpc-3653	124	26	vaccine	vaccine	NOUN
dpc-3653	124	27	.	.	PUNCT
dpc-3653	125	1	the	the	DET
dpc-3653	125	2	difference	difference	NOUN
dpc-3653	125	3	between	between	ADP
dpc-3653	125	4	the	the	DET
dpc-3653	125	5	candida	candida	PROPN
dpc-3653	125	6	antigen	antigen	NOUN
dpc-3653	125	7	and	and	CCONJ
dpc-3653	125	8	bivalent	bivalent	VERB
dpc-3653	125	9	hpv	hpv	ADJ
dpc-3653	125	10	vaccine	vaccine	NOUN
dpc-3653	125	11	groups	group	NOUN
dpc-3653	125	12	was	be	AUX
dpc-3653	125	13	statistically	statistically	ADV
dpc-3653	125	14	insignificant	insignificant	ADJ
dpc-3653	125	15	[	[	X
dpc-3653	125	16	16	16	NUM
dpc-3653	125	17	]	]	PUNCT
dpc-3653	125	18	.	.	PUNCT
dpc-3653	126	1	the	the	DET
dpc-3653	126	2	difference	difference	NOUN
dpc-3653	126	3	between	between	ADP
dpc-3653	126	4	our	our	PRON
dpc-3653	126	5	study	study	NOUN
dpc-3653	126	6	and	and	CCONJ
dpc-3653	126	7	this	this	DET
dpc-3653	126	8	study	study	NOUN
dpc-3653	126	9	may	may	AUX
dpc-3653	126	10	be	be	AUX
dpc-3653	126	11	explained	explain	VERB
dpc-3653	126	12	by	by	ADP
dpc-3653	126	13	the	the	DET
dpc-3653	126	14	differences	difference	NOUN
dpc-3653	126	15	in	in	ADP
dpc-3653	126	16	the	the	DET
dpc-3653	126	17	nature	nature	NOUN
dpc-3653	126	18	of	of	ADP
dpc-3653	126	19	the	the	DET
dpc-3653	126	20	treated	treat	VERB
dpc-3653	126	21	warts	wart	NOUN
dpc-3653	126	22	(	(	PUNCT
dpc-3653	126	23	recalcitrant	recalcitrant	ADJ
dpc-3653	126	24	in	in	ADP
dpc-3653	126	25	our	our	PRON
dpc-3653	126	26	study	study	NOUN
dpc-3653	126	27	)	)	PUNCT
dpc-3653	126	28	.	.	PUNCT
dpc-3653	127	1	also	also	ADV
dpc-3653	127	2	,	,	PUNCT
dpc-3653	127	3	the	the	DET
dpc-3653	127	4	previous	previous	ADJ
dpc-3653	127	5	study	study	NOUN
dpc-3653	127	6	used	use	VERB
dpc-3653	127	7	bivalent	bivalent	ADJ
dpc-3653	127	8	vaccine	vaccine	NOUN
dpc-3653	127	9	and	and	CCONJ
dpc-3653	127	10	our	our	PRON
dpc-3653	127	11	study	study	NOUN
dpc-3653	127	12	used	use	VERB
dpc-3653	127	13	quadrivalent	quadrivalent	NOUN
dpc-3653	127	14	vaccine	vaccine	NOUN
dpc-3653	127	15	that	that	PRON
dpc-3653	127	16	provide	provide	VERB
dpc-3653	127	17	greater	great	ADJ
dpc-3653	127	18	cross	cross	NOUN
dpc-3653	127	19	-	-	NOUN
dpc-3653	127	20	protection	protection	NOUN
dpc-3653	127	21	against	against	ADP
dpc-3653	127	22	hpv	hpv	NOUN
dpc-3653	127	23	strains	strain	NOUN
dpc-3653	127	24	than	than	SCONJ
dpc-3653	127	25	provided	provide	VERB
dpc-3653	127	26	by	by	ADP
dpc-3653	127	27	bivalent	bivalent	ADJ
dpc-3653	127	28	vaccine	vaccine	NOUN
dpc-3653	127	29	.	.	PUNCT
dpc-3653	128	1	the	the	DET
dpc-3653	128	2	rate	rate	NOUN
dpc-3653	128	3	of	of	ADP
dpc-3653	128	4	response	response	NOUN
dpc-3653	128	5	in	in	ADP
dpc-3653	128	6	the	the	DET
dpc-3653	128	7	candida	candida	PROPN
dpc-3653	128	8	antigen	antigen	NOUN
dpc-3653	128	9	group	group	NOUN
dpc-3653	128	10	was	be	AUX
dpc-3653	128	11	similar	similar	ADJ
dpc-3653	128	12	to	to	ADP
dpc-3653	128	13	many	many	ADJ
dpc-3653	128	14	other	other	ADJ
dpc-3653	128	15	studies	study	NOUN
dpc-3653	128	16	including	include	VERB
dpc-3653	128	17	signore	signore	NOUN
dpc-3653	128	18	(	(	PUNCT
dpc-3653	128	19	51	51	NUM
dpc-3653	128	20	%	%	NOUN
dpc-3653	128	21	)	)	PUNCT
dpc-3653	128	22	,	,	PUNCT
dpc-3653	128	23	clifton	clifton	PROPN
dpc-3653	128	24	et	et	PROPN
dpc-3653	128	25	al	al	PROPN
dpc-3653	128	26	(	(	PUNCT
dpc-3653	128	27	47	47	NUM
dpc-3653	128	28	%	%	NOUN
dpc-3653	128	29	)	)	PUNCT
dpc-3653	128	30	,	,	PUNCT
dpc-3653	128	31	horn	horn	VERB
dpc-3653	128	32	et	et	NOUN
dpc-3653	128	33	al	al	PROPN
dpc-3653	128	34	(	(	PUNCT
dpc-3653	128	35	54	54	NUM
dpc-3653	128	36	%	%	NOUN
dpc-3653	128	37	)	)	PUNCT
dpc-3653	128	38	,	,	PUNCT
dpc-3653	128	39	king	king	NOUN
dpc-3653	128	40	et	et	PROPN
dpc-3653	128	41	al	al	PROPN
dpc-3653	128	42	(	(	PUNCT
dpc-3653	128	43	50	50	NUM
dpc-3653	128	44	%	%	NOUN
dpc-3653	128	45	)	)	PUNCT
dpc-3653	128	46	,	,	PUNCT
dpc-3653	128	47	majid	majid	PROPN
dpc-3653	128	48	and	and	CCONJ
dpc-3653	128	49	imran	imran	PROPN
dpc-3653	128	50	(	(	PUNCT
dpc-3653	128	51	56	56	NUM
dpc-3653	128	52	%	%	NOUN
dpc-3653	128	53	)	)	PUNCT
dpc-3653	128	54	,	,	PUNCT
dpc-3653	128	55	alikhan	alikhan	ADV
dpc-3653	128	56	et	et	PROPN
dpc-3653	128	57	al	al	PROPN
dpc-3653	128	58	(	(	PUNCT
dpc-3653	128	59	39	39	NUM
dpc-3653	128	60	%	%	NOUN
dpc-3653	128	61	)	)	PUNCT
dpc-3653	128	62	,	,	PUNCT
dpc-3653	128	63	and	and	CCONJ
dpc-3653	128	64	nofal	nofal	NOUN
dpc-3653	128	65	et	et	PROPN
dpc-3653	128	66	al	al	PROPN
dpc-3653	128	67	.	.	PROPN
dpc-3653	129	1	(	(	PUNCT
dpc-3653	129	2	33.3	33.3	NUM
dpc-3653	129	3	%	%	NOUN
dpc-3653	129	4	)	)	PUNCT
dpc-3653	130	1	[	[	X
dpc-3653	130	2	17	17	NUM
dpc-3653	130	3	-	-	SYM
dpc-3653	130	4	23	23	NUM
dpc-3653	130	5	]	]	PUNCT
dpc-3653	130	6	.	.	PUNCT
dpc-3653	131	1	an	an	DET
dpc-3653	131	2	earlier	early	ADJ
dpc-3653	131	3	study	study	NOUN
dpc-3653	131	4	has	have	AUX
dpc-3653	131	5	shown	show	VERB
dpc-3653	131	6	higher	high	ADJ
dpc-3653	131	7	response	response	NOUN
dpc-3653	131	8	rate	rate	NOUN
dpc-3653	131	9	.	.	PUNCT
dpc-3653	132	1	johnson	johnson	PROPN
dpc-3653	132	2	et	et	PROPN
dpc-3653	132	3	al	al	PROPN
dpc-3653	132	4	showed	show	VERB
dpc-3653	132	5	74	74	NUM
dpc-3653	132	6	%	%	NOUN
dpc-3653	132	7	complete	complete	ADJ
dpc-3653	132	8	clearance	clearance	NOUN
dpc-3653	132	9	of	of	ADP
dpc-3653	132	10	wart	wart	NOUN
dpc-3653	132	11	among	among	ADP
dpc-3653	132	12	studied	studied	ADJ
dpc-3653	132	13	group	group	NOUN
dpc-3653	132	14	[	[	X
dpc-3653	132	15	24	24	NUM
dpc-3653	132	16	]	]	PUNCT
dpc-3653	132	17	.	.	PUNCT
dpc-3653	133	1	the	the	DET
dpc-3653	133	2	disparities	disparity	NOUN
dpc-3653	133	3	in	in	ADP
dpc-3653	133	4	the	the	DET
dpc-3653	133	5	success	success	NOUN
dpc-3653	133	6	rates	rate	NOUN
dpc-3653	133	7	between	between	ADP
dpc-3653	133	8	our	our	PRON
dpc-3653	133	9	study	study	NOUN
dpc-3653	133	10	and	and	CCONJ
dpc-3653	133	11	the	the	DET
dpc-3653	133	12	other	other	ADJ
dpc-3653	133	13	related	related	ADJ
dpc-3653	133	14	studies	study	NOUN
dpc-3653	133	15	might	might	AUX
dpc-3653	133	16	be	be	AUX
dpc-3653	133	17	attributed	attribute	VERB
dpc-3653	133	18	to	to	ADP
dpc-3653	133	19	factors	factor	NOUN
dpc-3653	133	20	related	relate	VERB
dpc-3653	133	21	to	to	ADP
dpc-3653	133	22	differences	difference	NOUN
dpc-3653	133	23	in	in	ADP
dpc-3653	133	24	the	the	DET
dpc-3653	133	25	nature	nature	NOUN
dpc-3653	133	26	of	of	ADP
dpc-3653	133	27	the	the	DET
dpc-3653	133	28	treated	treat	VERB
dpc-3653	133	29	warts	wart	NOUN
dpc-3653	133	30	(	(	PUNCT
dpc-3653	133	31	multiple	multiple	ADV
dpc-3653	133	32	recalcitrant	recalcitrant	ADJ
dpc-3653	133	33	in	in	ADP
dpc-3653	133	34	our	our	PRON
dpc-3653	133	35	study	study	NOUN
dpc-3653	133	36	)	)	PUNCT
dpc-3653	133	37	,	,	PUNCT
dpc-3653	133	38	degree	degree	NOUN
dpc-3653	133	39	of	of	ADP
dpc-3653	133	40	hpv	hpv	ADJ
dpc-3653	133	41	resistance	resistance	NOUN
dpc-3653	133	42	and	and	CCONJ
dpc-3653	133	43	different	different	ADJ
dpc-3653	133	44	hpv	hpv	ADJ
dpc-3653	133	45	serotypes	serotype	NOUN
dpc-3653	133	46	,	,	PUNCT
dpc-3653	133	47	and	and	CCONJ
dpc-3653	133	48	the	the	DET
dpc-3653	133	49	number	number	NOUN
dpc-3653	133	50	of	of	ADP
dpc-3653	133	51	the	the	DET
dpc-3653	133	52	studied	studied	ADJ
dpc-3653	133	53	patients	patient	NOUN
dpc-3653	133	54	.	.	PUNCT
dpc-3653	134	1	also	also	ADV
dpc-3653	134	2	,	,	PUNCT
dpc-3653	134	3	different	different	ADJ
dpc-3653	134	4	injection	injection	NOUN
dpc-3653	134	5	regimens	regimen	NOUN
dpc-3653	134	6	regarding	regard	VERB
dpc-3653	134	7	the	the	DET
dpc-3653	134	8	manufacturer	manufacturer	NOUN
dpc-3653	134	9	of	of	ADP
dpc-3653	134	10	the	the	DET
dpc-3653	134	11	antigen	antigen	NOUN
dpc-3653	134	12	,	,	PUNCT
dpc-3653	134	13	the	the	DET
dpc-3653	134	14	amount	amount	NOUN
dpc-3653	134	15	and	and	CCONJ
dpc-3653	134	16	concentration	concentration	NOUN
dpc-3653	134	17	of	of	ADP
dpc-3653	134	18	the	the	DET
dpc-3653	134	19	injected	inject	VERB
dpc-3653	134	20	antigen	antigen	NOUN
dpc-3653	134	21	per	per	ADP
dpc-3653	134	22	session	session	NOUN
dpc-3653	134	23	,	,	PUNCT
dpc-3653	134	24	the	the	DET
dpc-3653	134	25	number	number	NOUN
dpc-3653	134	26	of	of	ADP
dpc-3653	134	27	the	the	DET
dpc-3653	134	28	treatment	treatment	NOUN
dpc-3653	134	29	sessions	session	NOUN
dpc-3653	134	30	and	and	CCONJ
dpc-3653	134	31	the	the	DET
dpc-3653	134	32	interval	interval	NOUN
dpc-3653	134	33	between	between	ADP
dpc-3653	134	34	the	the	DET
dpc-3653	134	35	sessions	session	NOUN
dpc-3653	134	36	candida	candida	PROPN
dpc-3653	134	37	antigen	antigen	PROPN
dpc-3653	134	38	works	work	VERB
dpc-3653	134	39	primarily	primarily	ADV
dpc-3653	134	40	by	by	ADP
dpc-3653	134	41	inducing	induce	VERB
dpc-3653	134	42	th1	th1	NOUN
dpc-3653	134	43	cytokines	cytokine	NOUN
dpc-3653	134	44	including	include	VERB
dpc-3653	134	45	ifnand	ifnand	PROPN
dpc-3653	134	46	il-2	il-2	PROPN
dpc-3653	134	47	,	,	PUNCT
dpc-3653	134	48	which	which	PRON
dpc-3653	134	49	stimulate	stimulate	VERB
dpc-3653	134	50	cytotoxic	cytotoxic	ADJ
dpc-3653	134	51	and	and	CCONJ
dpc-3653	134	52	natural	natural	ADJ
dpc-3653	134	53	killer	killer	NOUN
dpc-3653	134	54	cells	cell	NOUN
dpc-3653	134	55	to	to	PART
dpc-3653	134	56	eliminate	eliminate	VERB
dpc-3653	134	57	hpv	hpv	ADJ
dpc-3653	134	58	infection	infection	NOUN
dpc-3653	134	59	not	not	PART
dpc-3653	134	60	only	only	ADV
dpc-3653	134	61	at	at	ADP
dpc-3653	134	62	the	the	DET
dpc-3653	134	63	injection	injection	NOUN
dpc-3653	134	64	site	site	NOUN
dpc-3653	134	65	but	but	CCONJ
dpc-3653	134	66	also	also	ADV
dpc-3653	134	67	at	at	ADP
dpc-3653	134	68	nearby	nearby	ADV
dpc-3653	134	69	and	and	CCONJ
dpc-3653	134	70	distant	distant	ADJ
dpc-3653	134	71	non	non	ADJ
dpc-3653	134	72	-	-	ADJ
dpc-3653	134	73	injected	inject	VERB
dpc-3653	134	74	sites	site	NOUN
dpc-3653	134	75	nofal	nofal	NOUN
dpc-3653	134	76	et	et	PROPN
dpc-3653	134	77	al	al	PROPN
dpc-3653	135	1	[	[	X
dpc-3653	135	2	25	25	NUM
dpc-3653	135	3	]	]	PUNCT
dpc-3653	135	4	.	.	PUNCT
dpc-3653	136	1	in	in	ADP
dpc-3653	136	2	the	the	DET
dpc-3653	136	3	current	current	ADJ
dpc-3653	136	4	study	study	NOUN
dpc-3653	136	5	,	,	PUNCT
dpc-3653	136	6	regarding	regard	VERB
dpc-3653	136	7	the	the	DET
dpc-3653	136	8	distant	distant	ADJ
dpc-3653	136	9	response	response	NOUN
dpc-3653	136	10	rate	rate	NOUN
dpc-3653	136	11	,	,	PUNCT
dpc-3653	136	12	the	the	DET
dpc-3653	136	13	highest	high	ADJ
dpc-3653	136	14	response	response	NOUN
dpc-3653	136	15	rate	rate	NOUN
dpc-3653	136	16	was	be	AUX
dpc-3653	136	17	detected	detect	VERB
dpc-3653	136	18	in	in	ADP
dpc-3653	136	19	the	the	DET
dpc-3653	136	20	hpv	hpv	PROPN
dpc-3653	136	21	vaccine	vaccine	NOUN
dpc-3653	136	22	group	group	NOUN
dpc-3653	136	23	followed	follow	VERB
dpc-3653	136	24	by	by	ADP
dpc-3653	136	25	the	the	DET
dpc-3653	136	26	candida	candida	PROPN
dpc-3653	136	27	antigen	antigen	NOUN
dpc-3653	136	28	group	group	NOUN
dpc-3653	136	29	.	.	PUNCT
dpc-3653	137	1	in	in	ADP
dpc-3653	137	2	the	the	DET
dpc-3653	137	3	candida	candida	PROPN
dpc-3653	137	4	antigen	antigen	NOUN
dpc-3653	137	5	group	group	NOUN
dpc-3653	137	6	,	,	PUNCT
dpc-3653	137	7	complete	complete	ADJ
dpc-3653	137	8	response	response	NOUN
dpc-3653	137	9	was	be	AUX
dpc-3653	137	10	detected	detect	VERB
dpc-3653	137	11	in	in	ADP
dpc-3653	137	12	33.3	33.3	NUM
dpc-3653	137	13	%	%	NOUN
dpc-3653	137	14	6	6	NUM
dpc-3653	137	15	original	original	ADJ
dpc-3653	137	16	article	article	NOUN
dpc-3653	137	17	|	|	ADV
dpc-3653	137	18	dermatol	dermatol	ADJ
dpc-3653	137	19	pract	pract	NOUN
dpc-3653	137	20	concept	concept	NOUN
dpc-3653	137	21	.	.	PUNCT
dpc-3653	138	1	2024;14(2):e2024066	2024;14(2):e2024066	NUM
dpc-3653	138	2	figure	figure	NOUN
dpc-3653	138	3	1	1	NUM
dpc-3653	138	4	.	.	PUNCT
dpc-3653	138	5	male	male	ADJ
dpc-3653	138	6	patient	patient	ADJ
dpc-3653	138	7	21	21	NUM
dpc-3653	138	8	-	-	PUNCT
dpc-3653	138	9	year	year	NOUN
dpc-3653	138	10	-	-	PUNCT
dpc-3653	138	11	old	old	ADJ
dpc-3653	138	12	with	with	ADP
dpc-3653	138	13	multiple	multiple	ADJ
dpc-3653	138	14	common	common	ADJ
dpc-3653	138	15	warts	wart	NOUN
dpc-3653	138	16	on	on	ADP
dpc-3653	138	17	both	both	DET
dpc-3653	138	18	hands	hand	NOUN
dpc-3653	138	19	(	(	PUNCT
dpc-3653	138	20	a	a	NOUN
dpc-3653	138	21	)	)	PUNCT
dpc-3653	138	22	before	before	ADV
dpc-3653	138	23	,	,	PUNCT
dpc-3653	138	24	(	(	PUNCT
dpc-3653	138	25	b	b	X
dpc-3653	138	26	)	)	PUNCT
dpc-3653	138	27	after	after	ADP
dpc-3653	138	28	treatment	treatment	NOUN
dpc-3653	138	29	with	with	ADP
dpc-3653	138	30	intralesional	intralesional	ADJ
dpc-3653	138	31	candida	candida	NOUN
dpc-3653	138	32	antigen	antigen	ADV
dpc-3653	138	33	.	.	PUNCT
dpc-3653	139	1	and	and	CCONJ
dpc-3653	139	2	partial	partial	ADJ
dpc-3653	139	3	response	response	NOUN
dpc-3653	139	4	in	in	ADP
dpc-3653	139	5	50	50	NUM
dpc-3653	139	6	%	%	NOUN
dpc-3653	139	7	while	while	NOUN
dpc-3653	139	8	in	in	ADP
dpc-3653	139	9	the	the	DET
dpc-3653	139	10	quadrivalent	quadrivalent	NOUN
dpc-3653	139	11	hpv	hpv	PROPN
dpc-3653	139	12	vaccine	vaccine	NOUN
dpc-3653	139	13	group	group	NOUN
dpc-3653	139	14	,	,	PUNCT
dpc-3653	139	15	complete	complete	ADJ
dpc-3653	139	16	response	response	NOUN
dpc-3653	139	17	was	be	AUX
dpc-3653	139	18	detected	detect	VERB
dpc-3653	139	19	in	in	ADP
dpc-3653	139	20	72.7	72.7	NUM
dpc-3653	139	21	%	%	NOUN
dpc-3653	139	22	and	and	CCONJ
dpc-3653	139	23	partial	partial	ADJ
dpc-3653	139	24	response	response	NOUN
dpc-3653	139	25	in	in	ADP
dpc-3653	139	26	27.3	27.3	NUM
dpc-3653	139	27	%	%	NOUN
dpc-3653	139	28	.	.	PUNCT
dpc-3653	140	1	this	this	PRON
dpc-3653	140	2	disagreed	disagree	VERB
dpc-3653	140	3	with	with	ADP
dpc-3653	140	4	nassar	nassar	PROPN
dpc-3653	140	5	et	et	PROPN
dpc-3653	140	6	al	al	PROPN
dpc-3653	140	7	who	who	PRON
dpc-3653	140	8	showed	show	VERB
dpc-3653	140	9	that	that	SCONJ
dpc-3653	140	10	the	the	DET
dpc-3653	140	11	rate	rate	NOUN
dpc-3653	140	12	of	of	ADP
dpc-3653	140	13	resolution	resolution	NOUN
dpc-3653	140	14	of	of	ADP
dpc-3653	140	15	distant	distant	ADJ
dpc-3653	140	16	,	,	PUNCT
dpc-3653	140	17	non	non	ADJ
dpc-3653	140	18	-	-	ADJ
dpc-3653	140	19	injected	injected	ADJ
dpc-3653	140	20	warts	wart	NOUN
dpc-3653	140	21	was	be	AUX
dpc-3653	140	22	71.4	71.4	NUM
dpc-3653	140	23	%	%	NOUN
dpc-3653	140	24	in	in	ADP
dpc-3653	140	25	the	the	DET
dpc-3653	140	26	candida	candida	PROPN
dpc-3653	140	27	group	group	NOUN
dpc-3653	140	28	versus	versus	ADP
dpc-3653	140	29	41.2	41.2	NUM
dpc-3653	140	30	%	%	NOUN
dpc-3653	140	31	in	in	ADP
dpc-3653	140	32	the	the	DET
dpc-3653	140	33	hpv	hpv	PROPN
dpc-3653	140	34	vaccine	vaccine	NOUN
dpc-3653	140	35	group	group	NOUN
dpc-3653	140	36	[	[	X
dpc-3653	140	37	16	16	NUM
dpc-3653	140	38	]	]	PUNCT
dpc-3653	140	39	.	.	PUNCT
dpc-3653	141	1	the	the	DET
dpc-3653	141	2	difference	difference	NOUN
dpc-3653	141	3	could	could	AUX
dpc-3653	141	4	be	be	AUX
dpc-3653	141	5	explained	explain	VERB
dpc-3653	141	6	due	due	ADP
dpc-3653	141	7	to	to	ADP
dpc-3653	141	8	that	that	SCONJ
dpc-3653	141	9	the	the	DET
dpc-3653	141	10	previous	previous	ADJ
dpc-3653	141	11	study	study	NOUN
dpc-3653	141	12	used	use	VERB
dpc-3653	141	13	bivalent	bivalent	ADJ
dpc-3653	141	14	vaccine	vaccine	NOUN
dpc-3653	141	15	and	and	CCONJ
dpc-3653	141	16	our	our	PRON
dpc-3653	141	17	study	study	NOUN
dpc-3653	141	18	used	use	VERB
dpc-3653	141	19	quadrivalent	quadrivalent	NOUN
dpc-3653	141	20	vaccine	vaccine	NOUN
dpc-3653	141	21	that	that	PRON
dpc-3653	141	22	provide	provide	VERB
dpc-3653	141	23	greater	great	ADJ
dpc-3653	141	24	cross	cross	NOUN
dpc-3653	141	25	-	-	NOUN
dpc-3653	141	26	protection	protection	NOUN
dpc-3653	141	27	against	against	ADP
dpc-3653	141	28	hpv	hpv	NOUN
dpc-3653	141	29	strains	strain	NOUN
dpc-3653	141	30	than	than	SCONJ
dpc-3653	141	31	provided	provide	VERB
dpc-3653	141	32	by	by	ADP
dpc-3653	141	33	bivalent	bivalent	ADJ
dpc-3653	141	34	vaccine	vaccine	NOUN
dpc-3653	141	35	.	.	PUNCT
dpc-3653	142	1	the	the	DET
dpc-3653	142	2	mechanism	mechanism	NOUN
dpc-3653	142	3	of	of	ADP
dpc-3653	142	4	action	action	NOUN
dpc-3653	142	5	of	of	ADP
dpc-3653	142	6	hpv	hpv	ADJ
dpc-3653	142	7	vaccines	vaccine	NOUN
dpc-3653	142	8	in	in	ADP
dpc-3653	142	9	the	the	DET
dpc-3653	142	10	treatment	treatment	NOUN
dpc-3653	142	11	of	of	ADP
dpc-3653	142	12	warts	wart	NOUN
dpc-3653	142	13	is	be	AUX
dpc-3653	142	14	not	not	PART
dpc-3653	142	15	yet	yet	ADV
dpc-3653	142	16	established	establish	VERB
dpc-3653	142	17	.	.	PUNCT
dpc-3653	143	1	this	this	PRON
dpc-3653	143	2	might	might	AUX
dpc-3653	143	3	be	be	AUX
dpc-3653	143	4	mediated	mediate	VERB
dpc-3653	143	5	by	by	ADP
dpc-3653	143	6	the	the	DET
dpc-3653	143	7	development	development	NOUN
dpc-3653	143	8	of	of	ADP
dpc-3653	143	9	igg	igg	PROPN
dpc-3653	143	10	neutralizing	neutralize	VERB
dpc-3653	143	11	antibodies	antibody	NOUN
dpc-3653	143	12	directed	direct	VERB
dpc-3653	143	13	against	against	ADP
dpc-3653	143	14	hpv	hpv	PROPN
dpc-3653	143	15	-	-	PUNCT
dpc-3653	143	16	l1	l1	PROPN
dpc-3653	143	17	capsid	capsid	NOUN
dpc-3653	143	18	proteins	protein	NOUN
dpc-3653	143	19	generated	generate	VERB
dpc-3653	143	20	as	as	ADP
dpc-3653	143	21	a	a	DET
dpc-3653	143	22	result	result	NOUN
dpc-3653	143	23	of	of	ADP
dpc-3653	143	24	vaccination	vaccination	NOUN
dpc-3653	143	25	.	.	PUNCT
dpc-3653	144	1	although	although	SCONJ
dpc-3653	144	2	the	the	DET
dpc-3653	144	3	hpv	hpv	NOUN
dpc-3653	144	4	strains	strain	VERB
dpc-3653	144	5	that	that	PRON
dpc-3653	144	6	cause	cause	VERB
dpc-3653	144	7	common	common	ADJ
dpc-3653	144	8	warts	wart	NOUN
dpc-3653	144	9	may	may	AUX
dpc-3653	144	10	be	be	AUX
dpc-3653	144	11	less	less	ADV
dpc-3653	144	12	genetically	genetically	ADV
dpc-3653	144	13	related	relate	VERB
dpc-3653	144	14	to	to	ADP
dpc-3653	144	15	those	those	PRON
dpc-3653	144	16	implicated	implicate	VERB
dpc-3653	144	17	in	in	ADP
dpc-3653	144	18	cervical	cervical	ADJ
dpc-3653	144	19	,	,	PUNCT
dpc-3653	144	20	vulvar	vulvar	NOUN
dpc-3653	144	21	,	,	PUNCT
dpc-3653	144	22	and	and	CCONJ
dpc-3653	144	23	anal	anal	ADJ
dpc-3653	144	24	cancer	cancer	NOUN
dpc-3653	144	25	,	,	PUNCT
dpc-3653	144	26	it	it	PRON
dpc-3653	144	27	has	have	AUX
dpc-3653	144	28	been	be	AUX
dpc-3653	144	29	previously	previously	ADV
dpc-3653	144	30	postulated	postulate	VERB
dpc-3653	144	31	that	that	SCONJ
dpc-3653	144	32	hpv	hpv	ADJ
dpc-3653	144	33	vaccines	vaccine	NOUN
dpc-3653	144	34	can	can	AUX
dpc-3653	144	35	provide	provide	VERB
dpc-3653	144	36	cross	cross	NOUN
dpc-3653	144	37	-	-	NOUN
dpc-3653	144	38	protection	protection	NOUN
dpc-3653	144	39	against	against	ADP
dpc-3653	144	40	hpv	hpv	NOUN
dpc-3653	144	41	strains	strain	NOUN
dpc-3653	144	42	other	other	ADJ
dpc-3653	144	43	than	than	ADP
dpc-3653	144	44	those	those	PRON
dpc-3653	144	45	targeted	target	VERB
dpc-3653	144	46	by	by	ADP
dpc-3653	144	47	the	the	DET
dpc-3653	144	48	individual	individual	ADJ
dpc-3653	144	49	vaccine	vaccine	NOUN
dpc-3653	144	50	administered	administer	VERB
dpc-3653	144	51	[	[	PUNCT
dpc-3653	144	52	26,27	26,27	NUM
dpc-3653	144	53	]	]	PUNCT
dpc-3653	144	54	.	.	PUNCT
dpc-3653	145	1	the	the	DET
dpc-3653	145	2	combination	combination	NOUN
dpc-3653	145	3	of	of	ADP
dpc-3653	145	4	drugs	drug	NOUN
dpc-3653	145	5	,	,	PUNCT
dpc-3653	145	6	with	with	ADP
dpc-3653	145	7	different	different	ADJ
dpc-3653	145	8	mechanisms	mechanism	NOUN
dpc-3653	145	9	of	of	ADP
dpc-3653	145	10	action	action	NOUN
dpc-3653	145	11	,	,	PUNCT
dpc-3653	145	12	has	have	AUX
dpc-3653	145	13	been	be	AUX
dpc-3653	145	14	postulated	postulate	VERB
dpc-3653	145	15	to	to	PART
dpc-3653	145	16	improve	improve	VERB
dpc-3653	145	17	treatment	treatment	NOUN
dpc-3653	145	18	response	response	NOUN
dpc-3653	145	19	,	,	PUNCT
dpc-3653	145	20	decrease	decrease	VERB
dpc-3653	145	21	adverse	adverse	ADJ
dpc-3653	145	22	effects	effect	NOUN
dpc-3653	145	23	,	,	PUNCT
dpc-3653	145	24	and	and	CCONJ
dpc-3653	145	25	minimize	minimize	VERB
dpc-3653	145	26	recurrence	recurrence	NOUN
dpc-3653	145	27	rate	rate	NOUN
dpc-3653	145	28	.	.	PUNCT
dpc-3653	146	1	many	many	ADJ
dpc-3653	146	2	authors	author	NOUN
dpc-3653	146	3	have	have	AUX
dpc-3653	146	4	reported	report	VERB
dpc-3653	146	5	better	well	ADJ
dpc-3653	146	6	control	control	NOUN
dpc-3653	146	7	of	of	ADP
dpc-3653	146	8	hpv	hpv	NOUN
dpc-3653	146	9	infections	infection	NOUN
dpc-3653	146	10	using	use	VERB
dpc-3653	146	11	combined	combine	VERB
dpc-3653	146	12	therapeutic	therapeutic	ADJ
dpc-3653	146	13	modalities	modality	NOUN
dpc-3653	146	14	compared	compare	VERB
dpc-3653	146	15	with	with	ADP
dpc-3653	146	16	monotherapy	monotherapy	NOUN
dpc-3653	146	17	in	in	ADP
dpc-3653	146	18	the	the	DET
dpc-3653	146	19	treatment	treatment	NOUN
dpc-3653	146	20	of	of	ADP
dpc-3653	146	21	warts	wart	NOUN
dpc-3653	146	22	,	,	PUNCT
dpc-3653	146	23	particularly	particularly	ADV
dpc-3653	146	24	the	the	DET
dpc-3653	146	25	recalcitrant	recalcitrant	ADJ
dpc-3653	146	26	ones	one	NOUN
dpc-3653	146	27	[	[	X
dpc-3653	146	28	25,28	25,28	X
dpc-3653	146	29	]	]	X
dpc-3653	146	30	.	.	PUNCT
dpc-3653	147	1	one	one	NUM
dpc-3653	147	2	of	of	ADP
dpc-3653	147	3	the	the	DET
dpc-3653	147	4	advantages	advantage	NOUN
dpc-3653	147	5	of	of	ADP
dpc-3653	147	6	hpv	hpv	ADJ
dpc-3653	147	7	vaccines	vaccine	NOUN
dpc-3653	147	8	is	be	AUX
dpc-3653	147	9	that	that	SCONJ
dpc-3653	147	10	the	the	DET
dpc-3653	147	11	vlps	vlp	NOUN
dpc-3653	147	12	are	be	AUX
dpc-3653	147	13	not	not	PART
dpc-3653	147	14	infectious	infectious	ADJ
dpc-3653	147	15	,	,	PUNCT
dpc-3653	147	16	since	since	SCONJ
dpc-3653	147	17	they	they	PRON
dpc-3653	147	18	lack	lack	VERB
dpc-3653	147	19	the	the	DET
dpc-3653	147	20	virus	virus	NOUN
dpc-3653	147	21	dna	dna	PROPN
dpc-3653	147	22	.	.	PUNCT
dpc-3653	148	1	therefore	therefore	ADV
dpc-3653	148	2	,	,	PUNCT
dpc-3653	148	3	they	they	PRON
dpc-3653	148	4	can	can	AUX
dpc-3653	148	5	be	be	AUX
dpc-3653	148	6	used	use	VERB
dpc-3653	148	7	safely	safely	ADV
dpc-3653	148	8	in	in	ADP
dpc-3653	148	9	case	case	NOUN
dpc-3653	148	10	of	of	ADP
dpc-3653	148	11	immunosuppression	immunosuppression	NOUN
dpc-3653	148	12	,	,	PUNCT
dpc-3653	148	13	a	a	DET
dpc-3653	148	14	major	major	ADJ
dpc-3653	148	15	obstacle	obstacle	NOUN
dpc-3653	148	16	for	for	ADP
dpc-3653	148	17	other	other	ADJ
dpc-3653	148	18	types	type	NOUN
dpc-3653	148	19	of	of	ADP
dpc-3653	148	20	immunotherapies	immunotherapy	NOUN
dpc-3653	148	21	.	.	PUNCT
dpc-3653	149	1	furthermore	furthermore	ADV
dpc-3653	149	2	,	,	PUNCT
dpc-3653	149	3	the	the	DET
dpc-3653	149	4	development	development	NOUN
dpc-3653	149	5	of	of	ADP
dpc-3653	149	6	hpv	hpv	NOUN
dpc-3653	149	7	-	-	PUNCT
dpc-3653	149	8	directed	direct	VERB
dpc-3653	149	9	immunity	immunity	NOUN
dpc-3653	149	10	after	after	ADP
dpc-3653	149	11	receiving	receive	VERB
dpc-3653	149	12	the	the	DET
dpc-3653	149	13	vaccine	vaccine	NOUN
dpc-3653	149	14	has	have	VERB
dpc-3653	149	15	a	a	DET
dpc-3653	149	16	double	double	ADJ
dpc-3653	149	17	benefit	benefit	NOUN
dpc-3653	149	18	in	in	ADP
dpc-3653	149	19	the	the	DET
dpc-3653	149	20	treatment	treatment	NOUN
dpc-3653	149	21	of	of	ADP
dpc-3653	149	22	current	current	ADJ
dpc-3653	149	23	infection	infection	NOUN
dpc-3653	149	24	and	and	CCONJ
dpc-3653	149	25	the	the	DET
dpc-3653	149	26	prevention	prevention	NOUN
dpc-3653	149	27	of	of	ADP
dpc-3653	149	28	future	future	ADJ
dpc-3653	149	29	one	one	NUM
dpc-3653	149	30	[	[	X
dpc-3653	149	31	29	29	NUM
dpc-3653	149	32	]	]	PUNCT
dpc-3653	149	33	.	.	PUNCT
dpc-3653	150	1	in	in	ADP
dpc-3653	150	2	the	the	DET
dpc-3653	150	3	current	current	ADJ
dpc-3653	150	4	study	study	NOUN
dpc-3653	150	5	,	,	PUNCT
dpc-3653	150	6	in	in	ADP
dpc-3653	150	7	the	the	DET
dpc-3653	150	8	control	control	NOUN
dpc-3653	150	9	group	group	NOUN
dpc-3653	150	10	who	who	PRON
dpc-3653	150	11	received	receive	VERB
dpc-3653	150	12	intralesional	intralesional	ADJ
dpc-3653	150	13	saline	saline	NOUN
dpc-3653	150	14	,	,	PUNCT
dpc-3653	150	15	local	local	ADJ
dpc-3653	150	16	partial	partial	ADJ
dpc-3653	150	17	response	response	NOUN
dpc-3653	150	18	was	be	AUX
dpc-3653	150	19	achieved	achieve	VERB
dpc-3653	150	20	in	in	ADP
dpc-3653	150	21	10	10	NUM
dpc-3653	150	22	%	%	NOUN
dpc-3653	150	23	of	of	ADP
dpc-3653	150	24	the	the	DET
dpc-3653	150	25	cases	case	NOUN
dpc-3653	150	26	with	with	ADP
dpc-3653	150	27	no	no	DET
dpc-3653	150	28	distant	distant	ADJ
dpc-3653	150	29	response	response	NOUN
dpc-3653	150	30	.	.	PUNCT
dpc-3653	151	1	fathy	fathy	PROPN
dpc-3653	151	2	and	and	CCONJ
dpc-3653	151	3	his	his	PRON
dpc-3653	151	4	colleagues	colleague	NOUN
dpc-3653	151	5	reported	report	VERB
dpc-3653	151	6	that	that	SCONJ
dpc-3653	151	7	intralesional	intralesional	ADJ
dpc-3653	151	8	injection	injection	NOUN
dpc-3653	151	9	of	of	ADP
dpc-3653	151	10	saline	saline	NOUN
dpc-3653	151	11	was	be	AUX
dpc-3653	151	12	associated	associate	VERB
dpc-3653	151	13	with	with	ADP
dpc-3653	151	14	20.7	20.7	NUM
dpc-3653	151	15	%	%	NOUN
dpc-3653	151	16	good	good	ADJ
dpc-3653	151	17	response	response	NOUN
dpc-3653	151	18	and	and	CCONJ
dpc-3653	151	19	79.3	79.3	NUM
dpc-3653	151	20	%	%	NOUN
dpc-3653	151	21	poor	poor	ADJ
dpc-3653	151	22	response	response	NOUN
dpc-3653	151	23	after	after	ADP
dpc-3653	151	24	the	the	DET
dpc-3653	151	25	5th	5th	ADJ
dpc-3653	151	26	session	session	NOUN
dpc-3653	151	27	in	in	ADP
dpc-3653	151	28	cases	case	NOUN
dpc-3653	151	29	with	with	ADP
dpc-3653	151	30	planter	planter	NOUN
dpc-3653	151	31	warts	wart	NOUN
dpc-3653	151	32	with	with	ADP
dpc-3653	151	33	no	no	DET
dpc-3653	151	34	complete	complete	ADJ
dpc-3653	151	35	clearance	clearance	NOUN
dpc-3653	151	36	of	of	ADP
dpc-3653	151	37	any	any	DET
dpc-3653	151	38	wart	wart	NOUN
dpc-3653	152	1	[	[	X
dpc-3653	152	2	30	30	NUM
dpc-3653	152	3	]	]	PUNCT
dpc-3653	152	4	.	.	PUNCT
dpc-3653	153	1	also	also	ADV
dpc-3653	153	2	,	,	PUNCT
dpc-3653	153	3	mohamed	mohamed	PROPN
dpc-3653	153	4	and	and	CCONJ
dpc-3653	153	5	his	his	PRON
dpc-3653	153	6	colleagues	colleague	NOUN
dpc-3653	153	7	reported	report	VERB
dpc-3653	153	8	a	a	DET
dpc-3653	153	9	statistically	statistically	ADV
dpc-3653	153	10	significant	significant	ADJ
dpc-3653	153	11	decrease	decrease	NOUN
dpc-3653	153	12	in	in	ADP
dpc-3653	153	13	the	the	DET
dpc-3653	153	14	number	number	NOUN
dpc-3653	153	15	of	of	ADP
dpc-3653	153	16	warts	wart	NOUN
dpc-3653	153	17	after	after	ADP
dpc-3653	153	18	5	5	NUM
dpc-3653	153	19	sessions	session	NOUN
dpc-3653	153	20	of	of	ADP
dpc-3653	153	21	injection	injection	NOUN
dpc-3653	153	22	of	of	ADP
dpc-3653	153	23	intralesional	intralesional	ADJ
dpc-3653	153	24	saline	saline	NOUN
dpc-3653	153	25	of	of	ADP
dpc-3653	153	26	warts	wart	NOUN
dpc-3653	153	27	.	.	PUNCT
dpc-3653	154	1	the	the	DET
dpc-3653	154	2	mechanism	mechanism	NOUN
dpc-3653	154	3	of	of	ADP
dpc-3653	154	4	action	action	NOUN
dpc-3653	154	5	of	of	ADP
dpc-3653	154	6	intralesional	intralesional	ADJ
dpc-3653	154	7	saline	saline	NOUN
dpc-3653	154	8	is	be	AUX
dpc-3653	154	9	unknown	unknown	ADJ
dpc-3653	154	10	;	;	PUNCT
dpc-3653	154	11	it	it	PRON
dpc-3653	154	12	may	may	AUX
dpc-3653	154	13	be	be	AUX
dpc-3653	154	14	due	due	ADJ
dpc-3653	154	15	to	to	ADP
dpc-3653	154	16	exposure	exposure	NOUN
dpc-3653	154	17	of	of	ADP
dpc-3653	154	18	the	the	DET
dpc-3653	154	19	viral	viral	ADJ
dpc-3653	154	20	particles	particle	NOUN
dpc-3653	154	21	to	to	ADP
dpc-3653	154	22	the	the	DET
dpc-3653	154	23	immune	immune	ADJ
dpc-3653	154	24	system	system	NOUN
dpc-3653	154	25	that	that	PRON
dpc-3653	154	26	later	later	ADV
dpc-3653	154	27	attacks	attack	VERB
dpc-3653	154	28	them	they	PRON
dpc-3653	154	29	through	through	ADP
dpc-3653	154	30	the	the	DET
dpc-3653	154	31	trauma	trauma	NOUN
dpc-3653	154	32	produced	produce	VERB
dpc-3653	154	33	during	during	ADP
dpc-3653	154	34	the	the	DET
dpc-3653	154	35	injection	injection	NOUN
dpc-3653	154	36	[	[	X
dpc-3653	154	37	31	31	NUM
dpc-3653	154	38	]	]	PUNCT
dpc-3653	154	39	.	.	PUNCT
dpc-3653	155	1	the	the	DET
dpc-3653	155	2	difference	difference	NOUN
dpc-3653	155	3	between	between	ADP
dpc-3653	155	4	our	our	PRON
dpc-3653	155	5	study	study	NOUN
dpc-3653	155	6	and	and	CCONJ
dpc-3653	155	7	these	these	DET
dpc-3653	155	8	studies	study	NOUN
dpc-3653	155	9	may	may	AUX
dpc-3653	155	10	be	be	AUX
dpc-3653	155	11	explained	explain	VERB
dpc-3653	155	12	by	by	ADP
dpc-3653	155	13	the	the	DET
dpc-3653	155	14	differences	difference	NOUN
dpc-3653	155	15	in	in	ADP
dpc-3653	155	16	the	the	DET
dpc-3653	155	17	nature	nature	NOUN
dpc-3653	155	18	of	of	ADP
dpc-3653	155	19	the	the	DET
dpc-3653	155	20	treated	treat	VERB
dpc-3653	155	21	warts	wart	NOUN
dpc-3653	155	22	(	(	PUNCT
dpc-3653	155	23	recalcitrant	recalcitrant	ADJ
dpc-3653	155	24	in	in	ADP
dpc-3653	155	25	our	our	PRON
dpc-3653	155	26	study	study	NOUN
dpc-3653	155	27	)	)	PUNCT
dpc-3653	155	28	as	as	SCONJ
dpc-3653	155	29	the	the	DET
dpc-3653	155	30	duration	duration	NOUN
dpc-3653	155	31	of	of	ADP
dpc-3653	155	32	the	the	DET
dpc-3653	155	33	warts	wart	NOUN
dpc-3653	155	34	show	show	VERB
dpc-3653	155	35	a	a	DET
dpc-3653	155	36	significant	significant	ADJ
dpc-3653	155	37	inverse	inverse	NOUN
dpc-3653	155	38	correlation	correlation	NOUN
dpc-3653	155	39	with	with	ADP
dpc-3653	155	40	the	the	DET
dpc-3653	155	41	treatment	treatment	NOUN
dpc-3653	155	42	response	response	NOUN
dpc-3653	155	43	(	(	PUNCT
dpc-3653	155	44	the	the	PRON
dpc-3653	155	45	longer	long	ADJ
dpc-3653	155	46	the	the	DET
dpc-3653	155	47	duration	duration	NOUN
dpc-3653	155	48	,	,	PUNCT
dpc-3653	155	49	the	the	PRON
dpc-3653	155	50	lower	low	ADJ
dpc-3653	155	51	the	the	DET
dpc-3653	155	52	response	response	NOUN
dpc-3653	155	53	)	)	PUNCT
dpc-3653	155	54	.	.	PUNCT
dpc-3653	156	1	also	also	ADV
dpc-3653	156	2	the	the	DET
dpc-3653	156	3	number	number	NOUN
dpc-3653	156	4	of	of	ADP
dpc-3653	156	5	the	the	DET
dpc-3653	156	6	treatment	treatment	NOUN
dpc-3653	156	7	sessions	session	NOUN
dpc-3653	156	8	(	(	PUNCT
dpc-3653	156	9	5	5	NUM
dpc-3653	156	10	sessions	session	NOUN
dpc-3653	156	11	versus	versus	ADP
dpc-3653	156	12	3	3	NUM
dpc-3653	156	13	 	 	SPACE
dpc-3653	156	14	sessions	session	NOUN
dpc-3653	156	15	in	in	ADP
dpc-3653	156	16	our	our	PRON
dpc-3653	156	17	study	study	NOUN
dpc-3653	156	18	)	)	PUNCT
dpc-3653	156	19	.	.	PUNCT
dpc-3653	157	1	the	the	DET
dpc-3653	157	2	main	main	ADJ
dpc-3653	157	3	strength	strength	NOUN
dpc-3653	157	4	point	point	NOUN
dpc-3653	157	5	of	of	ADP
dpc-3653	157	6	the	the	DET
dpc-3653	157	7	current	current	ADJ
dpc-3653	157	8	study	study	NOUN
dpc-3653	157	9	,	,	PUNCT
dpc-3653	157	10	the	the	DET
dpc-3653	157	11	first	first	ADJ
dpc-3653	157	12	to	to	PART
dpc-3653	157	13	evaluate	evaluate	VERB
dpc-3653	157	14	the	the	DET
dpc-3653	157	15	effectiveness	effectiveness	NOUN
dpc-3653	157	16	of	of	ADP
dpc-3653	157	17	the	the	DET
dpc-3653	157	18	quadrivalent	quadrivalent	ADJ
dpc-3653	157	19	hpv	hpv	NOUN
dpc-3653	157	20	vaccine	vaccine	NOUN
dpc-3653	157	21	in	in	ADP
dpc-3653	157	22	comparison	comparison	NOUN
dpc-3653	157	23	to	to	ADP
dpc-3653	157	24	the	the	DET
dpc-3653	157	25	candida	candida	PROPN
dpc-3653	157	26	antigen	antigen	NOUN
dpc-3653	157	27	and	and	CCONJ
dpc-3653	157	28	the	the	DET
dpc-3653	157	29	placebo	placebo	NOUN
dpc-3653	157	30	.	.	PUNCT
dpc-3653	158	1	however	however	ADV
dpc-3653	158	2	,	,	PUNCT
dpc-3653	158	3	the	the	DET
dpc-3653	158	4	current	current	ADJ
dpc-3653	158	5	study	study	NOUN
dpc-3653	158	6	had	have	VERB
dpc-3653	158	7	some	some	DET
dpc-3653	158	8	limitations	limitation	NOUN
dpc-3653	158	9	as	as	SCONJ
dpc-3653	158	10	it	it	PRON
dpc-3653	158	11	is	be	AUX
dpc-3653	158	12	a	a	DET
dpc-3653	158	13	single	single	ADJ
dpc-3653	158	14	center	center	NOUN
dpc-3653	158	15	study	study	NOUN
dpc-3653	158	16	and	and	CCONJ
dpc-3653	158	17	recruited	recruit	VERB
dpc-3653	158	18	a	a	DET
dpc-3653	158	19	relatively	relatively	ADV
dpc-3653	158	20	small	small	ADJ
dpc-3653	158	21	sample	sample	NOUN
dpc-3653	158	22	size	size	NOUN
dpc-3653	158	23	that	that	PRON
dpc-3653	158	24	could	could	AUX
dpc-3653	158	25	decrease	decrease	VERB
dpc-3653	158	26	the	the	DET
dpc-3653	158	27	power	power	NOUN
dpc-3653	158	28	of	of	ADP
dpc-3653	158	29	the	the	DET
dpc-3653	158	30	obtained	obtain	VERB
dpc-3653	158	31	results	result	NOUN
dpc-3653	158	32	,	,	PUNCT
dpc-3653	158	33	and	and	CCONJ
dpc-3653	158	34	there	there	PRON
dpc-3653	158	35	was	be	VERB
dpc-3653	158	36	no	no	DET
dpc-3653	158	37	efficacy	efficacy	NOUN
dpc-3653	158	38	analysis	analysis	NOUN
dpc-3653	158	39	taking	take	VERB
dpc-3653	158	40	into	into	ADP
dpc-3653	158	41	account	account	NOUN
dpc-3653	158	42	the	the	DET
dpc-3653	158	43	size	size	NOUN
dpc-3653	158	44	and	and	CCONJ
dpc-3653	158	45	duration	duration	NOUN
dpc-3653	158	46	of	of	ADP
dpc-3653	158	47	the	the	DET
dpc-3653	158	48	lesions	lesion	NOUN
dpc-3653	158	49	.	.	PUNCT
dpc-3653	159	1	also	also	ADV
dpc-3653	159	2	,	,	PUNCT
dpc-3653	159	3	the	the	DET
dpc-3653	159	4	short	short	ADJ
dpc-3653	159	5	duration	duration	NOUN
dpc-3653	159	6	of	of	ADP
dpc-3653	159	7	follow	follow	VERB
dpc-3653	159	8	up	up	ADP
dpc-3653	159	9	did	do	AUX
dpc-3653	159	10	not	not	PART
dpc-3653	159	11	enable	enable	VERB
dpc-3653	159	12	to	to	PART
dpc-3653	159	13	comment	comment	VERB
dpc-3653	159	14	on	on	ADP
dpc-3653	159	15	the	the	DET
dpc-3653	159	16	long	long	ADJ
dpc-3653	159	17	-	-	PUNCT
dpc-3653	159	18	term	term	NOUN
dpc-3653	159	19	outcomes	outcome	NOUN
dpc-3653	159	20	especially	especially	ADV
dpc-3653	159	21	the	the	DET
dpc-3653	159	22	rate	rate	NOUN
dpc-3653	159	23	of	of	ADP
dpc-3653	159	24	recurrence	recurrence	NOUN
dpc-3653	159	25	.	.	PUNCT
dpc-3653	160	1	based	base	VERB
dpc-3653	160	2	on	on	ADP
dpc-3653	160	3	our	our	PRON
dpc-3653	160	4	findings	finding	NOUN
dpc-3653	160	5	,	,	PUNCT
dpc-3653	160	6	intralesional	intralesional	ADJ
dpc-3653	160	7	antigen	antigen	ADJ
dpc-3653	160	8	immunotherapy	immunotherapy	NOUN
dpc-3653	160	9	seems	seem	VERB
dpc-3653	160	10	to	to	PART
dpc-3653	160	11	be	be	AUX
dpc-3653	160	12	an	an	DET
dpc-3653	160	13	effective	effective	ADJ
dpc-3653	160	14	therapeutic	therapeutic	ADJ
dpc-3653	160	15	option	option	NOUN
dpc-3653	160	16	for	for	ADP
dpc-3653	160	17	the	the	DET
dpc-3653	160	18	treatment	treatment	NOUN
dpc-3653	160	19	of	of	ADP
dpc-3653	160	20	non	non	ADJ
dpc-3653	160	21	-	-	ADJ
dpc-3653	160	22	genital	genital	ADJ
dpc-3653	160	23	warts	wart	NOUN
dpc-3653	160	24	.	.	PUNCT
dpc-3653	161	1	additionally	additionally	ADV
dpc-3653	161	2	,	,	PUNCT
dpc-3653	161	3	we	we	PRON
dpc-3653	161	4	came	come	VERB
dpc-3653	161	5	to	to	ADP
dpc-3653	161	6	the	the	DET
dpc-3653	161	7	conclusion	conclusion	NOUN
dpc-3653	161	8	that	that	SCONJ
dpc-3653	161	9	the	the	DET
dpc-3653	161	10	efficacy	efficacy	NOUN
dpc-3653	161	11	of	of	ADP
dpc-3653	161	12	intralesional	intralesional	ADJ
dpc-3653	161	13	quadrivalent	quadrivalent	NOUN
dpc-3653	161	14	hpv	hpv	NOUN
dpc-3653	161	15	vaccine	vaccine	NOUN
dpc-3653	161	16	was	be	AUX
dpc-3653	161	17	superior	superior	ADJ
dpc-3653	161	18	to	to	ADP
dpc-3653	161	19	intralesional	intralesional	ADJ
dpc-3653	161	20	candida	candida	PROPN
dpc-3653	161	21	antigen	antigen	ADV
dpc-3653	161	22	.	.	PUNCT
dpc-3653	162	1	original	original	ADJ
dpc-3653	162	2	article	article	NOUN
dpc-3653	162	3	|	|	ADV
dpc-3653	162	4	dermatol	dermatol	ADJ
dpc-3653	162	5	pract	pract	NOUN
dpc-3653	162	6	concept	concept	NOUN
dpc-3653	162	7	.	.	PUNCT
dpc-3653	163	1	2024;14(2):e2024066	2024;14(2):e2024066	NUM
dpc-3653	163	2	7	7	NUM
dpc-3653	163	3	figure	figure	NOUN
dpc-3653	163	4	2	2	NUM
dpc-3653	163	5	.	.	PUNCT
dpc-3653	163	6	female	female	ADJ
dpc-3653	163	7	patient	patient	NOUN
dpc-3653	163	8	15	15	NUM
dpc-3653	163	9	-	-	PUNCT
dpc-3653	163	10	year	year	NOUN
dpc-3653	163	11	-	-	PUNCT
dpc-3653	163	12	old	old	ADJ
dpc-3653	163	13	with	with	ADP
dpc-3653	163	14	multiple	multiple	ADJ
dpc-3653	163	15	common	common	ADJ
dpc-3653	163	16	warts	wart	NOUN
dpc-3653	163	17	on	on	ADP
dpc-3653	163	18	the	the	DET
dpc-3653	163	19	right	right	ADJ
dpc-3653	163	20	hand	hand	NOUN
dpc-3653	163	21	(	(	PUNCT
dpc-3653	163	22	a	a	NOUN
dpc-3653	163	23	)	)	PUNCT
dpc-3653	163	24	before	before	ADV
dpc-3653	163	25	,	,	PUNCT
dpc-3653	163	26	(	(	PUNCT
dpc-3653	163	27	b	b	X
dpc-3653	163	28	)	)	PUNCT
dpc-3653	163	29	after	after	ADP
dpc-3653	163	30	treatment	treatment	NOUN
dpc-3653	163	31	with	with	ADP
dpc-3653	163	32	intralesional	intralesional	ADJ
dpc-3653	163	33	quadrivalent	quadrivalent	NOUN
dpc-3653	163	34	hpv	hpv	NOUN
dpc-3653	163	35	vaccine	vaccine	NOUN
dpc-3653	163	36	.	.	PUNCT
dpc-3653	164	1	references	reference	NOUN
dpc-3653	164	2	1	1	NUM
dpc-3653	164	3	.	.	PUNCT
dpc-3653	164	4	doorbar	doorbar	PROPN
dpc-3653	164	5	j	j	PROPN
dpc-3653	164	6	,	,	PUNCT
dpc-3653	164	7	egawa	egawa	PROPN
dpc-3653	164	8	n	n	CCONJ
dpc-3653	164	9	,	,	PUNCT
dpc-3653	164	10	griffin	griffin	PROPN
dpc-3653	164	11	h	h	PROPN
dpc-3653	164	12	,	,	PUNCT
dpc-3653	164	13	kranjec	kranjec	PROPN
dpc-3653	164	14	c	c	NOUN
dpc-3653	164	15	,	,	PUNCT
dpc-3653	164	16	murakami	murakami	PROPN
dpc-3653	164	17	i.	i.	PROPN
dpc-3653	164	18	human	human	PROPN
dpc-3653	164	19	papillomavirus	papillomavirus	PROPN
dpc-3653	164	20	molecular	molecular	ADJ
dpc-3653	164	21	biology	biology	NOUN
dpc-3653	164	22	and	and	CCONJ
dpc-3653	164	23	disease	disease	NOUN
dpc-3653	164	24	association	association	PROPN
dpc-3653	164	25	.	.	PUNCT
dpc-3653	165	1	rev	rev	PROPN
dpc-3653	165	2	med	med	PROPN
dpc-3653	165	3	virol	virol	NOUN
dpc-3653	165	4	.	.	PUNCT
dpc-3653	166	1	2015;25	2015;25	NUM
dpc-3653	166	2	suppl	suppl	ADJ
dpc-3653	166	3	1(suppl	1(suppl	NUM
dpc-3653	166	4	suppl	suppl	PROPN
dpc-3653	166	5	1):2	1):2	NUM
dpc-3653	166	6	-	-	SYM
dpc-3653	166	7	23	23	NUM
dpc-3653	166	8	.	.	PUNCT
dpc-3653	167	1	doi	doi	NOUN
dpc-3653	167	2	:	:	PUNCT
dpc-3653	167	3	10.1002	10.1002	NUM
dpc-3653	167	4	/rmv.1822	/rmv.1822	NOUN
dpc-3653	167	5	.	.	PUNCT
dpc-3653	168	1	pmid	pmid	NOUN
dpc-3653	168	2	:	:	PUNCT
dpc-3653	168	3	25752814	25752814	NUM
dpc-3653	168	4	.	.	PUNCT
dpc-3653	169	1	pmcid	pmcid	NOUN
dpc-3653	169	2	:	:	PUNCT
dpc-3653	169	3	pmc5024016	pmc5024016	NOUN
dpc-3653	169	4	.	.	PUNCT
dpc-3653	170	1	2	2	X
dpc-3653	170	2	.	.	X
dpc-3653	170	3	bacaj	bacaj	PROPN
dpc-3653	170	4	p	p	NOUN
dpc-3653	170	5	,	,	PUNCT
dpc-3653	170	6	burch	burch	PROPN
dpc-3653	170	7	d.	d.	PROPN
dpc-3653	170	8	human	human	PROPN
dpc-3653	170	9	papillomavirus	papillomavirus	PROPN
dpc-3653	170	10	infection	infection	NOUN
dpc-3653	170	11	of	of	ADP
dpc-3653	170	12	the	the	DET
dpc-3653	170	13	skin	skin	NOUN
dpc-3653	170	14	.	.	PUNCT
dpc-3653	171	1	arch	arch	ADJ
dpc-3653	171	2	pathol	pathol	NOUN
dpc-3653	171	3	lab	lab	NOUN
dpc-3653	171	4	med	me	VERB
dpc-3653	171	5	.	.	PUNCT
dpc-3653	172	1	2018;142(6):700	2018;142(6):700	NUM
dpc-3653	172	2	-	-	SYM
dpc-3653	172	3	705	705	NUM
dpc-3653	172	4	.	.	PUNCT
dpc-3653	172	5	doi	doi	NOUN
dpc-3653	172	6	:	:	PUNCT
dpc-3653	172	7	10.5858	10.5858	NUM
dpc-3653	172	8	/arpa.2017	/arpa.2017	SYM
dpc-3653	172	9	-	-	PUNCT
dpc-3653	172	10	0572	0572	NUM
dpc-3653	172	11	-	-	PUNCT
dpc-3653	172	12	ra	ra	NOUN
dpc-3653	172	13	.	.	PUNCT
dpc-3653	173	1	pmid	pmid	NOUN
dpc-3653	173	2	:	:	PUNCT
dpc-3653	173	3	29848038	29848038	NUM
dpc-3653	173	4	.	.	PUNCT
dpc-3653	174	1	3	3	X
dpc-3653	174	2	.	.	X
dpc-3653	174	3	loo	loo	VERB
dpc-3653	174	4	sk	sk	ADP
dpc-3653	174	5	,	,	PUNCT
dpc-3653	175	1	tang	tang	PROPN
dpc-3653	175	2	wy	wy	PROPN
dpc-3653	175	3	.	.	PROPN
dpc-3653	175	4	warts	wart	NOUN
dpc-3653	175	5	(	(	PUNCT
dpc-3653	175	6	non	non	ADJ
dpc-3653	175	7	-	-	ADJ
dpc-3653	175	8	genital	genital	ADJ
dpc-3653	175	9	)	)	PUNCT
dpc-3653	175	10	.	.	PUNCT
dpc-3653	176	1	bmj	bmj	PROPN
dpc-3653	176	2	clin	clin	PROPN
dpc-3653	176	3	evid	evid	PROPN
dpc-3653	176	4	.	.	PUNCT
dpc-3653	177	1	2014;2014:1710	2014;2014:1710	NUM
dpc-3653	177	2	.	.	PUNCT
dpc-3653	178	1	pmid	pmid	NOUN
dpc-3653	178	2	:	:	PUNCT
dpc-3653	178	3	24921240	24921240	NUM
dpc-3653	178	4	.	.	PUNCT
dpc-3653	179	1	pmcid	pmcid	NOUN
dpc-3653	179	2	:	:	PUNCT
dpc-3653	179	3	pmc4054795	pmc4054795	NOUN
dpc-3653	179	4	.	.	PUNCT
dpc-3653	180	1	4	4	X
dpc-3653	180	2	.	.	X
dpc-3653	180	3	dall’oglio	dall’oglio	PROPN
dpc-3653	180	4	f	f	NOUN
dpc-3653	180	5	,	,	PUNCT
dpc-3653	180	6	d’amico	d’amico	PROPN
dpc-3653	180	7	v	v	NOUN
dpc-3653	180	8	,	,	PUNCT
dpc-3653	180	9	nasca	nasca	PROPN
dpc-3653	181	1	mr	mr	PROPN
dpc-3653	181	2	,	,	PUNCT
dpc-3653	181	3	micali	micali	NOUN
dpc-3653	181	4	g.	g.	PROPN
dpc-3653	181	5	treatment	treatment	NOUN
dpc-3653	181	6	of	of	ADP
dpc-3653	181	7	cutaneous	cutaneous	ADJ
dpc-3653	181	8	warts	wart	NOUN
dpc-3653	181	9	:	:	PUNCT
dpc-3653	181	10	an	an	DET
dpc-3653	181	11	evidence	evidence	NOUN
dpc-3653	181	12	-	-	PUNCT
dpc-3653	181	13	based	base	VERB
dpc-3653	181	14	review	review	NOUN
dpc-3653	181	15	.	.	PUNCT
dpc-3653	182	1	am	be	AUX
dpc-3653	182	2	j	j	PROPN
dpc-3653	182	3	clin	clin	PROPN
dpc-3653	182	4	dermatol	dermatol	NOUN
dpc-3653	182	5	.	.	PUNCT
dpc-3653	183	1	2012;13(2):73	2012;13(2):73	PROPN
dpc-3653	183	2	-	-	SYM
dpc-3653	183	3	96	96	NUM
dpc-3653	183	4	.	.	PUNCT
dpc-3653	183	5	doi	doi	NOUN
dpc-3653	183	6	:	:	PUNCT
dpc-3653	183	7	10.2165/11594610	10.2165/11594610	NUM
dpc-3653	183	8	-	-	PUNCT
dpc-3653	183	9	000000000	000000000	NUM
dpc-3653	183	10	-	-	PUNCT
dpc-3653	183	11	00000	00000	NUM
dpc-3653	183	12	.	.	PUNCT
dpc-3653	184	1	pmid	pmid	NOUN
dpc-3653	184	2	:	:	PUNCT
dpc-3653	184	3	22292461	22292461	NUM
dpc-3653	184	4	.	.	PUNCT
dpc-3653	185	1	5	5	X
dpc-3653	185	2	.	.	X
dpc-3653	185	3	gheisari	gheisari	PROPN
dpc-3653	185	4	m	m	PROPN
dpc-3653	185	5	,	,	PUNCT
dpc-3653	185	6	iranmanesh	iranmanesh	PROPN
dpc-3653	185	7	b	b	PROPN
dpc-3653	185	8	,	,	PUNCT
dpc-3653	185	9	nobari	nobari	PROPN
dpc-3653	185	10	nn	nn	PROPN
dpc-3653	185	11	,	,	PUNCT
dpc-3653	185	12	amani	amani	PROPN
dpc-3653	185	13	m.	m.	NOUN
dpc-3653	185	14	comparison	comparison	NOUN
dpc-3653	185	15	of	of	ADP
dpc-3653	185	16	long	long	ADV
dpc-3653	185	17	-	-	PUNCT
dpc-3653	185	18	pulsed	pulse	VERB
dpc-3653	185	19	nd	nd	NOUN
dpc-3653	185	20	:	:	PUNCT
dpc-3653	185	21	yag	yag	NOUN
dpc-3653	185	22	laser	laser	NOUN
dpc-3653	185	23	with	with	ADP
dpc-3653	185	24	cryotherapy	cryotherapy	NOUN
dpc-3653	185	25	in	in	ADP
dpc-3653	185	26	treatment	treatment	NOUN
dpc-3653	185	27	of	of	ADP
dpc-3653	185	28	acral	acral	ADJ
dpc-3653	185	29	warts	wart	NOUN
dpc-3653	185	30	.	.	PUNCT
dpc-3653	186	1	lasers	laser	NOUN
dpc-3653	186	2	med	med	PROPN
dpc-3653	186	3	sci	sci	PROPN
dpc-3653	186	4	.	.	PUNCT
dpc-3653	187	1	2019;34(2):397	2019;34(2):397	NUM
dpc-3653	187	2	-	-	SYM
dpc-3653	187	3	403	403	NUM
dpc-3653	187	4	.	.	PUNCT
dpc-3653	188	1	doi	doi	NOUN
dpc-3653	188	2	:	:	PUNCT
dpc-3653	188	3	10.1007	10.1007	NUM
dpc-3653	188	4	/s10103	/s10103	NOUN
dpc-3653	188	5	-	-	PUNCT
dpc-3653	188	6	018	018	NUM
dpc-3653	188	7	-	-	PUNCT
dpc-3653	188	8	2613	2613	NUM
dpc-3653	188	9	-	-	SYM
dpc-3653	188	10	7	7	NUM
dpc-3653	188	11	.	.	PUNCT
dpc-3653	189	1	pmid	pmid	NOUN
dpc-3653	189	2	:	:	PUNCT
dpc-3653	189	3	30112613	30112613	NUM
dpc-3653	189	4	.	.	PUNCT
dpc-3653	190	1	6	6	NUM
dpc-3653	190	2	.	.	NUM
dpc-3653	190	3	nofal	nofal	PROPN
dpc-3653	190	4	a	a	X
dpc-3653	190	5	,	,	PUNCT
dpc-3653	190	6	marei	marei	NOUN
dpc-3653	190	7	a	a	X
dpc-3653	190	8	,	,	PUNCT
dpc-3653	190	9	amer	amer	PROPN
dpc-3653	190	10	a	a	PROPN
dpc-3653	190	11	,	,	PUNCT
dpc-3653	190	12	amen	amen	INTJ
dpc-3653	190	13	h.	h.	NOUN
dpc-3653	190	14	significance	significance	NOUN
dpc-3653	190	15	of	of	ADP
dpc-3653	190	16	interferon	interferon	ADJ
dpc-3653	190	17	gamma	gamma	NOUN
dpc-3653	190	18	in	in	ADP
dpc-3653	190	19	the	the	DET
dpc-3653	190	20	prediction	prediction	NOUN
dpc-3653	190	21	of	of	ADP
dpc-3653	190	22	successful	successful	ADJ
dpc-3653	190	23	therapy	therapy	NOUN
dpc-3653	190	24	of	of	ADP
dpc-3653	190	25	common	common	ADJ
dpc-3653	190	26	warts	wart	NOUN
dpc-3653	190	27	by	by	ADP
dpc-3653	190	28	intralesional	intralesional	ADJ
dpc-3653	190	29	injection	injection	NOUN
dpc-3653	190	30	of	of	ADP
dpc-3653	190	31	candida	candida	PROPN
dpc-3653	190	32	antigen	antigen	PROPN
dpc-3653	190	33	.	.	PUNCT
dpc-3653	191	1	int	int	NOUN
dpc-3653	191	2	j	j	PROPN
dpc-3653	191	3	dermatol	dermatol	NOUN
dpc-3653	191	4	.	.	PUNCT
dpc-3653	192	1	2017;56(10):1003	2017;56(10):1003	NUM
dpc-3653	192	2	-	-	SYM
dpc-3653	192	3	1009	1009	NUM
dpc-3653	192	4	.	.	PUNCT
dpc-3653	193	1	doi	doi	NOUN
dpc-3653	193	2	:	:	PUNCT
dpc-3653	193	3	10.1111	10.1111	NUM
dpc-3653	193	4	/	/	SYM
dpc-3653	193	5	ijd.13709	ijd.13709	PROPN
dpc-3653	193	6	.	.	PUNCT
dpc-3653	194	1	pmid	pmid	NOUN
dpc-3653	194	2	:	:	PUNCT
dpc-3653	194	3	28791682	28791682	NUM
dpc-3653	194	4	.	.	PUNCT
dpc-3653	195	1	7	7	X
dpc-3653	195	2	.	.	X
dpc-3653	195	3	aldahan	aldahan	PROPN
dpc-3653	195	4	as	as	ADP
dpc-3653	195	5	,	,	PUNCT
dpc-3653	195	6	mlacker	mlacker	NOUN
dpc-3653	195	7	s	s	PROPN
dpc-3653	195	8	,	,	PUNCT
dpc-3653	195	9	shah	shah	NOUN
dpc-3653	195	10	vv	vv	PROPN
dpc-3653	195	11	,	,	PUNCT
dpc-3653	195	12	et	et	PROPN
dpc-3653	195	13	al	al	PROPN
dpc-3653	195	14	.	.	PROPN
dpc-3653	195	15	efficacy	efficacy	NOUN
dpc-3653	195	16	of	of	ADP
dpc-3653	195	17	intralesional	intralesional	ADJ
dpc-3653	195	18	immunotherapy	immunotherapy	NOUN
dpc-3653	195	19	for	for	ADP
dpc-3653	195	20	the	the	DET
dpc-3653	195	21	treatment	treatment	NOUN
dpc-3653	195	22	of	of	ADP
dpc-3653	195	23	warts	wart	NOUN
dpc-3653	195	24	:	:	PUNCT
dpc-3653	195	25	a	a	DET
dpc-3653	195	26	review	review	NOUN
dpc-3653	195	27	of	of	ADP
dpc-3653	195	28	the	the	DET
dpc-3653	195	29	literature	literature	NOUN
dpc-3653	195	30	.	.	PUNCT
dpc-3653	196	1	dermatol	dermatol	NOUN
dpc-3653	196	2	ther	ther	ADV
dpc-3653	196	3	.	.	PUNCT
dpc-3653	197	1	2016;29(3):197	2016;29(3):197	NUM
dpc-3653	197	2	-	-	PUNCT
dpc-3653	197	3	207	207	NUM
dpc-3653	197	4	.	.	PUNCT
dpc-3653	198	1	doi	doi	NOUN
dpc-3653	198	2	:	:	PUNCT
dpc-3653	198	3	10.1111	10.1111	NUM
dpc-3653	198	4	/dth.12352	/dth.12352	ADJ
dpc-3653	198	5	.	.	PUNCT
dpc-3653	199	1	pmid	pmid	NOUN
dpc-3653	199	2	:	:	PUNCT
dpc-3653	199	3	26991521	26991521	NUM
dpc-3653	199	4	.	.	PUNCT
dpc-3653	200	1	8	8	X
dpc-3653	200	2	.	.	X
dpc-3653	201	1	garg	garg	PROPN
dpc-3653	201	2	s	s	PROPN
dpc-3653	201	3	,	,	PUNCT
dpc-3653	201	4	baveja	baveja	PROPN
dpc-3653	201	5	s.	s.	PROPN
dpc-3653	201	6	intralesional	intralesional	PROPN
dpc-3653	201	7	immunotherapy	immunotherapy	NOUN
dpc-3653	201	8	for	for	ADP
dpc-3653	201	9	difficult	difficult	ADJ
dpc-3653	201	10	to	to	PART
dpc-3653	201	11	treat	treat	VERB
dpc-3653	201	12	warts	wart	NOUN
dpc-3653	201	13	with	with	ADP
dpc-3653	201	14	mycobacterium	mycobacterium	NOUN
dpc-3653	201	15	w	w	PROPN
dpc-3653	201	16	vaccine	vaccine	NOUN
dpc-3653	201	17	.	.	PUNCT
dpc-3653	202	1	j	j	PROPN
dpc-3653	202	2	cutan	cutan	PROPN
dpc-3653	202	3	aesthet	aesthet	PROPN
dpc-3653	202	4	surg	surg	PROPN
dpc-3653	202	5	.	.	PUNCT
dpc-3653	203	1	2014;7(4):203	2014;7(4):203	X
dpc-3653	203	2	-	-	SYM
dpc-3653	203	3	208	208	NUM
dpc-3653	203	4	.	.	PUNCT
dpc-3653	204	1	doi	doi	NOUN
dpc-3653	204	2	:	:	PUNCT
dpc-3653	204	3	10.4103/0974	10.4103/0974	NUM
dpc-3653	204	4	-	-	PUNCT
dpc-3653	204	5	2077.150740	2077.150740	NOUN
dpc-3653	204	6	.	.	PUNCT
dpc-3653	205	1	pmid	pmid	NOUN
dpc-3653	205	2	:	:	PUNCT
dpc-3653	205	3	25722598	25722598	NUM
dpc-3653	205	4	.	.	PUNCT
dpc-3653	206	1	pmcid	pmcid	NOUN
dpc-3653	206	2	:	:	PUNCT
dpc-3653	206	3	pmc4338463	pmc4338463	ADJ
dpc-3653	206	4	.	.	PUNCT
dpc-3653	207	1	9	9	X
dpc-3653	207	2	.	.	PUNCT
dpc-3653	208	1	chaudhary	chaudhary	PROPN
dpc-3653	208	2	m	m	PROPN
dpc-3653	208	3	,	,	PUNCT
dpc-3653	208	4	brar	brar	PROPN
dpc-3653	208	5	a	a	NOUN
dpc-3653	208	6	,	,	PUNCT
dpc-3653	208	7	agarwal	agarwal	PROPN
dpc-3653	208	8	p	p	X
dpc-3653	208	9	,	,	PUNCT
dpc-3653	208	10	chavda	chavda	NOUN
dpc-3653	208	11	v	v	NOUN
dpc-3653	208	12	,	,	PUNCT
dpc-3653	208	13	jagati	jagati	PROPN
dpc-3653	208	14	a	a	PROPN
dpc-3653	208	15	,	,	PUNCT
dpc-3653	208	16	rathod	rathod	PROPN
dpc-3653	208	17	sp	sp	PROPN
dpc-3653	208	18	.	.	PUNCT
dpc-3653	209	1	a	a	DET
dpc-3653	209	2	study	study	NOUN
dpc-3653	209	3	of	of	ADP
dpc-3653	209	4	comparison	comparison	NOUN
dpc-3653	209	5	and	and	CCONJ
dpc-3653	209	6	evaluation	evaluation	NOUN
dpc-3653	209	7	of	of	ADP
dpc-3653	209	8	various	various	ADJ
dpc-3653	209	9	intralesional	intralesional	ADJ
dpc-3653	209	10	therapies	therapy	NOUN
dpc-3653	209	11	in	in	ADP
dpc-3653	209	12	cutaneous	cutaneous	ADJ
dpc-3653	209	13	warts	wart	NOUN
dpc-3653	209	14	.	.	PUNCT
dpc-3653	210	1	indian	indian	ADJ
dpc-3653	210	2	dermatol	dermatol	NOUN
dpc-3653	210	3	online	online	ADJ
dpc-3653	210	4	j.	j.	PROPN
dpc-3653	210	5	2023;14(4):487	2023;14(4):487	PROPN
dpc-3653	210	6	-	-	SYM
dpc-3653	210	7	492	492	NUM
dpc-3653	210	8	.	.	PUNCT
dpc-3653	211	1	doi	doi	NOUN
dpc-3653	211	2	:	:	PUNCT
dpc-3653	211	3	10.4103	10.4103	NUM
dpc-3653	211	4	/	/	SYM
dpc-3653	211	5	idoj.idoj_492_22	idoj.idoj_492_22	NOUN
dpc-3653	211	6	.	.	PUNCT
dpc-3653	212	1	pmid	pmid	NOUN
dpc-3653	212	2	:	:	PUNCT
dpc-3653	212	3	37521234	37521234	NUM
dpc-3653	212	4	.	.	PUNCT
dpc-3653	213	1	pmcid	pmcid	ADJ
dpc-3653	213	2	:	:	PUNCT
dpc-3653	213	3	pmc10373804	pmc10373804	NOUN
dpc-3653	213	4	.	.	PUNCT
dpc-3653	214	1	10	10	NUM
dpc-3653	214	2	.	.	X
dpc-3653	214	3	ju	ju	PROPN
dpc-3653	214	4	hj	hj	PROPN
dpc-3653	214	5	,	,	PUNCT
dpc-3653	214	6	park	park	NOUN
dpc-3653	214	7	hr	hr	PROPN
dpc-3653	214	8	,	,	PUNCT
dpc-3653	214	9	kim	kim	PROPN
dpc-3653	214	10	jy	jy	PROPN
dpc-3653	214	11	,	,	PUNCT
dpc-3653	214	12	kim	kim	PROPN
dpc-3653	214	13	gm	gm	PROPN
dpc-3653	214	14	,	,	PUNCT
dpc-3653	214	15	bae	bae	PROPN
dpc-3653	214	16	jm	jm	PROPN
dpc-3653	214	17	,	,	PUNCT
dpc-3653	214	18	lee	lee	PROPN
dpc-3653	214	19	jh	jh	PROPN
dpc-3653	214	20	.	.	PUNCT
dpc-3653	215	1	intralesional	intralesional	ADJ
dpc-3653	215	2	immunotherapy	immunotherapy	NOUN
dpc-3653	215	3	for	for	ADP
dpc-3653	215	4	non	non	ADJ
dpc-3653	215	5	-	-	ADJ
dpc-3653	215	6	genital	genital	ADJ
dpc-3653	215	7	warts	wart	NOUN
dpc-3653	215	8	:	:	PUNCT
dpc-3653	215	9	a	a	DET
dpc-3653	215	10	systematic	systematic	ADJ
dpc-3653	215	11	review	review	NOUN
dpc-3653	215	12	and	and	CCONJ
dpc-3653	215	13	meta	meta	ADJ
dpc-3653	215	14	-	-	PUNCT
dpc-3653	215	15	analysis	analysis	NOUN
dpc-3653	215	16	.	.	PUNCT
dpc-3653	216	1	indian	indian	PROPN
dpc-3653	216	2	j	j	PROPN
dpc-3653	216	3	dermatol	dermatol	PROPN
dpc-3653	216	4	venereol	venereol	ADJ
dpc-3653	216	5	leprol	leprol	NOUN
dpc-3653	216	6	.	.	PUNCT
dpc-3653	217	1	2022;88(6):724	2022;88(6):724	NUM
dpc-3653	217	2	-	-	PUNCT
dpc-3653	217	3	737	737	NUM
dpc-3653	217	4	.	.	PUNCT
dpc-3653	218	1	doi	doi	NOUN
dpc-3653	218	2	:	:	PUNCT
dpc-3653	218	3	10.25259	10.25259	NUM
dpc-3653	218	4	/	/	SYM
dpc-3653	218	5	ijdvl_1369_20	ijdvl_1369_20	NOUN
dpc-3653	218	6	.	.	PUNCT
dpc-3653	219	1	pmid	pmid	NOUN
dpc-3653	219	2	:	:	PUNCT
dpc-3653	219	3	35962514	35962514	NUM
dpc-3653	219	4	.	.	PUNCT
dpc-3653	220	1	11	11	NUM
dpc-3653	220	2	.	.	X
dpc-3653	221	1	brunk	brunk	PROPN
dpc-3653	221	2	d.	d.	PROPN
dpc-3653	221	3	injection	injection	NOUN
dpc-3653	221	4	of	of	ADP
dpc-3653	221	5	candida	candida	PROPN
dpc-3653	221	6	antigen	antigen	NOUN
dpc-3653	221	7	works	work	VERB
dpc-3653	221	8	on	on	ADP
dpc-3653	221	9	warts	wart	NOUN
dpc-3653	221	10	.	.	PUNCT
dpc-3653	222	1	skin	skin	NOUN
dpc-3653	222	2	allergy	allergy	PROPN
dpc-3653	222	3	news	news	PROPN
dpc-3653	222	4	.	.	PUNCT
dpc-3653	223	1	1999;30:5	1999;30:5	NUM
dpc-3653	223	2	.	.	PUNCT
dpc-3653	224	1	12	12	NUM
dpc-3653	224	2	.	.	PUNCT
dpc-3653	225	1	1villa	1villa	NUM
dpc-3653	225	2	ll	ll	NOUN
dpc-3653	225	3	,	,	PUNCT
dpc-3653	225	4	costa	costa	PROPN
dpc-3653	225	5	rl	rl	X
dpc-3653	225	6	,	,	PUNCT
dpc-3653	225	7	petta	petta	NOUN
dpc-3653	225	8	ca	can	AUX
dpc-3653	225	9	,	,	PUNCT
dpc-3653	225	10	et	et	PROPN
dpc-3653	225	11	al	al	PROPN
dpc-3653	225	12	.	.	PROPN
dpc-3653	225	13	prophylactic	prophylactic	ADJ
dpc-3653	225	14	quadrivalent	quadrivalent	NOUN
dpc-3653	225	15	human	human	ADJ
dpc-3653	225	16	papillomavirus	papillomavirus	NOUN
dpc-3653	225	17	(	(	PUNCT
dpc-3653	225	18	types	type	NOUN
dpc-3653	225	19	6	6	NUM
dpc-3653	225	20	,	,	PUNCT
dpc-3653	225	21	11	11	NUM
dpc-3653	225	22	,	,	PUNCT
dpc-3653	225	23	16	16	NUM
dpc-3653	225	24	,	,	PUNCT
dpc-3653	225	25	and	and	CCONJ
dpc-3653	225	26	18	18	NUM
dpc-3653	225	27	)	)	PUNCT
dpc-3653	225	28	l1	l1	PROPN
dpc-3653	225	29	virus	virus	NOUN
dpc-3653	225	30	-	-	PUNCT
dpc-3653	225	31	like	like	ADJ
dpc-3653	225	32	particle	particle	NOUN
dpc-3653	225	33	vaccine	vaccine	NOUN
dpc-3653	225	34	in	in	ADP
dpc-3653	225	35	young	young	ADJ
dpc-3653	225	36	women	woman	NOUN
dpc-3653	225	37	:	:	PUNCT
dpc-3653	225	38	a	a	DET
dpc-3653	225	39	randomised	randomised	ADJ
dpc-3653	225	40	double	double	ADJ
dpc-3653	225	41	-	-	PUNCT
dpc-3653	225	42	blind	blind	ADJ
dpc-3653	225	43	placebo	placebo	NOUN
dpc-3653	225	44	-	-	PUNCT
dpc-3653	225	45	controlled	control	VERB
dpc-3653	225	46	multicentre	multicentre	NOUN
dpc-3653	225	47	phase	phase	NOUN
dpc-3653	225	48	ii	ii	PROPN
dpc-3653	225	49	efficacy	efficacy	NOUN
dpc-3653	225	50	trial	trial	NOUN
dpc-3653	225	51	.	.	PUNCT
dpc-3653	226	1	lancet	lancet	PROPN
dpc-3653	226	2	oncol	oncol	PROPN
dpc-3653	226	3	.	.	PUNCT
dpc-3653	227	1	2005;6(5):271	2005;6(5):271	X
dpc-3653	227	2	-	-	SYM
dpc-3653	227	3	278	278	NUM
dpc-3653	227	4	.	.	PUNCT
dpc-3653	228	1	doi	doi	NOUN
dpc-3653	228	2	:	:	PUNCT
dpc-3653	228	3	10.1016	10.1016	NUM
dpc-3653	228	4	/	/	SYM
dpc-3653	228	5	s1470	s1470	PROPN
dpc-3653	228	6	-	-	PUNCT
dpc-3653	228	7	2045(05)701017	2045(05)701017	NUM
dpc-3653	228	8	.	.	PUNCT
dpc-3653	229	1	pmid	pmid	NOUN
dpc-3653	229	2	:	:	PUNCT
dpc-3653	229	3	15863374	15863374	NUM
dpc-3653	229	4	.	.	PUNCT
dpc-3653	230	1	13	13	NUM
dpc-3653	230	2	.	.	X
dpc-3653	231	1	venugopal	venugopal	PROPN
dpc-3653	231	2	ss	ss	PROPN
dpc-3653	231	3	,	,	PUNCT
dpc-3653	231	4	murrell	murrell	PROPN
dpc-3653	231	5	df	df	PROPN
dpc-3653	231	6	.	.	PUNCT
dpc-3653	232	1	recalcitrant	recalcitrant	ADJ
dpc-3653	232	2	cutaneous	cutaneous	ADJ
dpc-3653	232	3	warts	wart	NOUN
dpc-3653	232	4	treated	treat	VERB
dpc-3653	232	5	with	with	ADP
dpc-3653	232	6	recombinant	recombinant	ADJ
dpc-3653	232	7	quadrivalent	quadrivalent	NOUN
dpc-3653	232	8	human	human	ADJ
dpc-3653	232	9	papillomavirus	papillomavirus	NOUN
dpc-3653	232	10	vaccine	vaccine	NOUN
dpc-3653	232	11	(	(	PUNCT
dpc-3653	232	12	types	type	NOUN
dpc-3653	232	13	6	6	NUM
dpc-3653	232	14	,	,	PUNCT
dpc-3653	232	15	11	11	NUM
dpc-3653	232	16	,	,	PUNCT
dpc-3653	232	17	16	16	NUM
dpc-3653	232	18	,	,	PUNCT
dpc-3653	232	19	and	and	CCONJ
dpc-3653	232	20	18	18	NUM
dpc-3653	232	21	)	)	PUNCT
dpc-3653	232	22	in	in	ADP
dpc-3653	232	23	a	a	DET
dpc-3653	232	24	developmentally	developmentally	ADV
dpc-3653	232	25	delayed	delay	VERB
dpc-3653	232	26	,	,	PUNCT
dpc-3653	232	27	31	31	NUM
dpc-3653	232	28	-	-	NUM
dpc-3653	232	29	yearold	yearold	NUM
dpc-3653	232	30	white	white	ADJ
dpc-3653	232	31	man	man	NOUN
dpc-3653	232	32	.	.	PUNCT
dpc-3653	233	1	arch	arch	ADJ
dpc-3653	233	2	dermatol	dermatol	NOUN
dpc-3653	233	3	.	.	PUNCT
dpc-3653	234	1	2010;146(5):475	2010;146(5):475	NUM
dpc-3653	234	2	-	-	SYM
dpc-3653	234	3	477	477	NUM
dpc-3653	234	4	.	.	PUNCT
dpc-3653	235	1	doi	doi	NOUN
dpc-3653	235	2	:	:	PUNCT
dpc-3653	235	3	10.1001	10.1001	NUM
dpc-3653	235	4	/	/	SYM
dpc-3653	235	5	archdermatol.2010.71	archdermatol.2010.71	PROPN
dpc-3653	235	6	.	.	PUNCT
dpc-3653	236	1	pmid	pmid	NOUN
dpc-3653	236	2	:	:	PUNCT
dpc-3653	236	3	20479293	20479293	NUM
dpc-3653	236	4	.	.	PUNCT
dpc-3653	237	1	14	14	NUM
dpc-3653	237	2	.	.	NOUN
dpc-3653	237	3	1	1	NUM
dpc-3653	237	4	abeck	abeck	PROPN
dpc-3653	237	5	d	d	NOUN
dpc-3653	237	6	,	,	PUNCT
dpc-3653	237	7	fölster	fölster	NOUN
dpc-3653	237	8	-	-	PUNCT
dpc-3653	237	9	holst	holst	NOUN
dpc-3653	237	10	r.	r.	PROPN
dpc-3653	237	11	quadrivalent	quadrivalent	PROPN
dpc-3653	237	12	human	human	ADJ
dpc-3653	237	13	papillomavirus	papillomavirus	NOUN
dpc-3653	237	14	vaccination	vaccination	NOUN
dpc-3653	237	15	:	:	PUNCT
dpc-3653	237	16	a	a	DET
dpc-3653	237	17	promising	promising	ADJ
dpc-3653	237	18	treatment	treatment	NOUN
dpc-3653	237	19	for	for	ADP
dpc-3653	237	20	recalcitrant	recalcitrant	ADJ
dpc-3653	237	21	cutaneous	cutaneous	ADJ
dpc-3653	237	22	warts	wart	NOUN
dpc-3653	237	23	in	in	ADP
dpc-3653	237	24	children	child	NOUN
dpc-3653	237	25	.	.	PUNCT
dpc-3653	238	1	acta	acta	PROPN
dpc-3653	238	2	derm	derm	PROPN
dpc-3653	238	3	venereol	venereol	NOUN
dpc-3653	238	4	.	.	PUNCT
dpc-3653	239	1	2015;95(8):1017	2015;95(8):1017	NUM
dpc-3653	239	2	-	-	SYM
dpc-3653	239	3	2029	2029	NUM
dpc-3653	239	4	.	.	PUNCT
dpc-3653	240	1	doi	doi	NOUN
dpc-3653	240	2	:	:	PUNCT
dpc-3653	240	3	10.2340/00015555	10.2340/00015555	NUM
dpc-3653	240	4	-	-	SYM
dpc-3653	240	5	2111	2111	NUM
dpc-3653	240	6	.	.	PUNCT
dpc-3653	241	1	pmid	pmid	NOUN
dpc-3653	241	2	:	:	PUNCT
dpc-3653	241	3	25824471	25824471	NUM
dpc-3653	241	4	.	.	PUNCT
dpc-3653	242	1	15	15	NUM
dpc-3653	242	2	.	.	X
dpc-3653	243	1	marei	marei	VERB
dpc-3653	243	2	a	a	X
dpc-3653	243	3	,	,	PUNCT
dpc-3653	243	4	boghdadi	boghdadi	ADP
dpc-3653	243	5	g	g	PROPN
dpc-3653	243	6	,	,	PUNCT
dpc-3653	243	7	tash	tash	PROPN
dpc-3653	243	8	rme	rme	PROPN
dpc-3653	243	9	,	,	PUNCT
dpc-3653	243	10	elgharabawy	elgharabawy	PROPN
dpc-3653	243	11	e.	e.	PROPN
dpc-3653	243	12	efficacy	efficacy	PROPN
dpc-3653	243	13	of	of	ADP
dpc-3653	243	14	intralesional	intralesional	ADJ
dpc-3653	243	15	candida	candida	NOUN
dpc-3653	243	16	antigen	antigen	ADJ
dpc-3653	243	17	immunotherapy	immunotherapy	NOUN
dpc-3653	243	18	in	in	ADP
dpc-3653	243	19	treatment	treatment	NOUN
dpc-3653	243	20	of	of	ADP
dpc-3653	243	21	recalcitrant	recalcitrant	ADJ
dpc-3653	243	22	warts	wart	NOUN
dpc-3653	243	23	.	.	PUNCT
dpc-3653	244	1	zagazig	zagazig	PROPN
dpc-3653	244	2	university	university	PROPN
dpc-3653	244	3	medical	medical	ADJ
dpc-3653	244	4	journal	journal	PROPN
dpc-3653	244	5	.	.	PUNCT
dpc-3653	245	1	2020;26(5):769	2020;26(5):769	NUM
dpc-3653	245	2	-	-	SYM
dpc-3653	245	3	774	774	NUM
dpc-3653	245	4	.	.	PUNCT
dpc-3653	246	1	16	16	NUM
dpc-3653	246	2	.	.	PUNCT
dpc-3653	247	1	nassar	nassar	PROPN
dpc-3653	247	2	a	a	PROPN
dpc-3653	247	3	,	,	PUNCT
dpc-3653	247	4	alakad	alakad	ADJ
dpc-3653	247	5	r	r	NOUN
dpc-3653	247	6	,	,	PUNCT
dpc-3653	247	7	essam	essam	NOUN
dpc-3653	247	8	r	r	PROPN
dpc-3653	247	9	,	,	PUNCT
dpc-3653	247	10	bakr	bakr	PROPN
dpc-3653	247	11	nm	nm	PROPN
dpc-3653	247	12	,	,	PUNCT
dpc-3653	247	13	nofal	nofal	ADJ
dpc-3653	247	14	a.	a.	NOUN
dpc-3653	247	15	comparative	comparative	PROPN
dpc-3653	247	16	efficacy	efficacy	NOUN
dpc-3653	247	17	of	of	ADP
dpc-3653	247	18	intralesional	intralesional	ADJ
dpc-3653	247	19	candida	candida	PROPN
dpc-3653	247	20	antigen	antigen	PROPN
dpc-3653	247	21	,	,	PUNCT
dpc-3653	247	22	intralesional	intralesional	ADJ
dpc-3653	247	23	bivalent	bivalent	ADJ
dpc-3653	247	24	human	human	ADJ
dpc-3653	247	25	papilloma	papilloma	NOUN
dpc-3653	247	26	virus	virus	NOUN
dpc-3653	247	27	vaccine	vaccine	NOUN
dpc-3653	247	28	,	,	PUNCT
dpc-3653	247	29	and	and	CCONJ
dpc-3653	247	30	cryotherapy	cryotherapy	NOUN
dpc-3653	247	31	in	in	ADP
dpc-3653	247	32	the	the	DET
dpc-3653	247	33	treatment	treatment	NOUN
dpc-3653	247	34	of	of	ADP
dpc-3653	247	35	common	common	ADJ
dpc-3653	247	36	warts	wart	NOUN
dpc-3653	247	37	.	.	PUNCT
dpc-3653	248	1	j	j	PROPN
dpc-3653	248	2	am	be	AUX
dpc-3653	248	3	acad	acad	ADJ
dpc-3653	248	4	dermatol	dermatol	NOUN
dpc-3653	248	5	.	.	PUNCT
dpc-3653	249	1	2022;87(2):419421	2022;87(2):419421	NUM
dpc-3653	249	2	.	.	PUNCT
dpc-3653	250	1	doi	doi	NOUN
dpc-3653	250	2	:	:	PUNCT
dpc-3653	250	3	10.1016	10.1016	NUM
dpc-3653	250	4	/	/	SYM
dpc-3653	250	5	j.jaad.2021.08.040	j.jaad.2021.08.040	PROPN
dpc-3653	250	6	.	.	PUNCT
dpc-3653	251	1	pmid	pmid	NOUN
dpc-3653	251	2	:	:	PUNCT
dpc-3653	251	3	34464624	34464624	NUM
dpc-3653	251	4	.	.	PUNCT
dpc-3653	252	1	17	17	NUM
dpc-3653	252	2	.	.	X
dpc-3653	252	3	signore	signore	PROPN
dpc-3653	252	4	rj	rj	PROPN
dpc-3653	252	5	.	.	PUNCT
dpc-3653	253	1	candida	candida	PROPN
dpc-3653	253	2	albicans	albican	VERB
dpc-3653	253	3	intralesional	intralesional	ADJ
dpc-3653	253	4	injection	injection	NOUN
dpc-3653	253	5	immunotherapy	immunotherapy	NOUN
dpc-3653	253	6	of	of	ADP
dpc-3653	253	7	warts	wart	NOUN
dpc-3653	253	8	.	.	PUNCT
dpc-3653	254	1	cutis	cutis	NOUN
dpc-3653	254	2	.	.	PUNCT
dpc-3653	255	1	2002;70(3):185	2002;70(3):185	NUM
dpc-3653	255	2	-	-	PUNCT
dpc-3653	255	3	192	192	NUM
dpc-3653	255	4	.	.	PUNCT
dpc-3653	256	1	pmid	pmid	NOUN
dpc-3653	256	2	:	:	PUNCT
dpc-3653	256	3	12353895	12353895	NUM
dpc-3653	256	4	.	.	X
dpc-3653	257	1	8	8	NUM
dpc-3653	257	2	original	original	ADJ
dpc-3653	257	3	article	article	NOUN
dpc-3653	257	4	|	|	ADV
dpc-3653	257	5	dermatol	dermatol	ADJ
dpc-3653	257	6	pract	pract	NOUN
dpc-3653	257	7	concept	concept	NOUN
dpc-3653	257	8	.	.	PUNCT
dpc-3653	258	1	2024;14(2):e2024066	2024;14(2):e2024066	NUM
dpc-3653	258	2	18	18	NUM
dpc-3653	258	3	.	.	PUNCT
dpc-3653	259	1	clifton	clifton	PROPN
dpc-3653	259	2	mm	mm	PROPN
dpc-3653	259	3	,	,	PUNCT
dpc-3653	259	4	johnson	johnson	PROPN
dpc-3653	259	5	sm	sm	PROPN
dpc-3653	259	6	,	,	PUNCT
dpc-3653	259	7	roberson	roberson	PROPN
dpc-3653	259	8	pk	pk	PROPN
dpc-3653	259	9	,	,	PUNCT
dpc-3653	259	10	kincannon	kincannon	PROPN
dpc-3653	259	11	j	j	PROPN
dpc-3653	259	12	,	,	PUNCT
dpc-3653	259	13	horn	horn	VERB
dpc-3653	259	14	td	td	NOUN
dpc-3653	259	15	.	.	PUNCT
dpc-3653	260	1	immunotherapy	immunotherapy	NOUN
dpc-3653	260	2	for	for	ADP
dpc-3653	260	3	recalcitrant	recalcitrant	ADJ
dpc-3653	260	4	warts	wart	NOUN
dpc-3653	260	5	in	in	ADP
dpc-3653	260	6	children	child	NOUN
dpc-3653	260	7	using	use	VERB
dpc-3653	260	8	intralesional	intralesional	ADJ
dpc-3653	260	9	mumps	mump	NOUN
dpc-3653	260	10	or	or	CCONJ
dpc-3653	260	11	candida	candida	NOUN
dpc-3653	260	12	antigens	antigen	NOUN
dpc-3653	260	13	.	.	PUNCT
dpc-3653	261	1	pediatr	pediatr	ADJ
dpc-3653	261	2	dermatol	dermatol	NOUN
dpc-3653	261	3	.	.	PUNCT
dpc-3653	262	1	2003;20(3):268	2003;20(3):268	PROPN
dpc-3653	262	2	-	-	PUNCT
dpc-3653	262	3	271	271	NUM
dpc-3653	262	4	.	.	PUNCT
dpc-3653	263	1	doi	doi	NOUN
dpc-3653	263	2	:	:	PUNCT
dpc-3653	263	3	10.1046	10.1046	NUM
dpc-3653	263	4	/	/	SYM
dpc-3653	263	5	j.1525	j.1525	NOUN
dpc-3653	263	6	-	-	PUNCT
dpc-3653	263	7	1470.2003.20318.x	1470.2003.20318.x	NUM
dpc-3653	263	8	.	.	PUNCT
dpc-3653	264	1	pmid	pmid	NOUN
dpc-3653	264	2	:	:	PUNCT
dpc-3653	264	3	12787281	12787281	NUM
dpc-3653	264	4	.	.	PUNCT
dpc-3653	265	1	19	19	NUM
dpc-3653	265	2	.	.	X
dpc-3653	266	1	1horn	1horn	NUM
dpc-3653	266	2	td	td	NOUN
dpc-3653	266	3	,	,	PUNCT
dpc-3653	266	4	johnson	johnson	PROPN
dpc-3653	266	5	sm	sm	PROPN
dpc-3653	266	6	,	,	PUNCT
dpc-3653	266	7	helm	helm	PROPN
dpc-3653	266	8	rm	rm	PROPN
dpc-3653	266	9	,	,	PUNCT
dpc-3653	266	10	roberson	roberson	PROPN
dpc-3653	266	11	pk	pk	PROPN
dpc-3653	266	12	.	.	PROPN
dpc-3653	266	13	intralesional	intralesional	ADJ
dpc-3653	266	14	immunotherapy	immunotherapy	NOUN
dpc-3653	266	15	of	of	ADP
dpc-3653	266	16	warts	wart	NOUN
dpc-3653	266	17	with	with	ADP
dpc-3653	266	18	mumps	mump	NOUN
dpc-3653	266	19	,	,	PUNCT
dpc-3653	266	20	candida	candida	PROPN
dpc-3653	266	21	,	,	PUNCT
dpc-3653	266	22	and	and	CCONJ
dpc-3653	266	23	trichophyton	trichophyton	PROPN
dpc-3653	266	24	skin	skin	NOUN
dpc-3653	266	25	test	test	NOUN
dpc-3653	266	26	antigens	antigen	NOUN
dpc-3653	266	27	:	:	PUNCT
dpc-3653	266	28	a	a	DET
dpc-3653	266	29	single	single	ADJ
dpc-3653	266	30	-	-	PUNCT
dpc-3653	266	31	blinded	blind	VERB
dpc-3653	266	32	,	,	PUNCT
dpc-3653	266	33	randomized	randomize	VERB
dpc-3653	266	34	,	,	PUNCT
dpc-3653	266	35	and	and	CCONJ
dpc-3653	266	36	controlled	control	VERB
dpc-3653	266	37	trial	trial	NOUN
dpc-3653	266	38	.	.	PUNCT
dpc-3653	267	1	arch	arch	ADJ
dpc-3653	267	2	dermatol	dermatol	NOUN
dpc-3653	267	3	.	.	PUNCT
dpc-3653	268	1	2005;141(5):589	2005;141(5):589	NUM
dpc-3653	268	2	-	-	SYM
dpc-3653	268	3	594	594	NUM
dpc-3653	268	4	.	.	PUNCT
dpc-3653	268	5	doi	doi	NOUN
dpc-3653	268	6	:	:	PUNCT
dpc-3653	268	7	10.1001	10.1001	NUM
dpc-3653	268	8	/	/	SYM
dpc-3653	268	9	archderm.141.5.589	archderm.141.5.589	NOUN
dpc-3653	268	10	.	.	PUNCT
dpc-3653	269	1	pmid	pmid	NOUN
dpc-3653	269	2	:	:	PUNCT
dpc-3653	269	3	15897380	15897380	NUM
dpc-3653	269	4	.	.	PUNCT
dpc-3653	270	1	20	20	NUM
dpc-3653	270	2	.	.	X
dpc-3653	271	1	king	king	PROPN
dpc-3653	271	2	m	m	PROPN
dpc-3653	271	3	,	,	PUNCT
dpc-3653	271	4	johnson	johnson	PROPN
dpc-3653	271	5	sm	sm	PROPN
dpc-3653	271	6	,	,	PUNCT
dpc-3653	271	7	horn	horn	VERB
dpc-3653	271	8	td	td	NOUN
dpc-3653	271	9	.	.	PUNCT
dpc-3653	271	10	intralesional	intralesional	ADJ
dpc-3653	271	11	immunotherapy	immunotherapy	NOUN
dpc-3653	271	12	for	for	ADP
dpc-3653	271	13	genital	genital	ADJ
dpc-3653	271	14	warts	wart	NOUN
dpc-3653	271	15	.	.	PUNCT
dpc-3653	272	1	arch	arch	ADJ
dpc-3653	272	2	dermatol	dermatol	NOUN
dpc-3653	272	3	.	.	PUNCT
dpc-3653	273	1	2005;141(12):1606	2005;141(12):1606	NUM
dpc-3653	273	2	-	-	PUNCT
dpc-3653	273	3	1607	1607	NUM
dpc-3653	273	4	.	.	PUNCT
dpc-3653	274	1	doi	doi	NOUN
dpc-3653	274	2	:	:	PUNCT
dpc-3653	274	3	10.1001	10.1001	NUM
dpc-3653	274	4	/	/	SYM
dpc-3653	274	5	archderm.141.12.1606	archderm.141.12.1606	NOUN
dpc-3653	274	6	.	.	PUNCT
dpc-3653	275	1	pmid	pmid	NOUN
dpc-3653	275	2	:	:	PUNCT
dpc-3653	275	3	16365274	16365274	NUM
dpc-3653	275	4	.	.	PUNCT
dpc-3653	276	1	21	21	NUM
dpc-3653	276	2	.	.	PUNCT
dpc-3653	277	1	majid	majid	PROPN
dpc-3653	277	2	i	i	PRON
dpc-3653	277	3	,	,	PUNCT
dpc-3653	277	4	imran	imran	PROPN
dpc-3653	277	5	s.	s.	PROPN
dpc-3653	277	6	immunotherapy	immunotherapy	PROPN
dpc-3653	277	7	with	with	ADP
dpc-3653	277	8	intralesional	intralesional	ADJ
dpc-3653	277	9	candida	candida	NOUN
dpc-3653	277	10	albicans	albican	NOUN
dpc-3653	277	11	antigen	antigen	ADV
dpc-3653	277	12	in	in	ADP
dpc-3653	277	13	resistant	resistant	ADJ
dpc-3653	277	14	or	or	CCONJ
dpc-3653	277	15	recurrent	recurrent	ADJ
dpc-3653	277	16	warts	wart	NOUN
dpc-3653	277	17	:	:	PUNCT
dpc-3653	277	18	a	a	DET
dpc-3653	277	19	study	study	NOUN
dpc-3653	277	20	.	.	PUNCT
dpc-3653	278	1	indian	indian	PROPN
dpc-3653	278	2	j	j	PROPN
dpc-3653	278	3	dermatol	dermatol	NOUN
dpc-3653	278	4	.	.	PUNCT
dpc-3653	279	1	2013;58(5):360	2013;58(5):360	NUM
dpc-3653	279	2	-	-	SYM
dpc-3653	279	3	365	365	NUM
dpc-3653	279	4	.	.	PUNCT
dpc-3653	280	1	doi	doi	NOUN
dpc-3653	280	2	:	:	PUNCT
dpc-3653	280	3	10.4103/00195154.117301	10.4103/00195154.117301	NUM
dpc-3653	280	4	.	.	PUNCT
dpc-3653	281	1	pmid	pmid	NOUN
dpc-3653	281	2	:	:	PUNCT
dpc-3653	281	3	24082180	24082180	NUM
dpc-3653	281	4	.	.	PUNCT
dpc-3653	282	1	pmcid	pmcid	NOUN
dpc-3653	282	2	:	:	PUNCT
dpc-3653	282	3	pmc3778775	pmc3778775	NOUN
dpc-3653	282	4	.	.	PUNCT
dpc-3653	283	1	22	22	NUM
dpc-3653	283	2	.	.	PUNCT
dpc-3653	284	1	alikhan	alikhan	PROPN
dpc-3653	284	2	a	a	PRON
dpc-3653	284	3	,	,	PUNCT
dpc-3653	284	4	griffin	griffin	PROPN
dpc-3653	284	5	jr	jr	PROPN
dpc-3653	284	6	,	,	PUNCT
dpc-3653	284	7	newman	newman	PROPN
dpc-3653	284	8	cc	cc	PROPN
dpc-3653	284	9	.	.	PROPN
dpc-3653	284	10	use	use	NOUN
dpc-3653	284	11	of	of	ADP
dpc-3653	284	12	candida	candida	PROPN
dpc-3653	284	13	antigen	antigen	NOUN
dpc-3653	284	14	injections	injection	NOUN
dpc-3653	284	15	for	for	ADP
dpc-3653	284	16	the	the	DET
dpc-3653	284	17	treatment	treatment	NOUN
dpc-3653	284	18	of	of	ADP
dpc-3653	284	19	verruca	verruca	NOUN
dpc-3653	284	20	vulgaris	vulgaris	NOUN
dpc-3653	284	21	:	:	PUNCT
dpc-3653	284	22	a	a	DET
dpc-3653	284	23	two	two	NUM
dpc-3653	284	24	-	-	PUNCT
dpc-3653	284	25	year	year	NOUN
dpc-3653	284	26	mayo	mayo	NOUN
dpc-3653	284	27	clinic	clinic	NOUN
dpc-3653	284	28	experience	experience	NOUN
dpc-3653	284	29	.	.	PUNCT
dpc-3653	285	1	j	j	PROPN
dpc-3653	285	2	dermatolog	dermatolog	PROPN
dpc-3653	285	3	treat	treat	NOUN
dpc-3653	285	4	.	.	PUNCT
dpc-3653	286	1	2016;27(4):355	2016;27(4):355	NUM
dpc-3653	286	2	-	-	SYM
dpc-3653	286	3	358	358	NUM
dpc-3653	286	4	.	.	PUNCT
dpc-3653	287	1	doi	doi	NOUN
dpc-3653	287	2	:	:	PUNCT
dpc-3653	287	3	10.3109/09546634.2015.1106436	10.3109/09546634.2015.1106436	NUM
dpc-3653	287	4	.	.	PUNCT
dpc-3653	288	1	pmid	pmid	NOUN
dpc-3653	288	2	:	:	PUNCT
dpc-3653	288	3	26558635	26558635	NUM
dpc-3653	288	4	.	.	PUNCT
dpc-3653	289	1	23	23	NUM
dpc-3653	289	2	.	.	PUNCT
dpc-3653	290	1	nofal	nofal	PROPN
dpc-3653	290	2	a	a	PROPN
dpc-3653	290	3	,	,	PUNCT
dpc-3653	290	4	salah	salah	PROPN
dpc-3653	290	5	e	e	NOUN
dpc-3653	290	6	,	,	PUNCT
dpc-3653	290	7	nofal	nofal	X
dpc-3653	290	8	e	e	NOUN
dpc-3653	290	9	,	,	PUNCT
dpc-3653	290	10	yosef	yosef	PROPN
dpc-3653	290	11	a.	a.	NOUN
dpc-3653	290	12	intralesional	intralesional	PROPN
dpc-3653	290	13	antigen	antigen	ADJ
dpc-3653	290	14	immunotherapy	immunotherapy	NOUN
dpc-3653	290	15	for	for	ADP
dpc-3653	290	16	the	the	DET
dpc-3653	290	17	treatment	treatment	NOUN
dpc-3653	290	18	of	of	ADP
dpc-3653	290	19	warts	wart	NOUN
dpc-3653	290	20	:	:	PUNCT
dpc-3653	290	21	current	current	ADJ
dpc-3653	290	22	concepts	concept	NOUN
dpc-3653	290	23	and	and	CCONJ
dpc-3653	290	24	future	future	ADJ
dpc-3653	290	25	prospects	prospect	NOUN
dpc-3653	290	26	.	.	PUNCT
dpc-3653	290	27	am	be	AUX
dpc-3653	290	28	j	j	PROPN
dpc-3653	290	29	clin	clin	PROPN
dpc-3653	290	30	dermatol	dermatol	NOUN
dpc-3653	290	31	.	.	PUNCT
dpc-3653	291	1	2013;14(4):253	2013;14(4):253	NUM
dpc-3653	291	2	-	-	PUNCT
dpc-3653	291	3	260	260	NUM
dpc-3653	291	4	.	.	PUNCT
dpc-3653	292	1	doi	doi	NOUN
dpc-3653	292	2	:	:	PUNCT
dpc-3653	292	3	10.1007	10.1007	NUM
dpc-3653	292	4	/	/	SYM
dpc-3653	292	5	s40257	s40257	NOUN
dpc-3653	292	6	-	-	PUNCT
dpc-3653	292	7	013	013	NUM
dpc-3653	292	8	-	-	PUNCT
dpc-3653	292	9	0018	0018	NUM
dpc-3653	292	10	-	-	SYM
dpc-3653	292	11	8	8	NUM
dpc-3653	292	12	.	.	PUNCT
dpc-3653	293	1	pmid	pmid	NOUN
dpc-3653	293	2	:	:	PUNCT
dpc-3653	293	3	23813361	23813361	NUM
dpc-3653	293	4	.	.	PUNCT
dpc-3653	294	1	24	24	NUM
dpc-3653	294	2	.	.	PUNCT
dpc-3653	295	1	johnson	johnson	PROPN
dpc-3653	295	2	sm	sm	PROPN
dpc-3653	295	3	,	,	PUNCT
dpc-3653	295	4	roberson	roberson	PROPN
dpc-3653	295	5	pk	pk	PROPN
dpc-3653	295	6	,	,	PUNCT
dpc-3653	295	7	horn	horn	NOUN
dpc-3653	295	8	td	td	NOUN
dpc-3653	295	9	.	.	PUNCT
dpc-3653	296	1	intralesional	intralesional	ADJ
dpc-3653	296	2	injection	injection	NOUN
dpc-3653	296	3	of	of	ADP
dpc-3653	296	4	mumps	mump	NOUN
dpc-3653	296	5	or	or	CCONJ
dpc-3653	296	6	candida	candida	PROPN
dpc-3653	296	7	skin	skin	NOUN
dpc-3653	296	8	test	test	NOUN
dpc-3653	296	9	antigens	antigen	NOUN
dpc-3653	296	10	:	:	PUNCT
dpc-3653	296	11	a	a	DET
dpc-3653	296	12	novel	novel	ADJ
dpc-3653	296	13	immunotherapy	immunotherapy	NOUN
dpc-3653	296	14	for	for	ADP
dpc-3653	296	15	warts	wart	NOUN
dpc-3653	296	16	.	.	PUNCT
dpc-3653	297	1	arch	arch	ADJ
dpc-3653	297	2	dermatol	dermatol	NOUN
dpc-3653	297	3	.	.	PUNCT
dpc-3653	298	1	2001;137(4):451	2001;137(4):451	NUM
dpc-3653	298	2	-	-	SYM
dpc-3653	298	3	455	455	NUM
dpc-3653	298	4	.	.	PUNCT
dpc-3653	299	1	pmid	pmid	NOUN
dpc-3653	299	2	:	:	PUNCT
dpc-3653	299	3	11295925	11295925	NUM
dpc-3653	299	4	.	.	PUNCT
dpc-3653	300	1	25	25	NUM
dpc-3653	300	2	.	.	PUNCT
dpc-3653	300	3	nofal	nofal	PROPN
dpc-3653	300	4	a	a	PRON
dpc-3653	300	5	,	,	PUNCT
dpc-3653	300	6	khattab	khattab	NOUN
dpc-3653	300	7	f	f	PROPN
dpc-3653	300	8	,	,	PUNCT
dpc-3653	300	9	nofal	nofal	X
dpc-3653	300	10	e	e	NOUN
dpc-3653	300	11	,	,	PUNCT
dpc-3653	300	12	elgohary	elgohary	ADV
dpc-3653	300	13	a.	a.	NOUN
dpc-3653	300	14	combined	combine	VERB
dpc-3653	300	15	acitretin	acitretin	NOUN
dpc-3653	300	16	and	and	CCONJ
dpc-3653	300	17	candida	candida	PROPN
dpc-3653	300	18	antigen	antigen	NOUN
dpc-3653	300	19	versus	versus	ADP
dpc-3653	300	20	either	either	CCONJ
dpc-3653	300	21	agent	agent	NOUN
dpc-3653	300	22	alone	alone	ADV
dpc-3653	300	23	in	in	ADP
dpc-3653	300	24	the	the	DET
dpc-3653	300	25	treatment	treatment	NOUN
dpc-3653	300	26	of	of	ADP
dpc-3653	300	27	recalcitrant	recalcitrant	ADJ
dpc-3653	300	28	warts	wart	NOUN
dpc-3653	300	29	.	.	PUNCT
dpc-3653	301	1	j	j	PROPN
dpc-3653	301	2	am	be	AUX
dpc-3653	301	3	acad	acad	ADJ
dpc-3653	301	4	dermatol	dermatol	NOUN
dpc-3653	301	5	.	.	PUNCT
dpc-3653	302	1	2018;79(2):377	2018;79(2):377	NUM
dpc-3653	302	2	-	-	PUNCT
dpc-3653	302	3	378	378	NUM
dpc-3653	302	4	.	.	PUNCT
dpc-3653	303	1	doi	doi	NOUN
dpc-3653	303	2	:	:	PUNCT
dpc-3653	303	3	10.1016	10.1016	NUM
dpc-3653	303	4	/	/	SYM
dpc-3653	303	5	j.jaad.2018.01.011	j.jaad.2018.01.011	PROPN
dpc-3653	303	6	.	.	PUNCT
dpc-3653	304	1	pmid	pmid	NOUN
dpc-3653	304	2	:	:	PUNCT
dpc-3653	304	3	29339242	29339242	NUM
dpc-3653	304	4	.	.	PUNCT
dpc-3653	305	1	26	26	NUM
dpc-3653	305	2	.	.	PUNCT
dpc-3653	305	3	cyrus	cyrus	PROPN
dpc-3653	305	4	n	n	CCONJ
dpc-3653	305	5	,	,	PUNCT
dpc-3653	305	6	blechman	blechman	PROPN
dpc-3653	305	7	ab	ab	PROPN
dpc-3653	305	8	,	,	PUNCT
dpc-3653	305	9	leboeuf	leboeuf	PROPN
dpc-3653	305	10	m	m	PROPN
dpc-3653	305	11	,	,	PUNCT
dpc-3653	305	12	et	et	PROPN
dpc-3653	305	13	al	al	PROPN
dpc-3653	305	14	.	.	PROPN
dpc-3653	305	15	effect	effect	NOUN
dpc-3653	305	16	of	of	ADP
dpc-3653	305	17	quadrivalent	quadrivalent	NOUN
dpc-3653	305	18	human	human	ADJ
dpc-3653	305	19	papillomavirus	papillomavirus	NOUN
dpc-3653	305	20	vaccination	vaccination	NOUN
dpc-3653	305	21	on	on	ADP
dpc-3653	305	22	oral	oral	ADJ
dpc-3653	305	23	squamous	squamous	ADJ
dpc-3653	305	24	cell	cell	NOUN
dpc-3653	305	25	papillomas	papilloma	NOUN
dpc-3653	305	26	.	.	PUNCT
dpc-3653	306	1	jama	jama	PROPN
dpc-3653	306	2	dermatol	dermatol	NOUN
dpc-3653	306	3	.	.	PUNCT
dpc-3653	307	1	2015;151(12):1359	2015;151(12):1359	NUM
dpc-3653	307	2	-	-	SYM
dpc-3653	307	3	1363	1363	NUM
dpc-3653	307	4	.	.	PUNCT
dpc-3653	308	1	doi	doi	NOUN
dpc-3653	308	2	:	:	PUNCT
dpc-3653	308	3	10.1001	10.1001	NUM
dpc-3653	308	4	/	/	SYM
dpc-3653	308	5	jamadermatol.2015.2805	jamadermatol.2015.2805	PROPN
dpc-3653	308	6	.	.	PUNCT
dpc-3653	309	1	pmid	pmid	NOUN
dpc-3653	309	2	:	:	PUNCT
dpc-3653	309	3	26332141	26332141	NUM
dpc-3653	309	4	.	.	PUNCT
dpc-3653	310	1	27	27	NUM
dpc-3653	310	2	.	.	PUNCT
dpc-3653	311	1	gattoc	gattoc	PROPN
dpc-3653	311	2	l	l	NOUN
dpc-3653	311	3	,	,	PUNCT
dpc-3653	311	4	nair	nair	PROPN
dpc-3653	311	5	n	n	CCONJ
dpc-3653	311	6	,	,	PUNCT
dpc-3653	311	7	ault	ault	PROPN
dpc-3653	311	8	k.	k.	PROPN
dpc-3653	311	9	human	human	PROPN
dpc-3653	311	10	papillomavirus	papillomavirus	PROPN
dpc-3653	311	11	vaccination	vaccination	NOUN
dpc-3653	311	12	:	:	PUNCT
dpc-3653	311	13	current	current	ADJ
dpc-3653	311	14	indications	indication	NOUN
dpc-3653	311	15	and	and	CCONJ
dpc-3653	311	16	future	future	ADJ
dpc-3653	311	17	directions	direction	NOUN
dpc-3653	311	18	.	.	PUNCT
dpc-3653	312	1	obstet	obstet	PROPN
dpc-3653	312	2	gynecol	gynecol	PROPN
dpc-3653	312	3	clin	clin	PROPN
dpc-3653	312	4	north	north	PROPN
dpc-3653	312	5	am	am	PROPN
dpc-3653	312	6	.	.	PUNCT
dpc-3653	313	1	2013;40(2):177	2013;40(2):177	NUM
dpc-3653	313	2	-	-	PUNCT
dpc-3653	313	3	197	197	NUM
dpc-3653	313	4	.	.	PUNCT
dpc-3653	314	1	doi	doi	NOUN
dpc-3653	314	2	:	:	PUNCT
dpc-3653	314	3	10.1016	10.1016	NUM
dpc-3653	314	4	/	/	SYM
dpc-3653	314	5	j.ogc.2013.03.007	j.ogc.2013.03.007	PROPN
dpc-3653	314	6	.	.	PUNCT
dpc-3653	315	1	pmid	pmid	NOUN
dpc-3653	315	2	:	:	PUNCT
dpc-3653	315	3	23732024	23732024	NUM
dpc-3653	315	4	.	.	PUNCT
dpc-3653	316	1	pmcid	pmcid	NOUN
dpc-3653	316	2	:	:	PUNCT
dpc-3653	316	3	pmc4416057	pmc4416057	ADJ
dpc-3653	316	4	.	.	PUNCT
dpc-3653	317	1	28	28	NUM
dpc-3653	317	2	.	.	X
dpc-3653	318	1	salman	salman	PROPN
dpc-3653	318	2	s	s	PROPN
dpc-3653	318	3	,	,	PUNCT
dpc-3653	318	4	s	s	VERB
dpc-3653	318	5	a	a	DET
dpc-3653	318	6	shehata	shehata	PROPN
dpc-3653	318	7	m	m	PROPN
dpc-3653	318	8	,	,	PUNCT
dpc-3653	318	9	ibrahim	ibrahim	PROPN
dpc-3653	318	10	am	be	AUX
dpc-3653	318	11	,	,	PUNCT
dpc-3653	318	12	et	et	PROPN
dpc-3653	318	13	al	al	PROPN
dpc-3653	318	14	.	.	PROPN
dpc-3653	318	15	efficacy	efficacy	NOUN
dpc-3653	318	16	of	of	ADP
dpc-3653	318	17	retinoids	retinoid	NOUN
dpc-3653	318	18	alone	alone	ADJ
dpc-3653	318	19	or	or	CCONJ
dpc-3653	318	20	in	in	ADP
dpc-3653	318	21	combination	combination	NOUN
dpc-3653	318	22	with	with	ADP
dpc-3653	318	23	other	other	ADJ
dpc-3653	318	24	remedies	remedy	NOUN
dpc-3653	318	25	in	in	ADP
dpc-3653	318	26	the	the	DET
dpc-3653	318	27	management	management	NOUN
dpc-3653	318	28	of	of	ADP
dpc-3653	318	29	warts	wart	NOUN
dpc-3653	318	30	:	:	PUNCT
dpc-3653	318	31	a	a	DET
dpc-3653	318	32	systematic	systematic	ADJ
dpc-3653	318	33	review	review	NOUN
dpc-3653	318	34	and	and	CCONJ
dpc-3653	318	35	network	network	NOUN
dpc-3653	318	36	meta	meta	ADJ
dpc-3653	318	37	-	-	PUNCT
dpc-3653	318	38	analysis	analysis	NOUN
dpc-3653	318	39	.	.	PUNCT
dpc-3653	319	1	dermatol	dermatol	NOUN
dpc-3653	319	2	ther	ther	ADV
dpc-3653	319	3	.	.	PUNCT
dpc-3653	320	1	2021;34(2):e14793	2021;34(2):e14793	NUM
dpc-3653	320	2	.	.	PUNCT
dpc-3653	320	3	doi	doi	NOUN
dpc-3653	320	4	:	:	PUNCT
dpc-3653	320	5	10.1111	10.1111	NUM
dpc-3653	320	6	/	/	SYM
dpc-3653	320	7	dth.14793	dth.14793	NUM
dpc-3653	320	8	.	.	PUNCT
dpc-3653	321	1	pmid	pmid	NOUN
dpc-3653	321	2	:	:	PUNCT
dpc-3653	321	3	33480148	33480148	NUM
dpc-3653	321	4	.	.	PUNCT
dpc-3653	322	1	29	29	NUM
dpc-3653	322	2	.	.	X
dpc-3653	323	1	ferguson	ferguson	PROPN
dpc-3653	323	2	sb	sb	PROPN
dpc-3653	323	3	,	,	PUNCT
dpc-3653	323	4	gallo	gallo	PROPN
dpc-3653	323	5	es	es	PROPN
dpc-3653	323	6	.	.	PROPN
dpc-3653	323	7	nonavalent	nonavalent	ADJ
dpc-3653	323	8	human	human	ADJ
dpc-3653	323	9	papillomavirus	papillomavirus	NOUN
dpc-3653	323	10	vaccination	vaccination	NOUN
dpc-3653	323	11	as	as	ADP
dpc-3653	323	12	a	a	DET
dpc-3653	323	13	treatment	treatment	NOUN
dpc-3653	323	14	for	for	ADP
dpc-3653	323	15	warts	wart	NOUN
dpc-3653	323	16	in	in	ADP
dpc-3653	323	17	an	an	DET
dpc-3653	323	18	immunosuppressed	immunosuppressed	ADJ
dpc-3653	323	19	adult	adult	NOUN
dpc-3653	323	20	.	.	PUNCT
dpc-3653	324	1	jaad	jaad	NOUN
dpc-3653	324	2	case	case	NOUN
dpc-3653	324	3	rep	rep	PROPN
dpc-3653	324	4	.	.	PROPN
dpc-3653	324	5	2017;3(4):367	2017;3(4):367	NUM
dpc-3653	324	6	-	-	SYM
dpc-3653	324	7	369	369	NUM
dpc-3653	324	8	.	.	PUNCT
dpc-3653	325	1	doi	doi	NOUN
dpc-3653	325	2	:	:	PUNCT
dpc-3653	325	3	10.1016	10.1016	NUM
dpc-3653	325	4	/	/	SYM
dpc-3653	325	5	j	j	PROPN
dpc-3653	325	6	.jdcr.2017.05.007	.jdcr.2017.05.007	X
dpc-3653	325	7	.	.	PUNCT
dpc-3653	326	1	pmid	pmid	NOUN
dpc-3653	326	2	:	:	PUNCT
dpc-3653	326	3	28795126	28795126	NUM
dpc-3653	326	4	.	.	PUNCT
dpc-3653	327	1	pmcid	pmcid	NOUN
dpc-3653	327	2	:	:	PUNCT
dpc-3653	327	3	pmc5537385	pmc5537385	NOUN
dpc-3653	327	4	.	.	PUNCT
dpc-3653	328	1	30	30	NUM
dpc-3653	328	2	.	.	PUNCT
dpc-3653	328	3	fathy	fathy	PROPN
dpc-3653	328	4	g	g	PROPN
dpc-3653	328	5	,	,	PUNCT
dpc-3653	328	6	abo	abo	NOUN
dpc-3653	328	7	-	-	PUNCT
dpc-3653	328	8	elmagd	elmagd	NOUN
dpc-3653	328	9	wm	wm	PROPN
dpc-3653	328	10	,	,	PUNCT
dpc-3653	328	11	afify	afify	VERB
dpc-3653	328	12	aa	aa	NOUN
dpc-3653	328	13	.	.	PUNCT
dpc-3653	329	1	intralesional	intralesional	ADJ
dpc-3653	329	2	combined	combine	VERB
dpc-3653	329	3	digoxin	digoxin	NOUN
dpc-3653	329	4	and	and	CCONJ
dpc-3653	329	5	furosemide	furosemide	ADJ
dpc-3653	329	6	in	in	ADP
dpc-3653	329	7	plantar	plantar	NOUN
dpc-3653	329	8	warts	wart	NOUN
dpc-3653	329	9	:	:	PUNCT
dpc-3653	329	10	does	do	AUX
dpc-3653	329	11	it	it	PRON
dpc-3653	329	12	work	work	VERB
dpc-3653	329	13	?	?	PUNCT
dpc-3653	330	1	j	j	PROPN
dpc-3653	330	2	cosmet	cosmet	PROPN
dpc-3653	330	3	dermatol	dermatol	NOUN
dpc-3653	330	4	.	.	PUNCT
dpc-3653	331	1	2021;20(8):2606	2021;20(8):2606	NUM
dpc-3653	331	2	-	-	PUNCT
dpc-3653	331	3	2611	2611	NUM
dpc-3653	331	4	.	.	PUNCT
dpc-3653	332	1	doi	doi	NOUN
dpc-3653	332	2	:	:	PUNCT
dpc-3653	332	3	10.1111	10.1111	NUM
dpc-3653	332	4	/	/	SYM
dpc-3653	332	5	jocd.13913	jocd.13913	PROPN
dpc-3653	332	6	.	.	PUNCT
dpc-3653	333	1	pmid	pmid	NOUN
dpc-3653	333	2	:	:	PUNCT
dpc-3653	333	3	33389796	33389796	NUM
dpc-3653	333	4	.	.	PUNCT
dpc-3653	334	1	31	31	NUM
dpc-3653	334	2	.	.	PUNCT
dpc-3653	335	1	mohammed	mohammed	PROPN
dpc-3653	335	2	gf	gf	PROPN
dpc-3653	335	3	,	,	PUNCT
dpc-3653	335	4	afify	afify	VERB
dpc-3653	335	5	aa	aa	NOUN
dpc-3653	335	6	-	-	PUNCT
dpc-3653	335	7	e	e	PROPN
dpc-3653	335	8	,	,	PUNCT
dpc-3653	335	9	abdel	abdel	PROPN
dpc-3653	335	10	latif	latif	PROPN
dpc-3653	335	11	wmae	wmae	PROPN
dpc-3653	335	12	.	.	PUNCT
dpc-3653	336	1	ionic	ionic	ADJ
dpc-3653	336	2	anti	anti	ADJ
dpc-3653	336	3	viral	viral	ADJ
dpc-3653	336	4	intralesional	intralesional	ADJ
dpc-3653	336	5	therapy	therapy	NOUN
dpc-3653	336	6	in	in	ADP
dpc-3653	336	7	plantar	plantar	NOUN
dpc-3653	336	8	warts	wart	NOUN
dpc-3653	336	9	.	.	PUNCT
dpc-3653	337	1	qjm	qjm	VERB
dpc-3653	337	2	:	:	PUNCT
dpc-3653	337	3	an	an	DET
dpc-3653	337	4	international	international	ADJ
dpc-3653	337	5	journal	journal	NOUN
dpc-3653	337	6	of	of	ADP
dpc-3653	337	7	medicine	medicine	NOUN
dpc-3653	337	8	.	.	PUNCT
dpc-3653	338	1	2021;114(supplement_1):hcab093	2021;114(supplement_1):hcab093	NUM
dpc-3653	338	2	.	.	PUNCT